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  Summary 
 
The main goal of this project was to elucidate the underlying genetic factors responsible for the 
different fermentation phenotypes and physiological adaptations of industrial wine yeast strains. To 
address this problem an ‘omic’ approach was pursued: Five industrial wine yeast strains, namely 
VIN13, EC1118, BM45, 285 and DV10, were subjected to transcriptional, proteomic and exo-
metabolomic profiling during alcoholic fermentation in simulated wine-making conditions. The aim 
was to evaluate and integrate the various layers of data in order to obtain a clearer picture of the 
genetic regulation and metabolism of wine yeast strains under anaerobic fermentative conditions. 
The five strains were also characterized in terms of their adhesion/flocculation phenotypes, 
tolerance to various stresses and survival under conditions of nutrient starvation. 
 
Transcriptional profiles for the entire yeast genome were obtained for three crucial stages during 
fermentation, namely the exponential growth phase (day 2), early stationary phase (day 5) and late 
stationary phase (day 14). Analysis of changes in gene expression profiles during the course of 
fermentation provided valuable insights into the genetic changes that occur as the yeast adapt to 
changing conditions during fermentation. Comparison of differentially expressed transcripts 
between strains also enabled the identification of genetic factors responsible for differences in the 
metabolism of these strains, and paved the way for genetic engineering of strains with directed 
modifications in key areas. In particular, the integration of exo-metabolite profiles and gene 
expression data for the strains enabled the construction of statistical models with a strong predictive 
capability which was validated experimentally.  
 
Proteomic analysis enabled correlations to be made between relative transcript abundance and 
protein levels for approximately 450 gene and protein pairs per analysis. The alignment of 
transcriptome and proteome data was very accurate for interstrain comparisons. For intrastrain 
comparisons, there was almost no correlation between trends in protein and transcript levels, except 
in certain functional categories such as metabolism.  The data also provide interesting insights into 
molecular evolutionary mechanisms that underlie the phenotypic diversity of wine yeast strains. 
 
Overall, the systems biology approach to the study of yeast metabolism during alcoholic 
fermentation opened up new avenues for hypothesis-driven research and targeted engineering 
strategies for the genetic enhancement/ modification of wine yeast for commercial applications. 
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Opsomming 
 
Die hoofdoelwit van hierdie projek was om die onderliggende genetiese faktore wat 
verantwoordelik is vir die verskillende fermentasie fenotiepes en fisiologiese aanpassings van 
industriële wyngiste, te ontrafel. Om hierdie probleem aan te spreek is ‘n ‘omiese’ aanslag 
nagevolg: Vyf industriële wyngiste, naamlik VIN13, EC1118, BM45, 285 en DV10, was onderwerp 
aan transkripsionele, proteïomiese en ekso-metaboliet profileering gedurende alkoholiese 
fermentasie in gesimuleerde wynmaak toestande. Die doel was om die data te evalueer en te 
integreer om ’n duideliker prentjie van die genetiese regulering en metabolisme van wyngis onder 
anaerobiese fermentasie toestande te verkry. Die vyf rasse was ook gekarakteriseer in terme van hul 
aanklewing/flokkulasie fenotipes, verdraagsaamheid van verskeie stres kondisies en oorlewing 
onder toestande van akute gebrek aan voedingstowwe. 
 
Transkripsionele profiele van die hele gisgenoom was verkry vir drie belangrike stadiums 
gedurende fermentasie, naamlik die eksponensiële groeifase (dag 2), vroeë stasionêre fase (dag 5) 
en laat stasionêre fase (dag 14). Analises van veranderinge in geen-uitdrukkingsprofiele gedurende 
die verloop van fermentasie het waardevolle insigte verskaf in terme van die genetiese veranderinge 
wat plaasvind soos die gis aanpas tot veranderende toestande gedurende fermentasie. Vergelykings 
van differensieel uitgedrukte transkripte tussen rasse het ook die identifisering van genetiese faktore 
wat verantwoordelik is vir verskille in die metabolisme van hierdie rasse in staat gestel, en het dit 
moontlik gemaak om rasse met gefokusde modifikasies in sleutelareas geneties te manipuleer. In 
besonder het die integrasie van ekso-metaboliet profiele en geen-uitdrukkingsdata van hierdie rasse 
die konstruksie van statistiese modelle met ’n sterk voorspellende kapasiteit in staat gestel wat 
eksperimenteel bevestig is. 
 
Proteomiese analise het dit moontlik gemaak om korrelasies tussen relatiewe geen kopie getalle en 
proteïen vlakke vir ongeveer 450 geen- en proteïen pare te verkry. Die ooreenkoms tussen 
transkriptoom en proteoom data was akkuraat vir vergelykings tussen gisrasse. Vir vergelykings 
tussen verskillende tydspunte was daar omtrent geen ooreenkoms tussen neigings in proteïen- en 
geenvlakke nie, behalwe in sekere funksionele kategorië soos metabolisme. 
 
In die geheel het hierdie sisteem biologiese benadering tot die studie van gismetabolisme gedurende 
alkoholiese fermentasie nuwe geleenthede geskep vir hipotese-gedrewe navorsing en geteikende 
strategië vir die genetiese verbetering/ modifikasie van wyngiste vir kommersiële doeleindes. 
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Preface 
 
This dissertation is presented as a compilation of 8 chapters. In Chapter 1 the general aims and 
motivation for this study are introduced. Chapter 2 is a review of the literature that is applicable to 
the field of study. Chapters 3, 4, 5, 6 and 7 are the experimental chapters which delineate the exact 
aims and outcomes that together comprise the full body of experimental work endeavoured in this 
research. Chapter 8 concludes the work with a general discussion aimed at coherently integrating 
the work presented in the preceding chapters.  
 
Each chapter that has been or will be submitted for publication is written according to the style of 
the particular journal as listed below. 
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wine science and biotechnology, particularly with reference to 
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Published in the South African Journal of Viticulture and Enology. 
 
Linking gene regulation and the exo-metabolome: A comparative 
transcriptomics approach to identify genes that impact on the 
production of volatile aroma compounds in yeast. 
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Comparative transcriptomic responses of wine yeast strains in 
different fermentation media: towards understanding the interaction 
between environment and transcriptome during alcoholic 
fermentation. 
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Transcriptional regulation and diversification of commercial wine 
yeast strains. 
To be submitted for publication in Molecular Microbiology. 
 
Comparative transcriptomic and proteomic profiling of industrial 
wine yeast strains: Towards an integrative understanding of yeast 
performance during fermentation. 
To be submitted for publication in PLoS Biology. 
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General introduction 
 2
CHAPTER 1  
General Introduction 
 
The advent of molecular biology revolutionised the biological sciences and led to an exponential 
increase in scientific knowledge in all biological disciplines. However, after almost 40 years a ‘ceiling’ 
has been reached in terms of the potential for these approaches to answer key questions and address 
needs in applied fields of research. The problem is that the more classic molecular biology approaches 
can be described as ‘reductionist’ in terms of their methodology. In other words, scientific problems are 
approached by dissecting the system in question into its component parts and studying these 
individually. Though invaluable, the shortfall of these approaches is the fact that biological systems are 
infinitely complex and the functioning of the whole system cannot simply be predicted by analysis of 
its component parts. Interactions between different modules of the biological system in question and 
interplay between various layers of regulatory mechanisms means that a holistic, interdisciplinary 
approach is needed to understand the biology of complex living systems.  
 
Biological problems in the context of yeast engineering have traditionally been dealt with by classic 
approaches such as isolation of new strains, hybridisation, mutagenesis and selection under competitive 
conditions (Pretorius & Bauer, 2002). In this manner more than 200 commercial wine yeast strains 
(mainly of the species Saccharomyces cerevisiae) have been isolated to meet specific requirements of 
wine producers and, more importantly, wine consumers. These requirements are primarily related to 
phenotypical traits such as fermentation performance, general stress resistance, the profile of aromatic 
compounds produced and the ability to release beneficial enzymes or mannoproteins (Bauer & 
Pretorius, 2002), and different strains differ significantly from each other to offer wine makers a wide 
variety of options.  
 
In recent times however, following the sequencing and annotation of the yeast genome (Goffeau et al., 
1996) it has become relatively easy to target specific yeast genes for knockout or overexpression in 
commercial wine yeast strains. This technology has been at the forefront of yeast research over the past 
decade and has proven to be a feasible means for introducing specific changes in yeast behaviour, 
based on known or predicted functions of the targeted genes (Bauer & Pretorius, 2002; Coulon, 2006). 
However, many wine-relevant traits are polygenic, and part of complex regulatory systems that can not 
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be controlled and manipulated in a predictive manner by simplistic, directed genetic engineering 
strategies (Marullo et al., 2004).  
 
In this project we sought to answer key questions related to the metabolic regulation and physiological 
adaptations of yeast strains by following a systems biology approach. By ‘systems biology’ we refer to 
the analysis of fermenting yeast in a top-down approach in which entire classes of biological molecules 
(i.e. mRNA, proteins, metabolites) are detected and quantified. 
 
For this purpose, we made use of several omics technologies, beginning with the relatively well-
established technology of large-scale gene expression analysis using microarrays. This is one of the 
most powerful systems methodologies that can be applied to yeast. Transcript levels of all known or 
predicted genes can be measured simultaneously, under any selected condition and at several time 
points, to identify sets of genes whose expression levels are induced or repressed relative to different 
time points or any other experimental parameter (Ashby & Rine, 1996). Transcriptional profiling 
presents the opportunity to examine gene expression changes in fermenting wine yeast strains at key 
points during fermentation, as well as the potential for comparisons of transcriptional patterns between 
different strains at these time points. Analysis of transcriptomes is usually the first step in any systems 
biology study as it enables the generation of systematic information on cellular functioning on a genetic 
level (Grigoriev, 2001; Ge et al., 2001). Transcriptome analysis of wine yeast strains has already 
proven useful to analyse the broad genetic regulation of fermentative growth in wine environments. 
These studies have illuminated the intrinsic genetic and regulatory mechanisms involved in 
fermentation, and have greatly increased our understanding of this important process (Alexandre et al., 
2001; Erasmus et al., 2003; Rossignol et al., 2003; Varela et al., 2005; Mendes-Ferreira et al., 2007; 
Marks et al., 2008). In the context of our research plan, transcriptional analysis was employed to help 
identify differentially expressed genes or differentially regulated modules between different strains as 
well as time points during fermentation. 
 
Transcript levels are unfortunately not always directly correlated to protein levels and in vivo metabolic 
fluxes (Griffin et al., 2002; Daran-Lapujade et al., 2004) For this reason transcriptomic datasets also 
need to be combined with other data subsets, such as proteomic data, so that the overlapping set of 
interactions provides more reliable and biologically valid insights/ information on the system in 
question (Tong et al., 2002; Walhout et al., 2002). The most accurate and reproducible proteomics 
methodology to date involves high-throughput chromatography in combination with mass 
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spectrometry. This approach can be used for fast and accurate protein identification as long as the 
protein/s already exist/s uniquely in a sequence database (Mann et al., 2001). A total of 1504 yeast 
proteins have already been unambiguously identified in a single analysis using such a dimensional 
chromatography approach coupled with tandem mass spectrometry (MS/MS) (Peng et al., 2002). In 
wine yeast, the proteomics field has remained largely unexplored, with very few forays into proteomic 
analysis having been reported (Trabalzini et al., 2003; Husnik et al., 2006; Salvadó et al., 2008). 
 
Ultimately, the particular phenotype of a yeast cell is essentially a function of the metabolic activity of 
the cell. This includes parameters such as the metabolic flux through key pathways, the steady state 
levels of intermediates in these pathways as well as the levels of the ‘end point’ compounds produced 
by the metabolic activity of the cells. In the wine context, yeast metabolism is the primary causative 
agent responsible for the transformation of grape must into wine. As the yeast utilizes the sugar present 
in the grape must it produces and releases a variety of metabolites. The impact of yeast on fermentation 
is a thus a direct function of the metabolic activity of the yeast cells. Fermenting yeast cells produce a 
number  of important metabolites that are released into the wine must (exometabolome),  most notably 
of which are the higher alcohols and esters which endow the wine with characteristic flavour or aroma 
tones.  
 
Advances in high-throughput methodologies in analytical chemistry now  allow  the detection and 
relative quantification of  a  large  number  of the important metabolites simultaneously (Dunn  &  Ellis  
2005,  Smedsgaard  &  Nielsen 2005). By combining such high-throughput metabolomics 
methodologies with other ‘omics’ platforms it becomes possible to correlate yeast metabolism and 
fermentative performance with the underlying gene expression patterns responsible for the overall 
phenotype in this regard.  
 
In this project, analyses based on the comparison of transcriptome and limited proteome and 
metabolome datasets derived from different commercial yeast strains were employed to identify genes 
which have a significant impact on interesting parts of the yeast metabolic network (under industrial 
wine-making conditions). The strength of our methodology is the fact that five different wine yeast 
strains were analysed at different time points during fermentation, as opposed to the single strain 
analyses reported in previous studies. Having such multidimensional datasets available is essential to 
achieving our principal goal of modeling wine yeast metabolism and predicting the effect of 
perturbations to the metabolic network. By combining the different ‘omic’ datasets of several strains 
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within the framework of strain phenotypic data we were uniquely positioned to identify specific gene 
expression programs that can be associated with particular traits of interest. Such areas of interest 
include aroma compound production, flocculation responses and stress tolerance. A second important 
aim was to understand the underlying genetic and regulatory factors that are responsible for the 
phenotypic divergence of the different yeast strains used in industrial wine-making. The last important 
outcome of this research pertains to the degree to which the different ‘omic’ datasets align with and 
corroborate one another. Having different layers of ‘omic’ information available provided a unique 
platform for cross-comparissons to evaluate the alignment of transcript and protein levels.  
 
The ultimate goal of our comparative systems biology study was to increase our knowledge and 
understanding of the metabolism and physiology of fermenting yeast in a holistic manner, as well as to 
identify targets and design intelligent strategies for the directed enhancement of wine yeast strains.  
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CHAPTER 2 
Wine science in the omics era: The impact of systems biology on the 
future of wine research 
 
2.1 Abstract 
Industrial wine making confronts viticulturalists, wine makers, process engineers and scientists alike 
with a bewildering array of independent and semi-independent parameters that can in many cases only 
be optimized by trial and error. Furthermore, as most parameters are outside of individual control, 
predictability and consistency of the end product remain difficult to achieve. The traditional wine 
sciences of viticulture and oenology have been accumulating data sets and generating knowledge and 
know-how that has resulted in a significant optimization of the vine growing and wine making 
processes. However, much of these processes remain based on empirical and even anecdotal evidence, 
and only a small part of all the interactions and cause-effect relationships between individual input and 
output parameters is scientifically well understood. Indeed, the complexity of the process has prevented 
a deeper understanding of such interactions and causal relationships. New technologies and methods in 
the biological and chemical sciences, combined with improved tools of multivariate data analysis, open 
new opportunities to assess the entire vine growing and wine making process from a more holistic 
perspective.  This review outlines the current efforts to use the tools of systems biology in particular to 
better understand complex industrial processes such as wine making.   
 
2.2 Introduction 
Grapevine growing and wine making have been a part of human agricultural activity for thousands of 
years. Today, grapes are the most planted fruit crop in the world, and the global wine industry has 
become a multi-billion dollar business. Yet, the process of vine growing and wine making continues to 
present tremendous challenges. The traditional wine sciences of viticulture and oenology are 
challenged by the complexity of the process, and many studies, while reporting on the effects of 
individual parameters, all too frequently fail to establish causality. The input variables in the vineyard 
involve a large number of factors that influence the growth of the grapevine and the composition of the 
grape berries, and in particular include many environmental factors such as soil, aspect, slope, and 
climate. These factors interact with and impact on the genetic potential of individual grapevine 
cultivars or rather individual plants. From a wine making perspective, the relevant end result of these 
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processes is defined by the chemical composition of the grape, otherwise known as the grape 
metabolome (Cramer et al. 2007, Da Silva et al. 2005, Driesel et al. 2003). Traditional research on 
grapevine biology (physiological, genetic and molecular approaches) has helped to establish broad 
correlations between specific environmental factors and aspects of the final grape and must 
composition. On the whole though, our current understanding of grapevine biology is curtailed by an 
incomplete molecular map and limited knowledge regarding the genetic regulation of this complex 
woody perennial.  
 
On the oenological side many factors will contribute to transform and give expression to the grape 
metabolome, and will impact on the character and quality of the final product. Such factors include the 
treatment of the grapes and of the must before fermentation, the physical parameters prevalent during 
fermentation, and the impact thereof on dynamic microbial ecosystem that will continuously adapt and 
change while alcoholic fermentation proceeds. This wine fermentation ecosystem usually includes 
numerous strains of lactic and acetic acid bacteria, as well as a large spectrum of yeast species and 
other fungi. From an oenological perspective, the most relevant of these organisms is the scientifically 
well studied yeast Saccharomyces cerevisiae. This yeast appears best adapted to the harsh 
environmental conditions prevalent during wine fermentation, such as high osmotic pressure, low pH 
and in particular the increasing levels of ethanol (Attfield, 1997). As a consequence, commercial wine 
yeast strains indeed are almost exclusively of this species, and spontaneously fermenting musts also 
usually end up with one or more S. cerevisiae strains as the dominant yeast (Frezier & Dubourdieu, 
1992). For this reason most research on alcoholic fermentation has centered on this organism.  
 
However, our current knowledge of grapevine and microbial biology and of the chemical processes that 
result in a specific wine remains limited. This lack of knowledge and understanding significantly limits 
our ability to further improve wine quality and consistency. In particular, modern biotechnological 
approaches are knowledge-based, and we are only able to change or manipulate a biological system to 
the extent that we understand its functioning. While the amount of data describing biological systems 
has been increasing rapidly, this increase has been largely built on approaches that can be qualified as 
reductionist. Such approaches focus on individual components, such as a single gene or protein within 
a biological system, and have contributed tremendously to our understanding of biological systems, in 
particular by mapping genetic and metabolic pathways and fluxes. However, they are inherently 
incapable of elucidating the nature of the complex biological networks that characterize living 
organisms. Ultimately, complex systems can only be interpreted by complex, high-level analyses.  
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With the recent development of new technologies in the biological and chemical sciences, as well as 
improvements in statistical and interpretation tools, such high level analyses have become a feasible 
option, and a unique opportunity exists to approach the analysis of biological systems in a holistic 
manner. Hence the birth of systems biology as a novel approach to investigate biological processes on a 
whole cell or whole organism level. Conveniently, S. cerevisiae also happens to be the traditional 
model organism of choice for molecular and cellular biologists. For this reason, S. cerevisiae will be 
the main focus of the following sections in this paper and will serve to highlight the role of ‘omic’-
applications in wine science and research. 
 
2.3 Yeast biotechnology in the food and beverage industry 
Indigenous fermented foods such as bread, cheese and wine have been prepared and consumed for 
thousands of years, and it is estimated that fermented foods contribute to about one-third of the human 
diet worldwide. Biotechnology in the food and beverage sector targets the selection and improvement 
of yeast strains with the objectives of improving process control, yields and efficiency as well as the 
quality, safety and consistency of the end-product (Wang & Hatzimanikatis, 2006). 
Wine and beer represent the two most popular products of alcoholic fermentation processes. The 
commercial yeast strains that are used in these processes have been primarily selected for their 
fermentation efficiency. However, besides the conversion of sugars to alcohol and CO2, yeast 
metabolism results in the production of a diversity of metabolites, including vitamins, antimicrobial 
compounds, amino acids, organic acids (e.g. citric acid, lactic acid) and flavour compounds (e.g. esters 
and aldehydes). These metabolites make an important contribution to the character and quality of the 
final product, in particular with regard to aroma, flavour, and microbiological stability (Lambrechts & 
Pretorius, 2000). A considerable volume of current research both in academia and industry therefore 
targets the application of yeast biotechnology to improve fermentation efficiency and the production, 
quality and yields of metabolites (Cereghino & Cregg, 1999; Stephanopoulos et al., 2004). 
Traditional methods of genetic improvement such as classical mutagenesis and hybridization have been 
used in the improvement of yeast strains which are widely used industrially in baking, brewing and 
wine making (Pretorius & Bauer, 2002). Recombinant DNA approaches have also been used for 
genetic modification of yeast strains to promote the expression of desirable genes, to hinder the 
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expression of others, to alter specific genes or to inactivate genes so as to block specific pathways. In 
the field of wine science specifically, genetic modification of wine yeast for improved secretion of 
oenologically relevant enzymes (Louw et al., 2006; Malherbe  et al., 2003), production of aroma 
compounds (Lilly  et  al., 2006 a, b), glycerol  production  (Cambon  et  al.,  2006), malate degradation 
(Volschenk et al., 1997 a, b)  and decreased  ethanol  production  (Heux  et  al.,  2006) has proven to be 
a feasible endeavour. 
Several genetically modified yeasts appropriate for brewing, baking and wine making have been 
approved for use, although, as far as can be ascertained, none of these strains have been widely used 
commercially in the past. The possibilities for further engineering improved yeast strains are however 
clearly enormous.  
2.4 Systems biology background 
Metabolic engineering is the rational alteration of the genetic architecture of an organism to achieve a 
specific phenotype (Bailey, 1991). Classic ‘bottleneck engineering’ targeting the so-called rate-limiting 
steps in a pathway has only met with partial success. This is because cells are comprised of a complex 
network of regulatory mechanisms that counteract genetic modifications such as those derived from 
mutations by employing alternative pathways for continued robust performance (Farmer & Liao, 2000). 
Control of metabolic processes is in part hierarchical, with information transfer occurring from the 
genome to the transcriptional level, moving on to translation and finally enzyme activity. However, 
feed-back loops among the different levels are numerous. ‘Omics’ technologies today can analyze and 
monitor entire classes of biological macromolecules, such as DNA, RNA and proteins, as well as 
metabolites on a whole cell, whole tissue, whole organism or whole population level (Brown & 
Botstein, 1999; Bruggeman & Westerhoff, 2007). Such omics-based technologies have led to the 
establishment of fields of expertise referred to as transcriptomics, proteomics and metabolomics, 
depending on the specific layer of biological information that is being monitored. Ideally, in a systems 
analysis approach, all biochemical components that are involved in the process of interest should be 
monitored. While most of these analyses have thus far been focusing on quantification, other 
technologies aim to determine the interactions between components (interactomics) and the genetic or 
metabolic flux (fluxomics) within the system. 
 
Taken together, such data can allow the reconstruction of in silico biological networks (Goryanin et al., 
1999). The properties of the reconstructed network are in principle amenable to mathematical 
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modeling, allowing incorporation into computer models that can be interrogated systematically to 
predict biological functions and system responses to specific perturbations (Palsson, 2000; Price et al., 
2003).  
 
The large volumes of data generated by these approaches necessitates concomitant development in 
fields known as bioinformatics and multivariate data analysis (Palsson, 2002; Ge et al., 2003; Larsson 
et al., 2006; Lavine & Workman, 2006). Fortunately for the wine sciences, S. cerevisiae retains its title 
as one of the preferred model organism in the field of systems biology and bioinformatics as well. This 
has meant that many cutting edge ‘omics’ technologies and supporting statistical analysis modules are 
routinely available for research on wine yeast strains, as will be discussed in the following sections. 
 
Figure 1 A schematic representation of the various ‘omics’ disciplines in grapevine and yeast research. 
The grape metabolome constitutes the grape must and is the starting matrix for fermentation. 
The grape metabolome is acted upon by the metabolic activities of the yeast and other 
microbial cells and transformed into the final fermented product. Wine is thus essentially a 
combinatorial product of the original grape berry composition and the cumulative metabolic 
effects of various wine microorganisms, principally S. cerevisiae. 
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2.4.1 Genomics 
The general starting point of any system-wide analysis is usually at the genome level, as phenotypic 
features and changes therein are due to changes in the primary genome sequence of a particular 
organism. Whole genome sequencing is the process whereby the complete DNA sequence of an 
organism's genome is determined at a single time. This entails sequencing all of an organism's 
chromosomal DNA as well as DNA contained in the mitochondria. Whole genome sequencing has 
changed in the most profound way the manner in which scientists plan and perform research as gene 
sequences have provided enabling information and resources for a wide variety of scientific 
applications.  
 
The most well known sequencing technique, called shotgun sequencing, is carried out by breaking up 
DNA randomly into numerous small segments, which are sequenced using the chain termination 
method. Multiple overlapping sequences are obtained by performing several rounds of fragmentation 
and sequencing, followed by assembly of the fragments into a continuous sequence (Anderson, 1981). 
Shotgun sequencing was the most advanced technique for sequencing genomes from about 1995-2005, 
but newer technologies (such as nanopore and pyrosequencing technology) have emerged in recent 
years (Ronaghi et al., 1998). Although these methods generate high volumes of data in a relatively 
short space of time, the assembly process is much more computationally expensive, and coverage is 
improved at the expense of accuracy. 
 
S. cerevisiae was one of the first organisms to have its genome completely sequenced, more than 10 
years ago (Goffeau et al., 1996). This breakthrough in yeast research opened the door for yeast 
biologists to gain insight into yeast physiology on a molecular level. One of the main goals of genome 
sequencing is to identify all the genes in an organism: Computational methods for protein-coding gene 
identification are reasonably well developed, especially for compact genomes such as that of S. 
cerevisiae, which has a coding density of around 75% (Goffeau et al., 1996). The genome of the 
original S288c laboratory strain is thus well annotated, with clearly delineated coding regions and 
regulatory elements, and is easily accessible to interested researchers. 
 
In the case of wine yeast strains, however, increased complexity becomes an important factor: These 
yeasts exhibit great variation in chromosome size and number in comparison to laboratory strains, and 
are also aneuploid (Bakalinsky & Snow, 1990). Chromosomal changes include gain or loss of whole 
chromosomes and large-scale deletions and/or duplications (Adams et al., 1992; Rachidi et al., 1999). 
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Unfortunately very few DNA sequences of wine yeasts have been published or are publicly accessible 
in databases (Masneuf et al., 1998). Overall though, the sequence homology between the laboratory 
strain S288c and wine yeasts is approximated at around 99% (Masneuf et al., 1998), which means that 
sequence information from the S288c strain can be used for general systematic analysis of wine yeast 
strains (Puig et al., 1998, 2000). 
 
Recently a major milestone in wine yeast genomics was reached when the Australian Wine Research 
Institute completed the genome sequencing of the commercial yeast AWRI1631 (Borneman et al., 
2008). Interestingly, about 0.6% of this sequence information differed from that of the laboratory strain 
S288c, and extra DNA sequences (enough to carry at least 27 genes) were discovered in the wine yeast.  
 
Three decades have passed since the invention of electrophoretic methods for DNA sequencing, and 
advancements in the efficiency and cost-effectiveness of sequencing has made rapid sequencing of 
small genomes financially and practically feasible. Various novel sequencing technologies are being 
developed, as well as software tools for automated genome annotation, together aspiring to reduce costs 
and time frames for genome analysis. This means that many more wine yeast genomes will be 
sequenced and become publicly available in the near future. Comparative genomics will thus become a 
major tool for the insightful interpretation of genomic data within the wine-making context.  
 
 
2.4.2 Transcriptomics 
As mentioned, system-wide endeavours tend to start at the genomic level, since phenotypic changes are 
due to perturbations of gene sequence and transcriptional levels. In the decade following the 
sequencing of the S. cerevisiae genome a whole suite of analysis tools were developed based on gene 
sequence knowledge and functional annotation of 90% of the coding sequences in the yeast genome. 
The challenge of large-scale functional genomics followed as the next key step in the pursuit of 
complete understanding of yeast physiology and metabolism. Functional genomics, a relatively new 
area of research, aims to determine patterns of gene expression and interaction in the genome. It can 
provide an understanding of how yeast responds to environmental influences at the genetic level, and 
should therefore allow adaptation of conditions to improve technological processes. Functional 
genomics holds the potential to shed light on genetic differences allowing some strains to perform 
better than others with regard to certain desirable processes. It also holds great promise for defining and 
modifying elusive metabolic mechanisms used by yeast to adapt to different environmental conditions. 
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The technology of transcriptomics is a result of the convergence of several technologies, such as DNA 
sequencing and amplification, synthesis of oligonucleotides, fluorescence biochemistry, and 
computational statistics. It basically confers the ability to measure mRNA abundance (Lander, 1999), 
which reveals the effects of the global physiological and metabolic control machinery on transcription 
by identifying differentially expressed genes. It is thus possible to observe the expression of many, if 
not all genes simultaneously, including those with unknown biological functions, as they are switched 
on and off during normal growth, or while the yeast attempts to cope with ever-changing environmental 
conditions such as those encountered during fermentation. By identifying similarities in the 
transcriptional profile, the role of many previously uncharacterized genes was predicted, based on the 
assumption that coexpressed genes are functionally related. An early example of such studies was the 
identification of genes that were differentially expressed in S. cerevisiae in response to a metabolic 
shift from growth on glucose to diauxic growth on glucose and ethanol (DeRisi et al., 1997). 
 
Numerous yeast transcriptomics studies have also been conducted in chemostat cultures, which 
revealed, among others, that growth-limiting nutrients have a profound impact on genome-wide 
transcriptional responses of yeast to process perturbations and/or molecular genetic interventions (Boer 
et al., 2003). Transcriptomic profiling of yeast exposed to various stress conditions has likewise 
provided insights into the effects of those stresses on the cell at the transcriptional level (Gasch et al., 
2000, Gasch & Werner-Washburne, 2002; Kuhn et al., 2001). These examples of iterative perturbations 
and systematic phenotype characterization (on a gene expression level) have yielded a plethora of 
system insights that have revolutionized microbial biology. 
 
Several transcriptomic studies have also been published for research conducted with wine yeast strains 
(Erasmus et al., 2003; Mendes-Ferreira et al., 2007; Rossignol et al., 2003; Varela et al., 2005; Marks 
et al., 2008; Rossouw & Bauer, 2008). These studies have illuminated the intrinsic genetic and 
regulatory mechanisms involved in fermentation, and have greatly increased our understanding of this 
important process. 
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2.4.3 Proteomics 
Moving from the gene to the protein level brings us to proteomics, an approach aiming to identify and 
characterize complete sets of proteins, and protein-protein interactions in a given species (Hartwell et 
al., 1999; Ideker et al., 2001). An increased transcript level cannot be interpreted as evidence for a 
contribution of the encoded protein to the cellular response in the immediate experimental context. But 
even though gene expression might not relate directly to protein expression (Ideker et al., 2001), the 
protein products of genes that are coexpressed under different conditions are often functionally related 
with one another as part of the same pathway or complex (Grigoriev, 2001; Ge et al., 2001). 
Considering, however, that transcript levels are not directly correlated to protein levels and in vivo 
fluxes (Griffin et al., 2002; Washburn et al., 2003; Daran-Lapujade et al., 2004), large-scale 
transcriptomic data sets need to be combined with other data subsets such that the overlapping set of 
interactions provides more insightful and meaningful information on the system in question (Tong et 
al., 2002). Combining many layers of systematic cell and molecular biology such as protein levels and 
transcript expression data enables the construction of an accurate information matrix and a complete 
cellular map (Walhout et al., 2002). 
 
Genome-scale protein quantification is not yet feasible, but methods for determining relative levels of 
protein between samples have been developed (Smolka et al., 2002). Conventional quantitative 
proteome analysis utilizes two-dimensional (2D) gel electrophoresis (O’Farrell, 1975) to separate 
complex protein mixtures followed by in-gel tryptic digestion and mass spectrometry for the 
identification of protein. More than 1500 soluble proteins of yeast are detectable and well separated of 
two-dimensional gels. This technique offers the opportunity to detect alterations in protein synthesis, 
protein modifications, and protein degradation occurring in response to environmental or genetic 
changes. However, the two-dimensional gel approach suffers from the low number of proteins which 
are identified on the yeast protein map, as well as poor gel-to-gel reproducibility, the under-
representation of low-abundant and hydrophobic proteins and the poor dynamic range of detection (Fey 
& Larsen, 2001; Rabilloud, 2002). 
 
To overcome some of these limitations, high-throughput chromatography in combination with mass 
spectrometry can be used for fast and accurate protein identification, as long as the protein/s already 
exist/s uniquely in a sequence database (Mann et al., 2001). The most commonly used high-
performance liquid chromatographic (HPLC) approach for the separation of peptides from protein 
digests in complex proteomic applications is 2D nano-liquid chromatography-mass spectrometry 
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(LC/MS). In this approach, a strong cation exchange (SCX) column is used for the first dimension and 
a reversed phase (RP) column for the second (Nägele et al., 2004). A total of 1504 yeast proteins have 
been unambiguously identified in a single analysis using this 2D chromatography approach coupled 
with tandem mass spectrometry (MS/MS) (Peng et al., 2002). 
 
In fermenting yeast, the first forays into proteomics have been reported, usually in conjunction with 
transcriptomic or metabolomic analysis (Brejning et al., 2005; Salvadó et al., 2008). Such studies have 
increased our knowledge regarding the growth phases of fermenting yeasts, and have suggested new 
methodologies for optimization and control of growth during fermentation-based industrial 
applications. Proteome studies of yeast responses to various stress conditions have also increased our 
knowledge of the functional modules involved in yeast responses to specific environmental factors 
(Vido et al., 2001; Kolkman et al., 2006). 
 
Another important goal of functional proteomics is the identification of functional modules based on 
the knowledge of protein action. Protein-protein interactions play a crucial role in elucidating the 
nature of these mechanisms. Innovative methods for the cell-wide analysis of protein interactions and 
signaling pathways have been developed in recent times (Templin et al., 2004). These include the high-
throughput yeast two-hybrid systems (Ito et al., 2001; Uetz et al., 2000), protein arrays (Walter et al., 
2000; Weiner et al., 2004; Zhu & Snyder, 2003), and fluorescence-based interaction assays (Hu & 
Kerppola, 2003). In contrast to clustering genes, clustering protein interactions reveals modules which 
have similar functionalities and are therefore more closely associated in bringing about a particular 
response. For yeast specifically, the protein interactions from a wide range of experiments were 
transformed into a weighted network, with the weights representing the experimentally determined 
confidence levels for a particular interaction (Pereira-Leal et al., 2004). Such models of protein-protein 
interactions in yeast form an invaluable framework for future analysis and evaluation of ‘omic’ data-
types.  
 
2.4.4 Metabolomics 
Strain phenotype characterization has relied primarily on transcript abundance and protein 
measurements. Only rarely have small metabolites been included in the analysis of the system due to 
difficulties in sampling and analyzing these molecules. The major complication is the rapid time scales 
of change, or oscillations in the levels of metabolites in a pathway, even if this pathway is in a 
balanced, unperturbed state of equilibrium. Small molecules also cover a wider range of chemical 
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characteristics than do RNA transcripts, for example, and are more difficult to measure simultaneously 
(Dettmer et al., 2006).  
 
Despite all the above-mentioned complications, advances in high-throughput methodologies in 
analytical chemistry now  allow  the detection and relative quantification of  a  large  number  of 
metabolites simultaneously (Dunn  &  Ellis  2005,  Smedsgaard  &  Nielsen 2005). Gas 
chromatography coupled to mass spectrometry allows high-throughput analysis in a relatively short 
time and at a fairly low cost. The gas chromatograph separates metabolites while the mass spectrometer 
identifies and quantifies metabolites corresponding to a given standard peak. Specifically, the chemical 
analysis of wine has made tremendous progress over the last decade, and it is now possible to quantify 
a large number of chemical compounds (both volatile and non-volatile) with relative accuracy. In 
addition to the normal  gas chromatography or liquid chromatography –mass spectrometry (GCMS or 
LCMS), the development of two dimensional techniques has increased throughput and effectiveness by 
allowing for the  analysis  of  compounds  with  different  physiochemical properties in  one analysis 
(Adahchour et al., 2006; Campo et al., 2006). 
 
Metabolites are known to be involved as key regulators of systems homeostasis. As such, level changes 
of specific groups of metabolites may be descriptive of systems responses to environmental 
interventions. Their study is therefore a powerful approach for characterizing complex phenotypes, as 
well as for identifying biomarkers for specific physiological responses. Globally assaying metabolic 
states does present the opportunity to identify a more diverse set of active molecular relationships, 
particularly in the context of high-level regulation of transcriptional and translational processes by 
certain metabolites. Metabolic profiles can be used to define a ‘footprint’ of processes that occur in 
response to developmental, genetic or environmental effects, and are thus useful in defining the cellular 
phenotype (Allen et al., 2003). Metabolic data can also be incorporated into databases that integrate 
transcription, protein-protein interactions and metabolism to identify multilevel subnetworks which are 
activated in response to a given perturbation to the system.   
 
To complement these types of analysis, chemometrics approaches have evolved to enable these large 
data sets to be mined for information through multivariate analysis of multi-level datasets. The broader 
metabolic state characterization of fermenting yeast should allow better understanding of the interplay 
between different pathways and may enhance our ability to identify key cellular mechanisms (Çakir et 
al., 2006).  Metabolomics studies focused on yeast have been on the increase over the past few years 
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(Daran-Lapujade et al., 2004; Beltran et al., 2006; Kresnowati et al., 2006; Villas-Bôas et al., 2007), 
and have provided new insights into molecular events associated with the responses of yeast to 
environmental factors such as fermentation temperature and the availability of carbon substrates.  
 
2.4.5 Fluxomics 
Another noteworthy obstacle to the rational optimization of yeast for industrial purposes is the lack of a 
reliable, global metabolic model that captures the majority of the stoichiometric, kinetic and regulatory 
effects on metabolite interconversions and metabolic flux distribution through the cellular reaction 
network (Edwards & Palsson, 2000). In order to gain full understanding of the metabolism of any 
cell/tissue/organism, both levels of metabolites and their fluxes need to be studied. Flux determination 
is thus an essential component of strain evaluation for metabolic engineering (Stephanopoulos, 1999). 
Methods for flux measurement have been developed based on NMR and MS technologies which allow 
accurate, high resolution measurements of pathway flux to be made using radiolabeled substrates, for 
example Szyperski (1998). Metabolic fluxes can be used to characterize phenotypes and carbon flow in 
a system due to any given perturbation (Nielsen, 2003) and forms an integral part of applications in 
yeast systems biology and metabolic engineering.  
 
Metabolic flux modeling can be used to capture the genome-scale systems properties of an organism's 
metabolism and further facilitate the construction, validation, and predictive capabilities of models 
constructed from ‘omic’ information (Sauer, 2004). For instance, constraint-based network models 
have been developed using reaction stoicheometry to represent the biological network (Reed & 
Palsson, 2003). Such models are built by connecting the metabolites and the reactions they participate 
in to form a metabolic graph which is then applied to optimize the reaction rates (fluxes) given a 
specific target function (ie biomass or fermentation product formation). These models have also been 
invaluable in predicting the impact of gene deletions in several model organisms (Edwards et al., 2001; 
Famili et al., 2003; Forster et al., 2003). Conveniently, genome-scale models have also been 
constructed for yeast (Forster et al., 2003; Duarte et al., 2004), which means that  predictions of carbon 
flux distribution can be integrated with other ‘omics’ data types for interpretation purposes and to 
further guide metabolic engineering strategies. 
 
2.5.6 Interactomics 
Ultimately, systems biology is faced with the formidable task of interpreting and contextualizing the 
diverse sets of biological data from the various levels of ‘omic’ analysis with the aim to elucidate the 
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mechanisms behind complex biological phenomena. Comparisons of yeast transcriptomes and 
proteomes under different cultivation conditions have shown that multilevel analysis is essential for 
yeast systems biology (Kolkman et al., 2006) to avoid possibly missing the cause and effect 
relationships from other stages which impact the system as a whole.  
 
The significant advances in genome sequencing, transcription, and protein and metabolite profiling 
have not always translated into successful metabolic engineering applications in yeast and other 
microbial systems. This is mainly due to a breach in the incorporation of these large datasets into 
meaningful models which explain how these components work in unison to produce the desired trait in 
the cell (Vemuri & Aristidou, 2005). A comparative transcriptomic and exometabolomic analysis has 
been successful in predicting the impact of changes in expression levels of individual genes on the 
complex network of pathways that lead to the production of aroma compounds (Rossouw et al., 2008). 
The final component of a successful systems biology study is thus within the sphere of interactomics, 
which aims to integrate the transfer of information between the other phases of analysis with the use of 
mathematical modeling and simulation tools (de Jong, 2002).  
 
Cellular computational models are becoming crucial for the analysis of complex biological systems. 
Various statistical methods, including pattern discovery and characterization tools, are available to 
create links between large data sets and phenotypes. Given enough data, it becomes possible to extract 
probabilistic models that can theoretically capture cellular interactions without prior knowledge of an 
interaction network (Jeong et al., 2000; de Jong et al., 2003). By building these cellular models, a 
comprehensive scaffold of molecular interactions is made available for mining to reveal a hierarchy of 
signaling, regulatory and metabolic pathways. Pathway maps can be extracted from this scaffold using 
computational models which identify the key components, interactions and influences required for 
more detailed interrogation using data from transcriptome or proteome analyses (Ideker & 
Lauffenberger, 2003). 
 
To summarize, the yeast cell is an elaborate network of molecular and environmental interactions that 
together bring about a highly complex phenotype. Understanding the functional consequences of the 
biomolecular interactions that occur in the yeast is a pre-requisite to understanding the relationship 
between yeast and must, and how each is changed by the other during the course of fermentation. 
Although we are still limited in our understanding of regulatory phenomena from a global perspective, 
high-throughput ‘omic’ techniques have the potential to provide such information.  In particular, the 
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combination of comparative microarray datasets with existing models of yeast metabolism and 
interaction networks offers the potential for in silico evaluation of biologically relevant gene expression 
changes in the context of key areas of metabolism (Förster et al., 2003; Patil & Nielsen, 2005). This 
approach is one of several accessible multi-level analyses that can be applied to fermenting yeast, and 
holds great potential in terms of providing answers to scientific questions of fundamental importance. 
 
2.5 Systems biology meets biotechnology 
The emergence of systems biology constitutes a massive paradigm shift for biotechnologists. The 
switch from reductionist approaches in molecular biology to a new school of biological thought that is 
dominated by integrative ‘big-picture’ thinking opens new perspectives for the design and 
implementation of biotechnological approaches. The high throughput technologies of the post-genomic 
era have effectively created a massive amount of largely unexplored datasets, mostly publicly available 
in various databases. Systems biology may hold the key to assimilating all this information together 
into coherent models that facilitate drug discovery and metabolic engineering, the two hubs of modern 
biotechnology. There is undoubtedly a desperate need for novel alternatives to the hit-and-miss 
approaches of bioprocess and bioproduct development in the past. A few systems biology companies 
have already emerged in the last decade, mostly in the spheres of drug discovery and development, as 
well as signal transduction. Global biotech companies such as Novartis have also embraced systems 
biology divisions into the folds of their existing corporate structure (Mark, 2004). By using systems 
biology approaches, established pharmaceutical companies have managed to drastically reduce their 
‘screening to compound development’ periods in drug development for diabetes, obesity, arthritis, 
asthma, several cancers and many more money-spinning diseases. Outside of healthcare, the same 
opportunity for accelerated success exists for metabolic engineers as well. 
 
Europe is taking the lead in the commercialization of ‘omics’-based biotechnology in metabolic 
engineering. A well-known French company is collaborating with several large chemical companies to 
genetically engineer bacterial strains capable of synthesizing valuable chemicals more economically 
than conventional manufacturing processes. Other leaders in the field include a German company 
involved in optimization of amino acid fermentation processes, as well as production of other 
undisclosed high-value products via fermentation. Another Paris-based biotech subsidiary of a well 
known seed producer is also using systems biology technology to characterize and manipulate plant 
secondary metabolism (Mack, 2004). 
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Systems biology also has the potential to be a key role-player in the strain improvement arena of 
biotechnology (Stephanopoulos et al., 2004). Successful exploitation of cellular complexity for strain 
enhancement relies on a coordinated understanding of multiple cellular processes. Progress in this area 
is thus dependent on the development of theoretical frameworks that facilitate the elucidation of 
molecular mechanisms and the identification of genetic targets for modification. Strain improvement 
does present a very specific and attainable goal in the context of systems biology, particularly in 
combination with genetic tools such as the yeast overexpression and deletion libraries. Strains can be 
modified by introducing specific transport, conversion or regulatory changes that result in flux 
redistribution and improved production of desired compounds, or altered strain physiology. Clearly 
innovative application of relevant technologies holds the potential to expedite insightful modifications 
to yeast strains for application in the wine-making industry. 
 
2.6 Conclusion 
The idea of wine science as a convergence of multidisciplinary scientific exploits is a well known and 
established reality. Core sciences include biological, chemical, ecological, geological and sensory 
sciences, as well as certain aspects of process and chemical engineering. As understood by everyone in 
the field, the process of winemaking on a large-scale agricultural and industrial level involves 
numerous interlinked factors that are to a large extent poorly characterized and even more poorly 
controlled. While the more classic methods of scientific research will always remain an integral and 
indispensable part of the biological sciences, a ceiling is eventually reached by these approaches which 
can only be breached by holistic interdisciplinary techniques that integrate biological information into 
knowledge-based models of complex systems. Systems biology has emerged as the scientific challenge 
of present times, and looks set to hold this title for a few more years to come. In order to be able to 
benefit from current and future scientific developments, wine science has to embrace the ‘omic’ era and 
incorporate its toolbox of profiling technologies into standard research practices. A holistic approach 
towards understanding the complex metabolic and regulatory phenomena that characterize living 
systems will undoubtedly reveal many of the unknown interactions between genes, proteins, and 
metabolites, facilitating the truly rational improvement of production processes and the development of 
new biotechnological approaches to address current limitations of vine growing and wine making. 
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CHAPTER 3 
Linking gene regulation and the exo-metabolome: A comparative 
transcriptomics approach to identify genes that impact on the 
production of volatile aroma compounds in yeast  
 
3.1 Abstract 
3.1.1 Background 
 ‘Omics’ tools provide novel opportunities for system-wide analysis of complex cellular functions. 
Secondary metabolism is an example of a complex network of biochemical pathways, which, although 
well mapped from a biochemical point of view, is not well understood with regards to its physiological 
roles and genetic and biochemical regulation. Many of the metabolites produced by this network such 
as higher alcohols and esters are significant aroma impact compounds in fermentation products, and 
different yeast strains are known to produce highly divergent aroma profiles. Here, we investigated 
whether we can predict the impact of specific genes of known or unknown function on this metabolic 
network by combining whole transcriptome and partial exo-metabolome analysis.  
3.1.2 Results 
For this purpose, the gene expression levels of five different industrial wine yeast strains that produce 
divergent aroma profiles were established at three different time points of alcoholic fermentation in 
synthetic wine must. A matrix of gene expression data was generated and integrated with the 
concentrations of volatile aroma compounds measured at the same time points. This relatively unbiased 
approach to the study of volatile aroma compounds enabled us to identify candidate genes for aroma 
profile modification. Five of these genes, namely YMR210W, BAT1, AAD10, AAD14 and ACS1 were 
selected for overexpression in commercial wine yeast, VIN13. Analysis of the data show a statistically 
significant correlation between the changes in the exo-metabome of the overexpressing strains and the 
changes that were predicted based on the unbiased alignment of transcriptomic and exo-metabolomic 
data.  
3.1.3 Conclusion 
The data suggest that a comparative transcriptomics and metabolomics approach can be used to identify 
the metabolic impacts of the expression of individual genes in complex systems, and the amenability of 
transcriptomic data to direct applications of biotechnological relevance.  
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3.2 Background 
Commercial wine yeast strains have been selected to meet specific requirements of wine producers 
with regard to phenotypical traits such as fermentation performance, general stress resistance, the 
profile of aromatic compounds produced, the ability to release enzymes or mannoproteins of 
oenological relevance and many more [1]. As a result, more than 200 different yeast strains, almost 
exclusively of the species S. cerevisiae are currently produced and sold in the global industry. Many 
research and development programs have focused on improving specific aspects of wine yeast strains 
[1]. However, many of the relevant traits are of a polygenic nature, and our understanding of the 
genetic and molecular regulation of complex, commercially relevant phenotypes is limited [2]. In this 
paper, we investigate the possibility of using a holistic systems biology approach to identify genes that 
impact on volatile aroma compound production during fermentation. The approach is based on 
combining comparative transcriptomics and aroma metabolomics of five commercial wine yeast strains 
that produce significantly different aroma profiles.  
 
During alcoholic fermentation, S. cerevisiae strains convert sugars to ethanol, but also produce a large 
number of volatile aroma compounds, including fatty acids, higher alcohols and esters (table 1).  
 
Table 1 Exo-metabolites measured in this study 
Primary 
metabolites 
Organic acids Higher alcohols Esters Acids Fatty Acids 
Glucose Citrate  Methanol Ethyl Acetate Valeric Acid Octanoic Acid 
Fructose Malate Propanol Hexyl acetate Propionic Acid Decanoic Acid 
Glycerol Acetate Isoamyl alcohol Isoamyl Acetate Iso-Valeric Acid Ethyl Caprylate 
Ethanol  2-Phenyl Ethanol 2-Phenylethyl Acetate  Iso-Butyric Acid Ethyl Lactate  
  Isobutanol  Butyric Acid Ethyl Caprate 
    Butanol       
 
Many of these compounds are important flavor and aroma compounds in wine and beer, and different 
strains of S. cerevisiae are well known to impart significantly different aroma profiles to the final 
product. The metabolic pathways responsible for the production of these compounds are responsive to 
many factors including the availability of precursors, different types of stress, the cellular redox 
potential and the energy status of the cell [3-11]. These pathways are not linear, but rather form a 
network of interlinked reactions converging and diverging from shared intermediates (figure 1). 
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Moreover, intermediates are not only shared between the different ‘branches’ of aroma compound 
production, but also with other pathways related to fatty acid metabolism, glycolysis, stress tolerance 
and detoxification to name a few. 
 
 
Figure 1 Diagrammatic representation of pathways associated with aroma production and links to 
associated metabolic activities.  Dashed arrows are used when one or more intermediates or 
reactions are omitted. Red font is used to identify relevant aroma compounds. Full gene names 
and functions can be viewed in the appendix. The main pathway for the production of higher 
alcohols is known as the Erlich Pathway [3]: it involves three basic enzyme activities and 
starts with the deamination of leucine, valine and isoleucine to the corresponding -ketoacids. 
Each -ketoacid is subsequently decarboxylated and converted to its branched-chain aldehyde 
[4, 5, 6]. The final step is an alcohol dehydrogenase-catalyzed step which could potentially be 
catalyzed by the seven putative aryl alcohol dehydrogenase genes [7], and the seven alcohol 
dehydrogenase genes [8]. Finally ester formation involves the enzyme-catalyzed condensation 
reaction between a higher alcohol and an activated acyl-coenzyme A [9, 10, 11]. Fatty acids 
are derived from fatty acid biosynthesis, but can also be produced as intermediates of the 
higher alcohol and ester producing pathways [9].  
 
Most of the genes encoding the enzyme activities of the aroma network are also co-regulated by 
transcription factors that are related to total nitrogen and amino acid availability [12]. Thus the 
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nutritional status of the cell as well as the nutrient composition of the growth media throughout 
fermentation plays a vital role in determining the aroma profile produced by the fermenting yeast. A 
further complication is due to the fact that very little is known about the kinetics of individual enzymes 
involved in these pathways. What is clear is that a number of these enzymes are capable of catalyzing 
both the forward and reverse reactions, depending on the ratios of substrates to end products, as well as 
the prevailing redox balance of the cell [13-15]. The various dehydrogenase- catalyzed reactions which 
are integral to most branches of aroma production are particularly sensitive to the ratios of enzyme co-
factors such as NAD and NADH, with obvious ramifications regarding the directionality of various key 
reactions [16].  
 
This intricate lattice of chemical and biological interactions makes interpretation of individual gene and 
enzyme contributions problematic in the context of aroma compound production as a whole (figure 1). 
Indeed, individual parts of the system can combine and interact in unexpected ways, giving rise to 
emergent properties or functions that would not be anticipated by studying a single part of the system. 
Such systems are thus irreducible, and cannot be understood by dissection and analysis of a single part 
at a time. In recognition of the complex and intricate nature of this process we have sought to follow an 
‘omics’ approach in the study of aroma compound production.  
 
In the present study our goal was to compare the aroma-relevant exo-metabolomes of five industrial 
yeast strains at three different stages of fermentation, and to align these data with gene expression data 
obtained through microarray-based genome-wide transcription analysis. This enabled the incorporation 
of gene expression levels and aroma compound production into multivariate statistical models. By 
using these models as a predictive tool various genes were identified as potential candidates for 
overexpression in order to increase / decrease the levels of key aroma compounds during fermentation. 
To verify whether genes whose differential regulation appeared most strongly linked to the differences 
observed in the aroma profiles of different strains were indeed impacting on aroma compound 
metabolism, five of these genes were individually overexpressed in one of the industrial strains. The 
data indicate that these genes indeed impacted significantly on the aroma profiles produced by the 
modified strains. Moreover, the pattern of changes observed was significantly correlated to the pattern 
predicted through the comparative analysis of transcriptome and metabolome. The data therefore 
clearly support our hypothesis that direct comparative analysis of transcriptomes and metabolomes can 
be used for the identification of genes that affect specific metabolic networks and for predicting the 
impact of the expression of such genes on these networks.      
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3.3 Methods 
3.3.1 Strains. media and culture conditions 
The yeast strains used in this study are listed in table 2. All are diploid S. cerevisiae strains used in 
industrial wine fermentations. Yeast cells were cultivated at 30oC in YPD synthetic media 1% yeast 
extract (Biolab, South Africa), 2% peptone (Fluka, Germany), 2% glucose (Sigma, Germany). Solid 
medium was supplemented with 2% agar (Biolab, South Africa). 
 
Table 2 Yeast strains used in this study 
Strain Source/ Reference 
VIN13 Anchor Yeast, South Africa 
EC1118 Lallemand Inc., Montréal, Canada 
BM45 Lallemand Inc., Montréal, Canada 
285 Lallemand Inc., Montréal, Canada 
DV10 Lallemand Inc., Montréal, Canada 
VIN13(pBAT1-s) Lilly et al., 2006 
 
3.3.2 Fermentation medium 
Fermentation experiments were carried out with synthetic must MS300 which approximates to a 
natural grape must as previously described [17]. The medium contained 125 g/L glucose and 125 g/L 
fructose, and the pH was buffered at 3.3 with NaOH. 
 
3.3.3 Fermentation conditions 
All fermentations were carried out under microaerophilic conditions in 100 ml glass bottles (containing 
80 ml of the medium) sealed with rubber stoppers with a CO2 outlet. The fermentation temperature was 
approximately 22oC and no stirring was performed during the course of the fermentation. Fermentation 
bottles were inoculated with YPD cultures in the logarithmic growth phase (around OD600 = 1) to an 
OD600 of 0.1 (i.e. a final cell density of approximately 106 cfu.ml-1). The cells from the YPD pre-
cultures were briefly centrifuged and resuspended in MS300 to avoid carryover of YPD to the 
fermentation media. The fermentations followed a time course of 14 days and the bottles were weighed 
daily to assess CO2 release and the progress of fermentation. Samples of the fermentation medium and 
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cells were taken at days 2, 5 and 14 as representative of the exponential, early stationary and late 
stationary growth phases respectively. It should be stressed that yeast cells in early stationary phase in 
these conditions are metabolically active, since growth arrest is due to ethanol toxicity. Sugar levels 
and fermentative activity are still high at this stage.  
 
3.3.4 Growth measurement 
Cell proliferation (i.e. growth) was determined spectrophotometrically (PowerwaveX, Bio-Tek 
Instruments) by measuring the optical density (at 600 nm) of 200 µl samples of the suspensions over 
the 14 day experimental period. 
 
3.3.5 Analytical methods - HPLC 
Culture supernatants were obtained from the cell-free upper layers of the fermentation media. For the 
purposes of glucose determination and carbon recovery, culture supernatants and starting media were 
analyzed by high performance liquid chromatography (HPLC) on an AMINEX HPX-87H ion exchange 
column using 5 mM H2SO4 as the mobile phase. Agilent RID and UV detectors were used in tandem 
for peak detection and quantification. Analysis was carried out using the HPChemstation software 
package. 
 
3.3.6 Analytical methods – GC-FID 
Each 5 ml sample of synthetic must taken during fermentation was spiked with an internal standard of 
4-methyl-2-pentanol to a final concentration of 10 mg.l-1. To each of these samples 1 ml of solvent 
(diethyl ether) was added and the tubes sonicated for 5 minutes. The top layer in each tube was 
separated by centrifugation at 3000 rpm for 5 minutes and the extract analyzed. After mixing, 3 μl of 
each sample was injected into the gas chromatograph (GC). All extractions were done in triplicate. 
The analysis of volatile compounds was carried out on a Hewlett Packard 5890 Series II GC coupled to 
an HP 7673 auto-sampler and injector and an HP 3396A integrator. The column used was a Lab 
Alliance organic-coated, fused silica capillary with dimensions of 60 m × 0.32 mm internal diameter 
with a 0.5 μm coating thickness. The injector temperature was set to 200°C, the split ratio to 20:1 and 
the flow rate to 15 ml.min 1, with hydrogen used as the carrier gas for a flame ionisation detector held 
at 250°C.  The oven temperature was increased from 35°C to 230°C at a ramp of 3°C min 1.  
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Internal standards (Merck, Cape Town) were used to calibrate the machine for each of the compounds 
measured. 
 
3.3.7 Statistical analysis of metabolite data 
T-tests and anova analyses were conducted using Statistica (version 7). HCL and KMC clustering were 
carried out using TIGR MeV v2.2 [18]. 
 
3.3.8 Microarray analysis 
Sampling of cells from fermentations and total RNA extraction was performed as described [19]. Probe 
preparation and hybridization to Affymetrix Genechip® microarrays were performed according to 
Affymetrix instructions, starting with 6 μg of total RNA. Results for each strain and time point were 
derived from three independent culture replicates. The quality of total RNA, cDNA, cRNA and 
fragmented cRNA were confirmed using the Agilent Bioanalyzer 2100.  
 
3.3.9 Transcriptomics data acquisition and statistical analysis 
Acquisition and quantification of array images and data filtering were performed using Affymetrix 
GeneChip® Operating Software (GCOS) version 1.4. All arrays were scaled to a target value of 500 
using the average signal from all gene features using GCOS. Genes with expression values below 12 
were set to 12 + the expression value as previously described in order to eliminate insignificant 
variations [20]. 
 
Variable (gene) selection is important for the successful analysis of gene expression data since most of 
the genes are unchanged and irrelevant to the prediction and analysis of phenotypic measurements. 
These non-informative genes should be removed before further analysis. One approach is by 
significance analysis of microarrays [21]. Determination of differential gene expression between 
experimental parameters was conducted using SAM (Significance Analysis of Microarrays) version 2. 
The two-class, unpaired setting was used and genes with a Q value less than 0.5 were considered 
differentially expressed. Only genes with a fold change greater than 2 (positive or negative) for inter- 
or intra- strain comparisons were taken into consideration. 
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3.3.10 Multivariate data analysis 
In terms of design, the samples represent the different fermentations (three independent replicates for 
each of the five strains) at different time points. The variables considered are the expression levels of 
the pre-selected genes (genes with a potential and established role in aroma compound metabolism 
according to GO and MIPS functional classification) as well as aroma compound concentrations in the 
synthetic must. The patterns within the different sets of data were investigated by principal-component 
analysis (PCA), while the correlations between different sets of data were determined by using partial 
least-squares (PLS) regression (The Unscrambler; Camo Inc., Corvallis, Oreg.).  
 
PCA is a bilinear modeling method which gives a visually interpretable overview of the main 
information in large, multidimensional datasets. By plotting the principal components it is possible to 
view statistical relationships between different variables in complex data sets and detect and interpret 
sample groupings, similarities or differences, as well as the relationships between the different 
variables [22].  
 
PLS regression is a bilinear modeling method for identifying the variations in a data matrix for 
explanatory or predictive purposes [23]. By plotting the first PLS components one can view main 
associations between X variables and Y variables and also relationships within X data and within Y 
data. PLS2 analysis was conducted using all X and Y variables considered in our study. For predictive 
purposes, PLS1 models were constructed for individual Y variables to increase model-specificity and 
reliability. 
 
The data were analyzed by using test-set validation with centered data and the variables were weighted 
according to their standard deviations. One strain was used as the test segment at each of the time 
points. Day 2 and 5 data were considered together as representative of the full scope of fermentation 
variability as the period from the start of fermentation until day 5 represents the period of maximum 
aroma compound production. The Y variables were the respective aroma compounds measured and the 
X variables were the gene expression levels of the gene set that was pre-selected for analysis [24]. 
Genes were selected based on known or putative functions related to amino acid transport, metabolism, 
regulation etc. as well as other enzymatic or regulatory activity in pathways leading to the production 
of higher alcohols and esters. The same set of genes (X variables) was used for each of the different 
PLS1 models. 
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3.3.11 Overexpression constructs and transformation of VIN13 
All plasmids used in this study are listed in table 3. Standard procedures for the isolation, cloning and 
modification of DNA were used throughout this study [25, 26]. All enzymes for cloning, restriction 
digest and ligation reactions were obtained from Roche Diagnostics (Randburg, South Africa) and used 
according to supplier specifications. 
 
Table 3 Description of plasmids used in this study 
Plasmid Name Relevant genotype Reference
pDM-PhR-YMR210W 2μ LEU2 TEF1P PhR322 TEF1T PGKP YMR210W PGKT This study
pDM-PhR-AAD10 2μ LEU2 TEF1P PhR322 TEF1T PGKP AAD10 PGKT This study
pDM-PhR-AAD14 2μ LEU2 TEF1P PhR322 TEF1T PGKP AAD14 PGKT This study
pDM-PhR-ACS1 2μ LEU2 TEF1P PhR322 TEF1T PGKP ACS1 PGKT This study  
 
The primers listed in table 4 were used to amplify the coding regions of the various genes by the PCR 
technique. Genomic DNA from the DV10 strain was used as the template. Eshericia coli DH5α 
(GIBCO-BRL/Life Technologies) was used as the host for the construction and propagation of the 
plasmids listed in table 3. Sequencing of all plasmids was carried out on an ABI PRISM automated 
sequencer. All plasmids contain the dominant marker PhR conferring phleomicin resistance (PhR), and 
were transformed into host VIN13 cells via electroporation [27, 28].  
 
Table 4 Sequences of the primers synthesized in order to amplify genes relevant to the present study 
Primer Name
PhR322F GATCCACGTCGGTACCCGGGGGATC
PhR322R GATCGCGATCGCAAGCTTGCAAATTAAAGCC
YMR210f AACGCTGGTAAACTTCCAGAGA
YMR210r GGCGAAGCTTTTCACGTTTT
AAD10f ATGCTTTTTACCAAGCAGGC
AAD10r CATCAAACTGTGTGTGTAAGCG
AAD14f ACCAATTAGCTGAACGGCTTTG
AAD14r ATTTGCACACACTCGGTGGATA
ACS1f AAAGACATTGCCCACTGTGCT
ACS1r CACGAAAAAAAAAAAGTCGTCA
Sequence (5'-3')
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3.4 Results 
3.4.1 Fermentation kinetics and formation of metabolites 
Fermentation behaviour of all five strains in our conditions followed typical wine fermentation 
patterns. All five strains fermented the synthetic must to dryness within the monitored period, broadly 
followed similar growth patterns (figure 2) and showed similar rates of fructose and glucose utilization 
as well as ethanol and glycerol production (figure 3). This is to be expected, as all five strains are 
widely used in the wine industry and are optimized for fermentation performance.  
 
 
Figure 2 Growth rate (frame A) and CO2 release (frame B) of the five commercial wine yeast strains 
during alcoholic fermentation. Values are the average of 4 biological repeats ± standard 
deviation. 
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Figure 3 Fermentation kinetics of the five yeast strains used in this study: Glucose utilization (A), 
fructose utilization (B), glycerol production (C) and ethanol production (D). All y-axis values 
are in g.l-1 and refer to extracellular metabolite concentrations in the synthetic must. Values 
are the average of 4 biological repeats ± standard deviation. 
 
On the other hand, the strains did show significant variability regarding the volatile organoleptic 
compounds produced during fermentation (tables 5-7), suggesting that these ‘secondary’ pathways of 
higher alcohol and ester production are less conserved between different strains.  
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Table 5 Volatile alcohols and esters present in the fermentation media at day 2 of fermentation. All 
values are expressed as mg.L-1 and are the average of 4 biological repeats ± standard 
deviation. Metabolites present at concentrations below the detection limit are indicated by 
“bd”. 
 
DAY2
THRESHOLD ODOR VIN13 EC1118 BM45 285 DV10
Ethyl Acetate 12 Apple, Pineapple, fruity, solvent, balsamic 4.87 ± 1.22 7.38 ± 0.72 7.32 ± 1.07 5.43 ± 1.27 7.32 ± 1.94
Methanol 0 ± 0.00 0 ± 0.00 0 ± 0.00 42.59 ± 3.08 41.72 ± 4.08
Propanol 306 Alcohol, ripe fruit, stupefying 27.16 ± 11.35 21.04 ± 4.26 20.87 ± 2.08 19.24 ± 2.60 23.15 ± 6.42
Isobutanol 74 Alcohol, nail polish 5.7 ± 1.25 6.77 ± 0.63 8.3 ± 0.81 7.28 ± 0.40 7.04 ± 0.61
Isoamyl Acetate 60 Solvent marzipan, malt bd bd bd bd 0.05 ± 0.01
Butanol 50 Medicinal, wine-like bd bd bd bd bd
Isoamyl alcohol 26.54 ± 5.51 31.23 ± 2.74 30.39 ± 3.12 27.31 ± 1.87 31.09 ± 4.74
Hexyl acetate 0.67 Apple, cherry, pear, ?oral bd bd bd bd 0.01 ± 0.01
Ethyl Lactate 150 Fruity, buttery bd bd 4.08 ± 0.07 bd bd
Ethyl Caprylate 0.58 sweet pear banana bd bd bd bd 0.05 ± 0.03
Acetic Acid Vinegar 549 ± 56 766 ± 19 841 ± 22 756 ± 32 733 ± 60
Propionic Acid 1.59 ± 0.62 1.55 ± 0.11 1.78 ± 0.32 1.7 ± 0.35 1.74 ± 0.15
Iso-Butyric Acid 8.1 rancid butter cheese 0.75 ± 0.11 0.6 ± 0.03 0.62 ± 0.05 0.56 ± 0.07 0.7 ± 0.04
Butyric Acid 2.2 rancid cheese, sweet 1.10 ± 0.27 1.19 ± 0.06 1.03 ± 0.06 0.96 ± 0.09 1.23 ± 0.08
Ethyl Caprate 0.5 brandy fruity grape floral 0.02 ± 0.01 0.07 ± 0.03 0.09 ± 0.00 0.09 ± 0.01 0.11 ± 0.01
Iso-Valeric Acid 0.7 rancid cheese putrid 0.36 ± 0.08 0.33 ± 0.13 0.28 ± 0.04 0.27 ± 0.04 0.340.05
Diethyl Succinate 1.2 Fruity, melon bd bd bd bd bd
Valeric Acid SWEATY 0.22 ± 0.05 0.29 ± 0.04 0.26 ± 0.08 0.29 ± 0.06 0.29 ± 0.06
2-Phenylethyl Acetate 1.8 rosy honey fruity 0.22 ± 0.05 0.51 ± 0.03 0.32 ± 0.03 0.33 ± 0.03 0.57 ± 0.03
2-Phenyl Ethanol 200 Rose, honey 9.07 ± 2.37 12.8 ± 0.41 13.38 ± 1.07 14.88 ± 1.33 12.67 ± 1.36
Octanoic Acid 10 Fatty, rancid, oily, soapy faint fruity 0.81 ± 0.04 1.57 ± 0.05 1.01 ± 0.05 1.11 ± 0.07 1.74 ± 0.08
Decanoic Acid 6 Fatty, rancid 0.66 ± 0.07 1.46 ± 0.02 1.06 ± 0.12 1.22 ± 0.13 1.7 ± 0.11  
 
Table 6 Volatile alcohols and esters present in the fermentation media at day 5 of fermentation. All 
values are expressed as mg.L-1 and are the average of 4 biological repeats ± standard 
deviation. Metabolites present at concentrations below the detection limit are indicated by 
“bd”. 
 
DAY5
THRESHOLD ODOR VIN13 EC1118 BM45 285 DV10
Ethyl Acetate 12 Apple, Pineapple, fruity, solvent, balsamic 15.8 ± 4.43 16.923 ± 4.22 14.37 ± 1.49 14.54 ± 1.9 23.87 ± 2.21
Methanol 15.80 ± 4.49 36.13 ± 6.26 0 ± 0.00 29.89 ± 34.7 34.42 ± 16.84
Propanol 306 Alcohol, ripe fruit, stupefying 77.11 ± 20.23 55.58 ± 7.76 31.67 ± 6.38 35.19 ± 7.65 58.1 ± 5.38
Isobutanol 74 Alcohol, nail polish 8.96 ± 2.15 11.98 ± 0.63 13.57 ± 1.60 11.54 ± 0.85 11.66 ± 0.60
Isoamyl Acetate 60 Solvent marzipan, malt 0.11 ± 0.04 0.09 ± 0.01 0.07 ± 0.01 0.07 ± 0.01 0.10 ± 0.01
Butanol 50 Medicinal, wine-like 0.95 ± 0.11 0.89 ± 0.05 0.7 ± 0.06 0.77 ± 0.05 0.98 ± 0.02
Isoamyl alcohol 57.02 ± 10.92 61.46 ± 6.52 51.46 ± 5.98 49.32 ± 3.95 67.15 ± 8.09
Hexyl acetate 0.67 Apple, cherry, pear, ?oral 0.01 ± 0.02 0.16 ± 0.01 0.1 ± 0.01 0.04 ± 0.01 0.16 ± 0.01
Ethyl Lactate 150 Fruity, buttery 4.33 ± 0.14 4.24 ± 0.12 bd bd 4.48 ± 0.06
Ethyl Caprylate 0.58 sweet pear banana 0.08 ± 0.02 0.11 ± 0.02 0.07 ± 0.01 0.07 ± 0.00 0.09 ± 0.01
Acetic Acid Vinegar 1306.24 ± 74.24 879.5 ± 22.00 1000.58 ± 27.72 703.33 ± 43.78 1105.93 ± 24.80
Propionic Acid 2.18 ± 0.35 2.32 ± 0.28 2.15 ± 0.29 2.01 ± 0.22 2.52 ± 0.19
Iso-Butyric Acid 8.1 rancid butter cheese 0.58 ± 0.12 0.58 ± 0.04 0.59 ± 0.04 0.54 ± 0.04 0.76 ± 0.04
Butyric Acid 2.2 rancid cheese, sweet 1.97 ± 0.41 2.50 ± 0.15 1.53 ± 0.30 1.57 ± 0.31 2.77 ± 0.62
Ethyl Caprate 0.5 brandy fruity grape floral 0.25 ± 0.05 0.32 ± 0.03 0.18 ± 0.03 0.2 ± 0.02 0.33 ± 0.05
Iso-Valeric Acid 0.7 rancid cheese putrid 0.59 ± 0.11 0.62 ± 0.04 0.53 ± 0.08 0.54 ± 0.16 0.66 ± 0.05
Diethyl Succinate 1.2 Fruity, melon bd bd bd bd bd
Valeric Acid SWEATY 0.57 ± 0.25 0.38 ± 0.07 0.23 ± 0.02 0.26 ± 0.03 0.39 ± 0.03
2-Phenylethyl Acetate 1.8 rosy honey fruity 0.33 ± 0.03 0.63 ± 0.02 0.35 ± 0.02 0.32 ± 0.03 0.68 ± 0.05
2-Phenyl Ethanol 200 Rose, honey 12.71 ± 2.47 14.98 ± 0.58 16.35 ± 1.68 17.21 ± 0.83 16.33 ± 0.87
Octanoic Acid 10 Fatty, rancid, oily, soapy faint fruity 0.95 ± 0.2 1.43 ± 0.05 0.9 ± 0.08 0.88 ± 0.09 1.59 ± 0.09
Decanoic Acid 6 Fatty, rancid 1.5 ± 0.41 2.86 ± 0.38 1.32 ± 0.15 1.42 ± 0.13 3.01 ± 0.22  
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Table 7 Volatile alcohols and esters present in the fermentation media at day 14 of fermentation. All 
values are expressed as mg.L-1 and are the average of 4 biological repeats ± standard 
deviation. Metabolites present at concentrations below the detection limit are indicated by 
“bd”. 
DAY14
THRESHOLD ODOR VIN13 EC1118 BM45 285 DV10
Ethyl Acetate 12 Apple, Pineapple, fruity, solvent, balsamic 29.56 ± 7.56 28.79 ± 1.83 23.58 ± 2.42 23.24 ± 1.87 27.83 ± 1.11
Methanol 68.39 ± 4.8 62.3 ± 20.12 70.87 ± 7.02 63.92 ± 4.49 62.18 ± 6.21
Propanol 306 Alcohol, ripe fruit, stupefying 83.23 ± 13.34 53.5 ± 7.49 39.72 ± 4.13 41.63 ± 5.337 64.14 ± 6.96
Isobutanol 74 Alcohol, nail polish 11.27 ± 2.80 15.44 ± 1.30 19.58 ± 2.03 15.18 ± 1.15 15.33 ± 0.76
Isoamyl Acetate 60 Solvent marzipan, malt 0.10 ± 0.03 0.09 ± 0.01 0.07 ± 0.01 0.06 ± 0.00 0.09 ± 0.01
Butanol 50 Medicinal, wine-like 1.36 ± 0.14 1.26 ± 0.08 1.02 ± 0.18 1.03 ± 0.05 1.32 ± 0.04
Isoamyl alcohol 67.29 ± 4.89 71.44 ± 2.54 68.17 ± 8.81 61.59 ± 4.25 76.86 ± 6.50
Hexyl acetate 0.67 Apple, cherry, pear, ?oral 0.05 ± 0.04 0.14 ± 0.01 0.1 ± 0.00 0.1 ± 0.00 0.14 ± 0.00
Ethyl Lactate 150 Fruity, buttery 3.86 ± 0.19 3.96 ± 0.04 bd bd 3.92 ± 0.09
Ethyl Caprylate 0.58 sweet pear banana 0.07 ± 0.00 0.11 ± 0.01 0.07 ± 0.01 0.07 ± 0.01 0.13 ± 0.01
Acetic Acid Vinegar 1616 ± 158 1061 ± 120 1197 ± 133 838 ± 114 1251 ± 71
Propionic Acid 1.96 ± 0.39 2.84 ± 0.22 2.18 ± 0.47 2.19 ± 0.24 3.4 ± 0.45
Iso-Butyric Acid 8.1 rancid butter cheese 0.74 ± 0.16 0.81 ± 0.079 0.7 ± 0.09 0.63 ±  ± 1.02 ± 0.12
Butyric Acid 2.2 rancid cheese, sweet 2.27 ± 0.66 4 ± 0.23 2.37 ± 0.62 2.35 ± 0.42 3.96 ± 0.29
Ethyl Caprate 0.5 brandy fruity grape floral 0.24 ± 0.04 0.45 ± 0.01 0.21 ± 0.04 0.26 ± 0.04 0.45 ± 0.03
Iso-Valeric Acid 0.7 rancid cheese putrid 0.74 ± 0.11 0.95 ± 0.11 0.71 ± 0.15 0.67 ± 0.05 1.01 ± 0.11
Diethyl Succinate 1.2 Fruity, melon 0.09 ± 0.02 0.17 ± 0.02 0.05 ± 0.03 0.04 ± 0.01 0.16 ± 0.03
Valeric Acid SWEATY 0.26 ± 0.03 0.49 ± 0.11 0.26 ± 0.03 0.26 ± 0.04 0.41 ± 0.04
2-Phenylethyl Acetate 1.8 rosy honey fruity 0.35 ± 0.06 0.55 ± 0.04 0.26 ± 0.04 0.27 ± 0.05 0.61 ± 0.05
2-Phenyl Ethanol 200 Rose, honey 11.88 ± 2.91 17.24 ± 0.69 16.68 ± 2.54 17.33 ± 2.28 17.98 ± 1.42
Octanoic Acid 10 Fatty, rancid, oily, soapy faint fruity 0.65 ± 0.08 1.07 ± 0.12 0.51 ± 0.14 0.65 ± 0.18 1.28 ± 0.09
Decanoic Acid 6 Fatty, rancid 0.84 ± 0.29 1.47 ± 0.07 0.64 ± 0.11 0.89 ± 0.19 1.52 ± 0.19  
 
In general, the aroma compounds produced all showed a steady increase in concentration in the 
synthetic must over time, although the most active period of aroma compound accumulation appears to 
be in the earlier stages of fermentation. For the most part, compounds such as methanol, isoamyl 
alcohol, butanol, ethyl caprylate are only detectable in the fermentation media by day 5 of fermentation 
(table 6), whereas others such as diethyl succinate can only be detected at the end of fermentation (table 
7). In general, the higher alcohols and their corresponding esters are present throughout fermentation at 
the highest concentration in the medium (tables 5-7). The aroma profiles of the DV10 and EC1118 
strain are very similar, while the BM45 and 285 strains also produce similar exometabolomic 
signatures. The aroma compounds that are proportionally the most variable between strains are 
propanol, isobutanol, ethyl caprylate, acetic acid, propionic acid, butyric acid, ethyl caprate, diethyl 
succinate, valeric acid, 2-phenylethyl acetate, octanoic- and decanoic acid, as well as ethyl lactate, 
which is completely absent in the BM45 and 285 strains (table 7).  
 
3.4.2 Microarray analysis 
The divergent aroma profiles of the different strains were mirrored by variable gene expression 
patterns. Since the Affymetrix DNA chips used for the analysis were designed based on the sequence 
of the laboratory yeast BY4742, a primary concern related to the quality of the microarray data. Both 
the internal controls and the expression of housekeeping genes were in keeping with international 
MIAME compliancy standards. Most notably, variation between independent biological repeats was 
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negligible, giving us confidence in the reliability and reproducibility of our microarray analysis. 
Furthermore, changes in gene expression during the course of fermentation matched up well to data 
from related microarray analysis for the EC1118 [29] and VIN13 strains [30].  
 
Between different time points approximately 1000-1500 genes significantly increased or decreased in 
expression (within the criteria specified in the materials and methods section) for the five yeast strains 
in our study. At the time points considered, the variation in gene expression between the different 
strains was in the range of about 50-400 transcripts. Strains that appear to be most similar to one 
another on a gene expression level were the EC1118 and DV10 strains, as well as the BM45 and 285 
strains. The VIN13 strain was least similar to any of the other four strains. This pattern is in line with 
the differences observed in aroma production for all of these strains. 
 
Numerous and substantial changes in the expression of genes involved in pathways that lead to the 
production of volatile aroma compounds were evident both between strains at comparable stages of 
fermentation and for individual strains at different fermentative stages. To identify relevant 
transcriptional variation in the context of aroma compound production, PCA analysis and PLS1 and 
PLS2 models were constructed for the compounds in tables 5-7 using the transcriptomic data as X 
variables. Transcriptomic data from days 2 and 5 were used for modeling purposes as these time points 
represent the period when the accumulation rate of most aroma compounds is at a maximum. From 
these models, transcripts with a strong positive or negative loading were selected for further in depth 
statistical analysis. The corresponding ORFs, together with a brief annotation, are listed in the appendix 
to this chapter. 
 
The general intrastrain trend revealed a decrease in the transcript levels of enzymes involved in the 
synthesis of aromatic and branched-chain amino acids, while transcript levels encoding aldehyde and 
alcohol dehydrogenases, as well as certain acetyltransferases were generally increased. Fold changes 
for differentially expressed transcripts, both between different strains at either day 2 or day 5 of 
fermentation (tables 8 and 9) and between day 2 and day 5 in individual strains (table 10), are listed 
below. 
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Table 8 List of aroma compound production -related transcripts significantly up/down regulated 
between different strains at day 2 of fermentation. 
 
GENE ID
BM45 vs 
EC1118
BM45 vs 
VIN13
EC1118
vs VIN13
DV10 vs 
VIN13
285 vs 
VIN13
DV10 vs 
EC1118
DV10 vs 
BM45
285 vs 
EC1118
285 vs 
BM45
DV10 vs 
285
AAD3 2.28 1.72 -1.32 -1.43 1.46 -1.08 -2.47 1.93 -1.18 -2.09
POT1 -1.05 1.80 1.88 1.75 2.25 -1.08 -1.03 1.19 1.25 -1.29
LEU2 1.50 1.13 -1.33 -1.76 -3.63 -1.32 -1.98 -2.72 -4.08 2.06
ALD3 -1.43 1.60 2.28 3.38 4.78 1.49 2.12 2.10 3.00 -1.41
SFA1 1.09 1.14 1.05 1.15 1.66 1.10 1.01 1.58 1.45 -1.44
EEB1 -1.44 1.25 1.80 1.63 -1.43 -1.10 1.30 -2.57 -1.79 2.33
YJL218W -7.01 -7.88 -1.12 1.04 -6.75 1.17 8.22 -6.00 1.17 7.04
ARO1 1.03 -1.43 -1.47 -1.39 -4.83 1.06 1.03 -3.28 -3.37 3.48
ADH6 1.52 1.10 -1.37 -1.15 -3.25 1.20 -1.27 -2.37 -3.59 2.83
ATF2 1.62 -1.02 -1.65 -1.46 -2.86 1.13 -1.43 -1.74 -2.81 1.96
ARO10 2.18 1.31 -1.67 -4.62 -15.11 -2.77 -6.05 -9.05 -19.78 3.27
PDC6 -1.13 1.18 1.33 1.10 1.05 -1.21 -1.07 -1.27 -1.12 1.04
ALP1 2.20 4.32 1.96 2.02 -2.03 1.03 -2.14 -3.99 -8.79 4.11
ALD5 1.14 1.06 -1.08 -1.20 -2.53 -1.12 -1.28 -2.35 -2.68 2.10
ARO7 -1.16 -1.11 1.05 -1.13 -1.71 -1.19 -1.02 -1.79 -1.54 1.51
ADH3 -1.06 -1.05 1.01 -1.21 -1.66 -1.22 -1.15 -1.68 -1.58 1.38
ACS1 1.05 1.06 1.01 1.04 2.34 1.03 -1.02 2.33 2.21 -2.26
GRE2 1.51 1.97 1.30 1.32 3.64 1.01 -1.50 2.79 1.84 -2.76
HPA3 1.16 1.05 -1.10 -1.26 -3.32 -1.14 -1.32 -3.01 -3.48 2.64
BAP3 -1.09 1.39 1.51 1.15 2.03 -1.31 -1.21 1.34 1.46 -1.76
HAT2 1.04 -1.10 -1.14 -1.42 -1.03 -1.25 -1.29 1.10 1.06 -1.38
ILV5 -1.24 -1.15 1.08 -1.24 -2.41 -1.34 -1.08 -2.60 -2.10 1.94
ARO4 1.20 -1.13 -1.37 -1.70 -6.22 -1.24 -1.50 -4.56 -5.48 3.66
ILV3 -1.34 -1.53 -1.14 -1.38 -5.55 -1.21 1.11 -4.86 -3.62 4.02
ADH2 1.42 1.02 -1.39 -1.53 2.32 -1.10 -1.56 3.23 2.28 -3.55
VBA3 3.25 11.31 3.48 4.54 -1.30 1.30 -2.49 -4.51 -14.65 5.88
FDH1 /// FDH 3.80 3.74 -1.02 -1.03 4.01 -1.01 -3.84 4.08 1.07 -4.12
AAD10 1.18 -1.96 -2.30 -1.62 -1.01 1.42 1.21 2.29 1.95 -1.61
YJL045W -1.50 -1.48 1.01 1.02 2.44 1.01 1.51 2.41 3.60 -2.38
PDC5 -3.05 -3.33 -1.09 -1.74 -6.19 -1.59 1.92 -5.68 -1.86 3.57
ACS2 1.12 1.38 1.23 1.24 -1.78 1.01 -1.11 -2.19 -2.46 2.21
BAP2 1.38 4.53 3.29 4.52 9.44 1.37 -1.00 2.87 2.09 -2.09
ERG10 1.19 1.33 1.11 1.15 -1.16 1.03 -1.15 -1.30 -1.54 1.34
ARO9 2.02 -1.24 -2.49 -5.85 -3.79 -2.35 -4.74 -1.52 -3.07 -1.54
YMR041C 2.00 3.05 1.52 1.13 2.41 -1.35 -2.70 1.59 -1.26 -2.14
ARO8 1.35 -1.07 -1.44 -2.04 -6.63 -1.41 -1.91 -4.61 -6.23 3.26
ERG13 1.13 1.23 1.09 1.14 -1.65 1.05 -1.08 -1.79 -2.03 1.88
ADR1 1.50 1.97 1.31 1.17 22.48 -1.12 -1.69 17.15 11.40 -19.21
TAT1 1.32 1.52 1.15 -1.06 -1.06 -1.22 -1.61 -1.22 -1.61 1.00
ILV1 -1.09 -1.10 -1.02 -1.47 -2.81 -1.45 -1.33 -2.77 -2.55 1.92
ALD4 1.45 2.05 1.42 1.26 4.00 -1.12 -1.63 2.83 1.95 -3.17
MAE1 -1.08 -1.75 -1.61 -3.14 -2.22 -1.95 -1.80 -1.37 -1.27 -1.42
BAT2 1.46 1.39 -1.05 -1.34 1.18 -1.28 -1.87 1.24 -1.18 -1.58
BDH1 1.65 1.65 -1.00 1.20 2.35 1.20 -1.37 2.35 1.43 -1.96
LEU1 -1.36 -1.55 -1.13 -1.27 -1.31 -1.12 1.22 -1.16 1.18 1.03
YMR210W 1.24 1.22 -1.02 -1.05 2.58 -1.03 -1.28 2.63 2.11 -2.71
YGL039W 1.57 1.45 -1.08 -1.13 -3.35 -1.04 -1.64 -3.09 -4.86 2.97
YGL157W -1.13 -1.05 1.07 -1.39 -2.87 -1.48 -1.31 -3.07 -2.72 2.07
THI3 -1.18 -1.21 -1.03 -1.56 -1.01 -1.52 -1.29 1.01 1.20 -1.54
ADH7 -1.89 -2.44 -1.30 -2.51 -4.90 -1.94 -1.03 -3.78 -2.00 1.95
AYT1 17.30 2.50 -6.91 -6.86 2.45 1.01 -17.18 16.93 -1.02 -16.81
TKL2 1.77 5.07 2.86 2.52 5.38 -1.14 -2.01 1.88 1.06 -2.14
TMT1 3.10 3.05 -1.02 -1.05 1.18 -1.03 -3.19 1.20 -2.58 -1.24
ADH4 1.08 -2.18 -2.36 -2.63 -2.24 -1.12 -1.21 1.05 -1.03 -1.18
ALD6 1.08 1.51 1.40 1.14 -2.36 -1.23 -1.33 -3.31 -3.57 2.69
CHA1 -1.05 4.30 4.49 1.17 -2.08 -3.84 -3.68 -9.33 -8.93 2.43
TKL1 -1.00 -1.05 -1.05 -1.26 -3.77 -1.21 -1.20 -3.60 -3.59 2.98
BAT1 -1.09 -1.18 -1.08 -1.62 -3.07 -1.50 -1.37 -2.86 -2.61 1.90
GRE3 1.19 1.65 1.38 1.77 2.39 1.28 1.08 1.73 1.45 -1.35
EHT1 1.37 -1.03 -1.40 -1.56 1.90 -1.11 -1.52 2.67 1.95 -2.97
ADH5 1.36 1.48 1.09 1.08 1.86 -1.01 -1.38 1.72 1.26 -1.73
ILV6 -1.02 -1.09 -1.07 -2.25 -4.47 -2.11 -2.07 -4.19 -4.11 1.98
MAK3 -1.53 -2.39 -1.56 -1.37 -1.80 1.14 1.75 -1.15 1.33 1.31
ATF1 2.00 1.67 -1.19 -1.24 1.10 -1.03 -2.07 1.31 -1.53 -1.36
ILV2 1.13 -1.10 -1.24 -1.67 -1.54 -1.35 -1.52 -1.24 -1.40 -1.09
LEU9 -1.04 -1.36 -1.31 -1.42 -3.69 -1.08 -1.04 -2.82 -2.70 2.60
YPL113C -1.81 -1.38 1.32 -1.03 -2.13 -1.35 1.34 -2.80 -1.54 2.07
AAD14 -2.04 -1.14 1.80 1.55 1.72 -1.16 1.76 -1.05 1.95 -1.10
DAY 2 FOLD CHANGE
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Table 9 List of aroma compound production -related transcripts significantly up/down regulated 
between different strains at day 5 of fermentation.  
 
GENE ID
BM45 vs 
EC1118
BM45 vs 
VIN13
EC1118
vs VIN13
DV10 vs 
VIN13
285 vs 
VIN13
DV10 vs 
EC1118
DV10 vs 
BM45
285 vs 
EC1118
285 vs 
BM45
DV10 vs 
285
AAD3 1.85 1.51 -1.23 -1.36 -1.21 -1.11 -2.05 1.02 -1.82 -1.13
POT1 -1.09 1.29 1.41 2.07 1.38 1.47 1.60 -1.02 1.06 1.50
LEU2 -1.77 -1.65 1.07 -1.16 -1.78 -1.25 1.42 -1.91 -1.08 1.53
ALD3 -1.35 -1.08 1.25 1.26 -1.60 1.01 1.36 -2.00 -1.48 2.02
SFA1 1.06 1.02 -1.04 1.12 -1.02 1.16 1.10 1.02 -1.04 1.14
EEB1 -1.58 -1.78 -1.13 1.03 -1.20 1.16 1.84 -1.06 1.48 1.24
YJL218W -1.71 -1.65 1.04 1.47 -1.44 1.42 2.42 -1.50 1.14 2.12
ARO1 -1.97 -1.99 -1.01 -1.09 -1.83 -1.09 1.82 -1.82 1.08 1.68
ADH6 1.20 -1.03 -1.23 -1.09 1.07 1.13 -1.06 1.33 1.11 -1.17
ATF2 1.77 2.46 1.39 1.42 2.39 1.02 -1.73 1.72 -1.03 -1.68
ARO10 1.77 1.02 -1.74 -1.92 -1.60 -1.11 -1.96 1.09 -1.63 -1.21
PDC6 1.20 1.19 -1.01 1.27 1.46 1.28 1.07 1.48 1.23 -1.15
ALP1 -1.50 -1.08 1.39 1.72 -1.28 1.23 1.85 -1.78 -1.19 2.20
ALD5 -1.53 -1.35 1.13 -1.09 -1.97 -1.23 1.24 -2.22 -1.45 1.81
ARO7 1.17 -1.13 -1.33 -1.38 -1.13 -1.04 -1.22 1.17 -1.00 -1.22
ADH3 1.02 1.03 1.01 1.20 -1.16 1.19 1.17 -1.17 -1.19 1.38
ACS1 -1.36 1.06 1.43 1.20 -1.35 -1.20 1.13 -1.93 -1.42 1.61
GRE2 1.26 1.38 1.10 1.13 1.09 1.03 -1.22 -1.01 -1.27 1.04
HPA3 1.36 1.12 -1.21 1.06 1.24 1.29 -1.05 1.51 1.11 -1.17
BAP3 2.48 1.89 -1.31 -1.94 1.07 -1.48 -3.67 1.40 -1.77 -2.08
HAT2 1.01 -1.12 -1.14 1.06 -1.05 1.20 1.19 1.09 1.07 1.11
ILV5 1.21 1.05 -1.16 1.08 -1.25 1.26 1.04 -1.08 -1.31 1.36
ARO4 1.07 -1.11 -1.20 -1.30 -1.47 -1.09 -1.17 -1.23 -1.32 1.13
ILV3 -1.76 -1.68 1.05 -1.07 -2.35 -1.12 1.57 -2.46 -1.40 2.19
ADH2 1.26 1.24 -1.02 -1.04 1.24 -1.02 -1.29 1.26 -1.00 -1.29
VBA3 -1.24 1.87 2.30 2.34 1.22 1.01 1.25 -1.88 -1.52 1.91
FDH1 /// FD 3.04 2.51 -1.21 -1.13 1.27 1.07 -2.85 1.54 -1.97 -1.44
AAD10 1.68 2.48 1.48 1.63 1.51 1.10 -1.53 1.02 -1.65 1.08
YJL045W -1.25 -1.33 -1.07 1.38 -1.70 1.47 1.84 -1.60 -1.28 2.35
PDC5 1.32 -1.33 -1.76 -2.23 -2.07 -1.27 -1.68 -1.18 -1.56 -1.08
ACS2 1.23 1.20 -1.02 1.27 1.21 1.29 1.06 1.23 1.00 1.05
BAP2 -1.82 -1.44 1.26 -1.11 -1.76 -1.40 1.30 -2.23 -1.22 1.59
ERG10 1.20 1.05 -1.14 1.13 1.02 1.29 1.07 1.17 -1.03 1.11
ARO9 1.05 1.10 1.05 1.04 1.11 -1.01 -1.06 1.05 1.01 -1.07
YMR041C 1.03 1.28 1.25 1.63 -1.06 1.31 1.27 -1.33 -1.36 1.73
ARO8 1.02 -1.46 -1.49 -1.54 -1.68 -1.03 -1.05 -1.13 -1.15 1.09
ERG13 1.08 1.09 1.01 1.18 1.16 1.16 1.08 1.15 1.07 1.01
ADR1 -1.88 -1.53 1.23 1.12 -1.49 -1.10 1.72 -1.83 1.03 1.67
TAT1 1.21 -1.52 -1.85 -1.39 -1.65 1.33 1.10 1.12 -1.08 1.19
ILV1 1.28 1.35 1.06 1.25 -1.01 1.18 -1.09 -1.07 -1.36 1.26
ALD4 -1.36 -1.15 1.19 1.39 -1.03 1.17 1.60 -1.22 1.11 1.43
MAE1 2.94 1.24 -2.38 -2.49 -1.36 -1.05 -3.08 1.74 -1.69 -1.83
BAT2 1.14 1.20 1.05 1.18 1.12 1.12 -1.01 1.07 -1.07 1.05
BDH1 2.39 1.89 -1.27 -1.09 1.36 1.16 -2.06 1.72 -1.39 -1.48
LEU1 -1.87 -1.48 1.26 1.14 -1.46 -1.10 1.70 -1.84 1.01 1.67
YMR210W 1.17 -1.12 -1.31 -1.14 -1.03 1.15 -1.02 1.27 1.08 -1.10
YGL039W 1.42 1.12 -1.27 -1.18 -1.20 1.07 -1.32 1.05 -1.35 1.02
YGL157W 1.53 2.26 1.47 1.62 1.12 1.10 -1.40 -1.32 -2.01 1.44
THI3 1.17 1.13 -1.04 -1.05 -1.08 -1.01 -1.18 -1.04 -1.22 1.03
ADH7 1.32 2.05 1.56 1.52 1.25 -1.02 -1.35 -1.25 -1.65 1.22
AYT1 19.10 1.93 -9.90 -8.88 1.86 1.12 -17.12 18.42 -1.04 -16.51
TKL2 -1.10 2.16 2.38 3.10 1.38 1.31 1.44 -1.73 -1.56 2.25
TMT1 -1.30 -1.29 1.01 1.34 -1.57 1.33 1.73 -1.58 -1.21 2.10
ADH4 -1.29 -1.17 1.10 1.13 -1.17 1.03 1.33 -1.29 -1.00 1.33
ALD6 1.56 1.49 -1.05 1.23 1.22 1.29 -1.21 1.29 -1.21 1.00
CHA1 -1.38 1.37 1.89 1.57 -1.08 -1.21 1.15 -2.03 -1.47 1.69
TKL1 1.54 1.13 -1.36 -1.04 1.03 1.31 -1.18 1.41 -1.09 -1.08
BAT1 -2.09 -1.67 1.25 1.05 -1.93 -1.20 1.74 -2.42 -1.16 2.02
GRE3 -1.20 -1.25 -1.04 1.19 -1.23 1.24 1.49 -1.18 1.02 1.46
EHT1 1.07 1.12 1.05 1.16 1.39 1.10 1.03 1.32 1.24 -1.20
ADH5 -1.08 -1.07 1.01 1.31 1.07 1.30 1.40 1.06 1.14 1.22
ILV6 -1.10 -1.03 1.06 1.29 -1.39 1.22 1.33 -1.48 -1.35 1.80
MAK3 1.21 -1.03 -1.24 -1.18 1.04 1.05 -1.15 1.29 1.07 -1.23
ATF1 -1.05 1.01 1.06 -1.14 -1.05 -1.20 -1.14 -1.11 -1.05 -1.09
ILV2 -1.57 -1.70 -1.09 -1.13 -1.45 -1.04 1.50 -1.33 1.17 1.28
LEU9 1.29 1.26 -1.03 -1.25 1.02 -1.21 -1.57 1.05 -1.23 -1.27
YPL113C -2.67 -1.77 1.51 2.26 -1.22 1.50 4.01 -1.84 1.46 2.75
AAD14 -1.85 -1.15 1.61 1.60 -1.05 -1.01 1.84 -1.69 1.09 1.68
DAY 5 FOLD CHANGE
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Table 10 List of aroma compound production -related transcripts significantly up/down regulated 
within each strain between days 2 and 5 of fermentation. 
 
GENE ID GENE ID
VIN13 EC1118 BM45 285 DV10 VIN13 EC1118 BM45 285 DV10
POT1 1.63 1.22 1.17 1.34 2.42 ERG13 -1.92 -2.07 -2.16 -2.02 -1.49
LEU2 -2.04 -1.43 -3.78 -4.19 -1.08 ADR1 33.47 31.45 11.10 24.70 40.17
ALD3 7.67 4.21 4.44 5.26 3.57 TAT1 1.56 -1.37 -1.49 -1.13 1.48
SFA1 1.69 1.55 1.50 1.51 2.06 ILV1 -2.79 -2.59 -1.87 -2.28 -1.22
EEB1 -1.19 -2.41 -2.65 -1.80 -1.50 ALD4 4.13 3.46 1.75 3.70 5.68
YJL218W -10.59 -6.23 6.61 -19.99 -2.65 MAE1 -1.62 -2.39 1.33 -1.08 -1.03
ARO1 -2.64 -1.80 -3.66 -3.86 -1.66 BAT2 1.05 1.16 -1.11 -1.52 2.08
ADH6 -3.49 -3.14 -3.97 -4.35 -2.65 BDH1 1.73 1.37 1.98 2.12 1.66
ATF2 -6.83 -2.98 -2.72 -3.90 -2.63 LEU1 1.11 1.59 1.16 -1.10 2.02
ARO10 -9.46 -9.86 -12.15 -14.27 -3.15 YMR210W 2.67 2.07 1.96 2.30 3.08
PDC6 -1.39 -1.87 -1.38 -1.09 1.04 YGL039W -2.78 -3.25 -3.61 -4.23 -2.33
ALP1 -1.59 -2.24 -7.40 -8.46 -1.50 YGL157W -3.21 -2.34 -1.35 -1.66 -1.15
ALD5 -1.29 -1.06 -1.85 -2.33 1.07 THI3 1.06 1.05 1.46 1.41 1.99
ARO7 -1.50 -2.10 -1.54 -1.71 -1.48 ADH7 -6.10 -3.03 -1.22 -1.48 -1.28
ADH3 -1.44 -1.44 -1.33 -1.63 1.26 AYT1 1.32 -3.20 1.01 1.36 1.43
ACS1 3.15 4.49 3.14 2.22 4.56 TKL2 3.91 3.25 1.66 2.56 6.02
GRE2 3.34 2.82 2.34 2.94 3.59 TMT1 1.86 1.90 -2.12 1.22 3.26
HPA3 -4.14 -4.55 -3.86 -5.28 -2.48 ADH4 -1.91 1.36 -1.03 -1.06 1.95
BAP3 1.90 -1.04 2.58 1.67 1.06 ALD6 -2.89 -4.26 -2.95 -2.70 -2.15
HAT2 1.02 1.01 -1.01 1.05 1.91 CHA1 -1.93 -4.59 -6.07 -4.89 -1.15
ILV5 -1.92 -2.40 -1.60 -1.99 -1.14 TKL1 -3.90 -5.07 -3.29 -3.35 -2.57
ARO4 -4.24 -3.71 -4.16 -5.31 -2.59 BAT1 -1.59 -1.18 -2.25 -2.47 1.33
ILV3 -2.37 -1.98 -2.60 -4.51 -1.47 GRE3 2.93 2.04 1.43 1.82 2.46
ADH2 1.87 2.56 2.29 3.00 3.45 EHT1 1.37 2.02 1.58 2.15 3.09
VBA3 -2.56 -2.39 -9.61 -4.29 -2.46 ADH5 1.75 1.62 1.10 1.14 2.65
FDH1 /// FD 3.15 2.65 2.12 2.56 3.57 ILV6 -3.22 -2.84 -3.05 -3.00 1.13
AAD10 -1.52 2.25 3.21 1.21 2.17 AAD3 1.83 1.33 1.53 1.42 1.91
YJL045W 4.15 3.84 4.60 2.67 7.01 MAK3 -1.88 -1.49 1.24 -1.07 -1.29
PDC5 -2.99 -4.83 -1.20 -2.42 -3.08 ATF1 1.15 1.45 -1.45 -1.11 1.56
ACS2 -2.14 -2.69 -2.46 -2.20 -1.67 AAD3 1.20 1.35 1.37 1.43 1.86
BAP2 16.64 6.39 2.55 2.17 4.14 ILV2 -1.06 1.08 -1.65 -1.10 1.74
ERG10 -1.19 -1.51 -1.49 -1.41 1.03 LEU9 -3.76 -2.95 -2.19 -3.54 -2.66
ARO9 -4.19 -1.60 -3.09 -2.11 1.81 YPL113C -1.75 -1.52 -2.25 -2.12 1.66
YMR041C 2.57 2.10 1.08 2.29 4.63 AAD14 1.80 1.62 1.78 1.87 2.32
ARO8 -3.94 -4.08 -5.40 -5.03 -2.38
DAY 5 vs DAY 2 DAY 5 vs DAY 2
 
 
3.4.3 Results of multivariate analysis of metabolites and gene expression 
Figure 4 shows a PLS2 plot which depicts the variation/ relationships between all the measured aroma 
compounds as well as the 70 genes selected for multivariate modeling purposes. These genes were 
selected due to their varying expression levels between different strains as well as different time points 
during fermentation. Also, we selected genes whose annotation suggested that they may have a role in 
aroma compound production, such as enzymes whose sequence suggests a role in redox reactions, 
central carbon metabolism, and amino acid uptake and metabolism (GO and MIPS classification). 
 
The X-Y scores and loading plots (figure 4) are clearly useful in representing the overall ‘structure’ of 
the entire dataset, and are pointing out possible connections between specific compounds/ groups of 
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compounds and certain genes. Likewise, scores plots proved a neat way of validating the general 
design and data generated by our experimental setup/ process (figure 5).  
 
 
Figure 4 PLS2 scores and loadings plot of all X and Y variables considered in this study, plotted as 
coordinates on a PC1 and PC2 plane. 
 
 
 
 
Figure 5 Scores plot for the ethyl caprylate (frame A) and octanoic acid (frame B) PLS1 models. 
 
The samples of independent biological repeats for each of the 5 strains group together closely at both 
time points. All five strains also clearly segregate into two clusters based on the stage (time point) of 
fermentation. For example, in the first frame it is clear that the stage of fermentation is the major source 
of variation (PC1) and strain identity is the source of the second-greatest explained variation (PC2), 
while this pattern is reversed in frame B.  
 
A B 
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Of the 22 volatile aroma compounds measured in this study, 13 were amenable to PLS1 modeling 
(using transcriptome data) based on our selected criteria for model validation (slope > 0.8; Y-var 
explained > 75%). The details of these models are summarized in a table 11 below. 
 
Table 11 Summaries of PLS1 models 
# PC's Slope % RMSEP Y-var (%) X-var (%)
Ethyl Acetate 3 0.88 12.67 93 66
Isobutanol 2 1.02 6.30 95 57
Isoamyl Acetate 3 0.93 13.75 94 67
Butanol 4 0.94 13.33 99 59
Isoamyl alcohol 4 0.96 10.50 96 76
Ethyl Caprylate 3 0.99 15.71 92 66
Propanol 9 0.98 14.29 78 83
Iso-Butyric Acid 4 0.97 16.00 98 75
Butyric Acid 2 0.90 20.00 78 52
Ethyl Caprate 2 0.93 16.00 92 54
2-Phenyl Ethanol 6 0.97 8.30 79 78
Octanoic Acid 5 0.94 14.44 93 85
Decanoic Acid 5 0.97 15.56 97 84  
 
3.4.4 Overexpression of selected genes 
Of the genes listed in the tables presented in the supplementary material, five were chosen for in-depth 
analysis due to their significant contributions to the respective prediction models for several of the 
important higher alcohols and esters, as well as their amenability to easy cloning and vector 
construction. These genes were BAT1, AAD10, AAD14, ACS1 and YMR210W. AAD10 and AAD14 
encode aryl alcohol dehydrogenases which are believed to be responsible for the putative role of 
degrading the complex aromatic compounds in grape must into their corresponding higher alcohols [7]. 
BAT1 encodes a mitochondrial branched-chain amino acid aminotransferase that is involved in 
catalyzing the first transamination step of the catabolic formation of fusel alcohols via the Ehrlich 
pathway [31].  The YMR210 gene codes for a putative acyltransferase enzyme (similar to EEB1 and 
EHT1) and is believed to play a role in medium-chain fatty acid ethyl ester biosynthesis. Lastly, the 
ACS1 gene (encoding an acetyl-coA synthetase isoform) codes for the enzyme responsible for the 
conversion of acetate to acetyl-coA, which is an intermediate or reactant in several of the aroma 
compound producing pathways [32].  
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An in-house BAT1 overexpressing strain was already available for use. For the other 4 genes, a multi-
copy overexpression plasmid-based cloning strategy was employed to allow for maximum gene 
expression and rapid characterization of the transformed VIN13 strains. Fermentations were carried out 
as before with the 5 transformed cell lines and a VIN13 control. Samples for HPLC and GC-FID 
analysis were taken at the same time points, namely days 2, 5 and 14 of fermentation. No significant 
differences were observed regarding the glucose and fructose utilization of the overexpression strains 
during fermentation (data not shown). Slight differences were found for ethanol production, while 
some changes in glycerol production were evident for the different strains (figure 6). 
 
Figure 6 Concentrations of ethanol (frame A) and glycerol (frame B) in the must during fermentation. 
Values are the average of 4 independant repeats ± standard deviation. 
 
Figure 7 depicts the aroma compound concentrations at the end of fermentation (day 14) only, as this is 
the most important time point from an enological perspective. Four of the five overexpressing strains 
showed significant changes in the aroma profiles produced at the end of fermentation. Only the 
YMR210W overexpressing strain did not show any changes, and is therefore not included in the figures 
below. We did not further investigate whether this absence of changes in aroma production is due to 
problems with the expression construct or reflects the absence of aroma- related activity of the gene 
product.  
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Figure 7 Aroma compound production (μg.L-1) in MS300 fermentations carried out by VIN13 
transformed with overexpression constructs. Values are the average of 4 biological repeats ± 
standard deviation. 
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Significant differences were evident in the aroma profiles of the four transformed yeast strains under 
consideration. We investigated whether the observed changes in aroma compound concentrations at the 
end of fermentation can be reconciled with the anticipated changes based on multivariate prediction 
models. Figure 8 represents the qualitative alignment of real vs. predicted changes in aroma compound 
concentrations. Only aroma compounds with statistically reliable PLS models (test-set validation; slope 
>0.88; % RMSEP < 20) were taken into consideration. The dashed lines indicate the relative loading 
weights of each of the four genes (for each of the aroma compound models represented by the plot 
axes). The solid lines in the figures represent the log ratios of the actual aroma compound 
concentrations normalized to the VIN13 concentrations of the particular compound.  
 
Figure 8 Qualitative representation of relative real vs. predicted aroma compound levels in the four 
transformed VIN13 lines. Dashed gray lines indicate predicted values and solid black lines 
indicate log-normalised values of real compound concentrations. 
 
To clarify, the predicted influence of a given gene on a particular compound is represented on a scale 
from -1 to +1, based on statistical projections related to PLS loading weights. On this scale a value of -
1 suggests a strong probability of significant concentration decreases of a given compound (for 
overexpression of the gene), while a value of +1 is indicative of a strong positive correlation between 
the expression levels of the gene of interest and the compound in question. A value of zero indicates no 
expected influence of gene expression on the relevant aroma compound. Likewise, log-normalization 
was carried out on the actual metabolite concentrations measured in the overexpression strains to 
represent these values on a scale from -1 to 1, relative to the corresponding concentrations of the 
control fermentations. Figure 8 clearly shows that predicted and real changes overlapped significantly.   
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3.5 Discussion 
3.5.1 Over expression of genes 
The aim of this study was to determine whether the transcription profiles of the various strains during 
fermentation could be reconciled with the volatile aroma compound production of these strains, and 
whether this comparative analysis could be used to predict the impact of individual gene expression 
levels on aroma compounds and profiles. The data generated by the overexpression of four of the genes 
whose expression was statistically most significantly linked to the production of aroma profiles suggest 
that this approach has been successful. Indeed, overexpression of the selected genes had a far reaching 
impact on the aroma profiles produced by the fermenting yeast, and this impact was generally well 
aligned with the impact predicted from the comparative omics analysis. The data aligned better than 
we, considering the significant challenges when approaching complex systems, had expected. Our data 
show that the metabolic changes observed upon overexpression of three of the four genes, AAD10, 
AAD14 and BAT1, were very significantly aligned with the changes that were predicted from the 
alignment of transcriptome and metabolome data alone.  
 
The predictions, as can be seen from the alignment of predicted vs. observed changes in metabolite 
levels in a qualitative manner, indeed proved fairly reliable. The model was able to assign positive and 
negative influences on a particular compound with relative accuracy. Although the extent / magnitude 
of the increase / decrease is not always well aligned with model values, the absolute direction of the 
change holds true in most cases. An absolute alignment would not be expected, since the level of 
expression in a plasmid-based system can not be adjusted to the differences of expression observed 
between the different strains.  
 
In the case of AAD10, only the influence of the overexpression on decanoic acid was not in line with 
the projection. Predictions for AAD14 and BAT1 were well matched with the observed changes in 
metabolite profiles. Predicted and real changes did not match satisfactorily in only one case, ACS1. 
Nevertheless, even in this case, eight out of the thirteen compounds evolved in the predicted direction. 
It should also be noted that the expression of this gene had generally a less severe impact on changes in 
the aroma profile than those of the other three genes.  
 
Considering the complexity of the system, the rate of success achieved in this study can be considered 
as highly significant. To our knowledge, this is the first report to exploit such an intra- and interstrain 
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comparative approach to identify genes that play a significant role in a complex metabolic network. 
While we were clearly able to identify genes with significant impact on aroma compound production in 
a specific industrial environment, and which in some cases had not been previously directly linked to 
these pathways, the data do not allow a firm conclusion on the exact metabolic role of these genes. 
Indeed, the vast number of significant changes to metabolite levels makes it difficult to identify the 
specific ‘point of influence’ of any overexpressed gene in a given pathway.  
 
The increases/ decreases in specific volatile compounds seen for the VIN13(pBAT1-s) strain is in 
keeping with the results reported in colombar fermentations [28]. The two AAD gene overexpressing 
strains also showed interesting trends: Both strains produced higher levels (at comparable 
concentrations) of isoamyl alcohol, ethyl acetate, butanol, ethyl caprylate, ethyl caprate and hexanoic 
acid. However, noticeable differences can be seen in the levels of isobutanol, 2-phenyl ethanol, 
propionic acid, isoamyl acetate, ethyl hexanoate, isobutyric acid and isovaleric acid, relative to the 
control and to one another. This is indicative of the potential for the AAD genes to have overlapping 
yet distinct functional roles in the pathways leading to higher alcohol and ester production. 
Overexpression of the ACS1 gene did not lead to such numerous and substantial increases/ decreases in 
volatile production as was the case for the other three genes. Interestingly, valeric and isovaleric acid 
were below detection levels in these fermentations. Concentrations of isoamyl acetate, ethyl acetate, 
butanol and butyric acid were significantly higher, and ethyl caprate lower relative to control 
fermentations. 
 
On the whole though, our analysis shows that the cross-comparison of gene expression data with 
metabolite levels has the potential to identify points of interest on a genomic scale. This also opens new 
possibilities to design improved yeast enhancement strategies for optimized aroma production and 
fermentation performance.  
 
3.5.2 Other genes of interest 
Many other genes showed significant variation in expression between different strains and / or time 
points, as well as high loadings on PLS models and strong negative or positive correlations with 
specific aroma compounds. These genes encode enzymes that either are known to participate in aroma 
compound production, or have activities (either experimentally proven or suggested through sequence 
alignments) that could suggest such roles. Here we discuss some of the most relevant of these enzymes, 
which fall into several categories, either according to their place in a specific metabolic pathway such 
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as  the metabolisms of branched chain amino acids or of aromatic amino acids, or based on their 
specific activity such as dehydrogenases (in particular aldehyde and alcohol dehydrogenases) and 
acetyl transferases.  
 
Of the enzymes involved in branched chain amino acid metabolism, BAT1 has been discussed above. 
Other genes that encode enzymes in this pathway and that were identified in our study for their strong 
statistical link between expression levels and the production of specific compounds include LEU2, 
encoding a beta-isopropylmalate dehydrogenase that catalyzes the third step in the leucine biosynthesis 
pathway, and, to a lesser degree, LEU1, which encodes an isopropylmalate isomerase [33, 34]. Both of 
these genes showed a significant statistical correlation with compounds such as isobutanol. Of the 
genes involved in the metabolism of isoleucine and valine (Ilv), only ILV5, which encodes an 
acetohydroxyacid reductoisomerase involved in branched-chain amino acid biosynthesis [35], showed 
a very strong positive correlation with almost all of the compounds analysed here, and, interestingly, a 
negative correlation with ethanol, suggesting that this gene could be an interesting target for metabolic 
engineering.   
  
While BAT1 expression showed a significant positive correlation with a large number of the volatile 
compounds measured in our study, the cytosolic isoform (BAT2) of this enzyme showed no significant 
correlations with any of these aroma compounds. Although this isoform is supposedly highly expressed 
during stationary phase and repressed during the logarithmic phase, BAT2 expression levels in our 
study were found to stay constant, if not to decrease slightly upon entry into stationary phase in 
comparison to the exponential phase at day 2. In addition, BAT2 expression levels were generally 
considerably lower throughout fermentation when compared to BAT1.  
 
Of the genes involved in aromatic amino acid metabolism, three, ARO1, which encodes a 
pentafunctional arom protein, ARO7, which encodes a chorismate mutase responsible for the 
conversion of chorismate to prephenate and ARO8, which codes for an aromatic aminotransferase 
showed statistically significant correlations between expression levels and metabolite production [36, 
37]. All three genes showed a modest positive correlation (r2 = 0.7) with 2-phenyl ethanol and mild 
negative correlations with all the other compounds. Only octanoic acid showed a very strong (r2 = 0.82) 
negative correlation with ARO8 expression at day 2 of fermentation. Despite its seemingly crucial role, 
ARO10, which encodes a phenylpyruvate decarboxylase corresponding to the first specific step in the 
Ehrlich pathway did not show any noteworthy correlations between its expression and any of the 
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volatile compounds in our study [38]. Of course the possibility of translational or post-translational 
control of activity cannot be excluded.  
 
Several specific enzyme activities were also overrepresented in our list. Such enzymes include many 
dehydrogensases. Aldehyde and alcohol dehydrogenases such as those encoded by ALD5, ALD6, 
ADH6 and ADH7 showed a substantial decline in expression levels between days 2 and 5 of 
fermentation, while others (such as ALD3, ALD4, ADH2 and ADH5) increased during this time. The 
distinct expression patterns during fermentation reflects the different regulatory mechanisms governing 
the expression of these genes (i.e. expression of ALD3 is glucose-repressed and stress-induced) and 
suggests that the different ALD gene products have specific roles during different stages of 
fermentation [39].  
 
ALD4 and ALD5 (mitochondrial), and ALD3 and ALD6 (cytoplasmic) encode aldehyde dehydrogenases 
involved in the conversion of acetaldehyde to acetate [40]. ALD4 encodes a mitochondrial aldehyde 
dehydrogenase (utilizing NADP+ or NAD+) that is required for growth on ethanol and conversion of 
acetaldehyde to acetate [40]. Expression of ALD4 is also glucose repressed, and increases 2 to 4-fold 
from day 2 to 5 of fermentation. ALD4 expression shows a very strong correlation to the amount of 
hexyl acetate (R2 = 0.82) produced by the fermenting yeast, as well as to ethyl acetate (0.77), isoamyl 
alcohol (0.91) and isoamyl acetate (0.85). 
 
ALD6 encodes a constitutively expressed cytosolic aldehyde dehydrogenase (utilizes NADP+ as the 
preferred coenzyme) and is required for conversion of acetaldehyde to acetate [41]. Not surprisingly, 
ALD6 expression showed a very strong positive correlation to the levels of acetic acid produced by the 
fermenting cells (0.92). Also, expression was very strongly inversely correlated to ethanol production 
(R2 = 0.81). Interestingly, fairly strong positive correlations were also evident for 2-phenyl ethanol (R2 
= 0.79) and 2-phenyl ethyl acetate (R2 = 0.67).  
 
ADH6 encodes an NADPH-dependent cinnamyl alcohol dehydrogenase family member with broad 
substrate specificity [42]. Expression was correlated very strongly with isobutanol levels (0.81), 
isobutyric acid (0.86), propionic acid (0.81), acetic acid (0.87) and 2-phenyl ethanol (0.92).  ADH4, 
ADH5 and ADH7 on the other hand showed only modest correlations with the above-mentioned, or any 
other aroma compounds for that matter.  
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With respect to the aryl alcohol dehydrogenase family of genes, the transcripts for AAD3, AAD10 and 
AAD14 showed the greatest variation in expression, both on an intra- and interstrain level. Expression 
of AAD10 and AAD14, for example, was increased more than twofold in most of the strains at day 5 
relative to day 2 of fermentation. No distinct physiological role has been established for the products of 
these genes [7], but it is reasonable to suspect that the consistent increase in their respective transcript 
levels during the course of fermentation could be associated with the increase in one or several of the 
long chain alcohols or their acid counterparts as fermentation progresses (Tables 5 & 6). 
 
This hypothesis is supported by the data generated through the overexpression of these genes. Indeed, 
overexpression yielded changes to the aroma profile that were very similar to those predicted from the 
alignment of transcriptome and metabolome data sets. The expression of AAD10 showed weak yet 
significant positive correlations with a number of the aroma compounds. Expression of AAD14 
between different strains and time points was also highly variable. Highest expression levels were 
noted for the DV10 strain, and significant positive correlations with ethyl acetate (0.67) and ethyl 
caprate (0.74) were observed for this gene. 
 
Acetyl transferases are another family of enzymes of relevance to aroma compound metabolism [43]. 
However, neither ATF1 nor ATF2, the two most prominent alcohol acetyl transferases, showed 
statistically strong correlations between expression levels and metabolite production. EEB1, on the 
other hand, which encodes an acyl-coenzymeA:ethanol O-acyltransferase and is responsible for the 
major part of medium-chain fatty acid ethyl ester biosynthesis during fermentation [44], showed weak 
negative correlations with ethanol and other higher alcohols, and a strong positive correlation for 2-
phenylethyl acetate (0.9) as well as octanoic acid (0.78). It is tempting to speculate that Eeb1p may thus 
be largely responsible for the acetylation of 2-phenyl ethanol to produce 2-phenylethyl acetate. 
 
EHT1 encodes an acyl-coenzymeA:ethanol O-acyltransferase that plays a role in medium-chain fatty 
acid ethyl ester biosynthesis, but also contains a known esterase activity [44]. EHT1 expression 
increased somewhat as fermentation progressed and inter-strain expression at both day 2 and 5 of 
fermentation varied significantly. Interestingly, EHT1 expression showed a fairly strong inverse 
correlated with 2-phenylethyl acetate (R2 = 0.74) and octanoic acid (R2 = 0.75), as well as a weaker yet 
significant inverse correlation with decanoic acid (R2 = 0.59). This could indicate that the esterase 
activity of Eht1p could predominate under certain conditions. 
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YMR210W encodes a putative acyltransferase with similarity to both Eeb1p and Eht1p, and may have a 
minor role in medium-chain fatty acid ethyl ester biosynthesis [44]. Expression was positively 
correlated with ethyl acetate (0.74), ethyl caprylate (0.85) and isoamyl acetate (0.78). In addition to 
these relatively well studied acetyltransferases, the mRNA levels of the AYT1 gene, encoding a 
transferase of unknown substrate specificity, also showed considerable variation at different 
fermentative stages [45].   
 
3.6 Conclusions 
The impact of these individual genes on aroma compound metabolism has to be assessed individually. 
However, from the data presented here, it is clear that an analysis based on the comparison of 
transcriptome and metabolome data derived from different commercial yeast strains can help to 
identify genes that most significantly impact a metabolic network in specific environmental and 
industrial conditions. Our over-expression analysis of five genes that were randomly selected from the 
list of ORFs identified for their statistically significant impact on aroma production also clearly 
suggests that the method has significant predictive power regarding the reorientation of metabolic flux 
through the network in response to changes in gene expression levels. Indeed, for four out of five 
selected genes, BAT1, AAD10, AAD14 and ACS1, the match between predicted and real changes is 
highly significant. This is the first study linking metabolic networks to transcriptome analysis through 
the comparative analysis of different wine yeast strains.   
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Appendix 
 
GENE NAME SYSTEMATICNAME
AAD3 YCR107W
AAD3 YCR107W
POT1 YIL160C
LEU2 YCL018W
ALD3 YMR169C
SFA1 YDL168W
EEB1 YPL095C
YJL218W YJL218W
ARO1 YDR127W
ADH6 YMR318C
ATF2 YGR177C
ARO10 YDR380W
PDC6 YGR087C
ALP1 YNL270C
ALD5 YER073W
ARO7 YPR060C
ADH3 YMR083W
ACS1 YAL054C
GRE2 YOL151W
HPA3 YEL066W
BAP3 YDR046C
HAT2 YEL056W
ILV5 YLR355C
ARO4 YBR249C
ILV3 YJR016C
ADH2 YMR303C
VBA3 YCL069W
FDH1 /// FDH2 YOR388C
AAD10 YJR155W
FUNCTIONAL DESCRIPTION (BRIEF)
Putative aryl-alcohol dehydrogenase with similarity to P. chrysosporium aryl-alcohol dehydrogenase; mutational analysis has not 
yet revealed a physiological role
Putative aryl-alcohol dehydrogenase with similarity to P. chrysosporium aryl-alcohol dehydrogenase; mutational analysis 
has not yet revealed a physiological role
3-ketoacyl-CoA thiolase with broad chain length specificity, cleaves 3-ketoacyl-CoA into acyl-CoA and acetyl-CoA during beta-
oxidation of fatty acids
Beta-isopropylmalate dehydrogenase, catalyzes the third step in the leucine biosynthesis pathway
Cytoplasmic aldehyde dehydrogenase, involved in beta-alanine synthesis; uses NAD+ as the preferred coenzyme; very similar to 
Ald2p; expression is induced by stress and repressed by glucose
Bifunctional enzyme containing both alcohol dehydrogenase and glutathione-dependent formaldehyde dehydrogenase activities, 
functions in formaldehyde detoxification and formation of long chain and complex alcohols
Acyl-coenzymeA:ethanol O-acyltransferase responsible for the major part of medium-chain fatty acid ethyl ester biosynthesis 
during fermentation; possesses short chain esterase activity
Putative protein of unknown function, similar to bacterial galactoside O-acetyltransferases; induced by oleate in an OAF1/PIP2-
dependent manner
Pentafunctional arom protein, catalyzes steps 2 through 6 in the biosynthesis of chorismate, which is a precursor to aromatic 
amino acids
NADPH-dependent cinnamyl alcohol dehydrogenase family member with broad substrate specificity; may be involved in fusel 
alcohol synthesis or in aldehyde tolerance
Alcohol acetyltransferase, may play a role in steroid detoxification; forms volatile esters during fermentation, which is important in 
brewing
Phenylpyruvate decarboxylase, catalyzes decarboxylation of phenylpyruvate to phenylacetaldehyde, which is the first specific step 
in the Ehrlich pathway
Minor isoform of pyruvate decarboxylase, key enzyme in alcoholic fermentation, decarboxylates pyruvate to acetaldehyde, 
regulation is glucose- and ethanol-dependent, involved in amino acid catabolism
Basic amino acid transporter, involved in uptake of cationic amino acids
Mitochondrial aldehyde dehydrogenase, involved in regulation or biosynthesis of electron transport chain components and acetate 
formation; activated by K+; utilizes NADP+ as the preferred coenzyme; constitutively expressed
Chorismate mutase, catalyzes the conversion of chorismate to prephenate to initiate the tyrosine/phenylalanine-specific branch of 
aromatic amino acid biosynthesis
Mitochondrial alcohol dehydrogenase isozyme III; involved in the shuttling of mitochondrial NADH to the cytosol under anaerobic 
conditions and ethanol production
Acetyl-coA synthetase isoform which, along with Acs2p, is the nuclear source of acetyl-coA for histone acetlyation; expressed 
during growth on nonfermentable carbon sources and under aerobic conditions
NADPH-dependent methylglyoxal reductase (D-lactaldehyde dehydrogenase); stress induced (osmotic, ionic, oxidative, heat 
shock and heavy metals); regulated by the HOG pathway
D-Amino acid N-acetyltransferase; similar to Hpa2p, acetylates histones weakly in vitro
Amino acid permease involved in the uptake of cysteine, leucine, isoleucine and valine
Subunit of the Hat1p-Hat2p histone acetyltransferase complex; 
Acetohydroxyacid reductoisomerase, mitochondrial protein involved in branched-chain amino acid biosynthesis, also required for 
maintenance of wild-type mitochondrial DNA
3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP) synthase, catalyzes the first step in aromatic amino acid biosynthesis and 
is feedback-inhibited by tyrosine or high concentrations of phenylalanine or tryptophan
Dihydroxyacid dehydratase, catalyzes third step in the common pathway leading to biosynthesis of branched-chain amino acids
Glucose-repressible alcohol dehydrogenase II, catalyzes the conversion of ethanol to acetaldehyde; involved in the production of 
certain carboxylate esters; regulated by ADR1
Permease of basic amino acids in the vacuolar membrane /// Hypothetical protein
NAD(+)-dependent formate dehydrogenase, may protect cells from exogenous formate
Putative aryl-alcohol dehydrogenase with similarity to P. chrysosporium aryl-alcohol dehydrogenase; mutational analysis has not 
yet revealed a physiological role  
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GENE NAME SYSTEMATICNAME
YJL045W YJL045W
PDC5 YLR134W
ACS2 YLR153C
BAP2 YBR068C
ERG10 YPL028W
ARO9 YHR137W
YMR041C YMR041C
ARO8 YGL202W
ERG13 YML126C
ADR1 YDR216W
TAT1 YBR069C
ILV1 YER086W
ALD4 YOR374W
MAE1 YKL029C
BAT2 YJR148W
BDH1 YAL060W
LEU1 YGL009C
YMR210W YMR210W
YGL039W YGL039W
YGL157W YGL157W
THI3 YDL080C
ADH7 YCR105W
AYT1 YLL063C
TKL2 YBR117C
TMT1 YER175C
ADH4 YGL256W
ALD6 YPL061W
CHA1 YCL064C
TKL1 YPR074C
FUNCTIONAL DESCRIPTION (BRIEF)
Minor succinate dehydrogenase isozyme; homologous to Sdh1p, the major isozyme reponsible for the oxidation of succinate and 
transfer of electrons to ubiquinone; induced during the diauxic shift in a Cat8p-dependent manner
Minor isoform of pyruvate decarboxylase, key enzyme in alcoholic fermentation, decarboxylates pyruvate to acetaldehyde, 
regulation is glucose- and ethanol-dependent, repressed by thiamine, involved in amino acid catabolism
Acetyl-coA synthetase isoform which, along with Acs1p, is the nuclear source of acetyl-coA for histone acetlyation; required for 
growth on glucose; expressed under anaerobic conditions
High-affinity leucine permease, functions as a branched-chain amino acid permease involved in the uptake of leucine, isoleucine 
and valine
Acetyl-CoA C-acetyltransferase (acetoacetyl-CoA thiolase), cytosolic enzyme that transfers an acetyl group from one acetyl-CoA 
molecule to another, forming acetoacetyl-CoA; involved in the first step in mevalonate biosynthesis
Aromatic aminotransferase, catalyzes the first step of tryptophan, phenylalanine, and tyrosine catabolism
Putative protein of unknown function with similarity to aldo/keto reductases; YMR041C is not an essential gene
NADPH-dependent cinnamyl alcohol dehydrogenase family member with broad substrate specificity; may be involved in fusel 
alcohol synthesis
Acetyltransferase; catalyzes trichothecene 3-O-acetylation, suggesting a possible role in trichothecene biosynthesis
NAD-dependent (2R,3R)-2,3-butanediol dehydrogenase, a zinc-containing medium-chain alcohol dehydrogenase, produces 2,3-
butanediol from acetoin during fermentation
Isopropylmalate isomerase, catalyzes the second step in the leucine biosynthesis pathway
Putative acyltransferase with similarity to Eeb1p and Eht1p, has a minor role in medium-chain fatty acid ethyl ester biosynthesis; 
may be involved in lipid metabolism and detoxification
Oxidoreductase, catalyzes NADPH-dependent reduction of the bicyclic diketone bicyclo[2.2.2]octane-2,6-dione (BCO2,6D) to the 
chiral ketoalcohol (1R,4S,6S)-6-hydroxybicyclo[2.2.2]octane-2-one (BCO2one6ol)
Oxidoreductase, catalyzes NADPH-dependent reduction of the bicyclic diketone bicyclo[2.2.2]octane-2,6-dione (BCO2,6D) to the 
chiral ketoalcohol (1R,4S,6S)-6-hydroxybicyclo[2.2.2]octane-2-one (BCO2one6ol)
Probable decarboxylase, required for expression of enzymes involved in thiamine biosynthesis; may have a role in catabolism of 
amino acids to long-chain and complex alcohols
Catabolic L-serine (L-threonine) deaminase, catalyzes the degradation of both L-serine and L-threonine; required to use serine or 
threonine as the sole nitrogen source, transcriptionally induced by serine and threonine
Transketolase; catalyzes conversion of xylulose-5-phosphate and ribose-5-phosphate to sedoheptulose-7-phosphate and 
glyceraldehyde-3-phosphate in the pentose phosphate pathway; needed for synthesis of aromatic amino acids
Threonine deaminase, catalyzes the first step in isoleucine biosynthesis; expression is under general amino acid control
Mitochondrial aldehyde dehydrogenase, required for growth on ethanol and conversion of acetaldehyde to acetate; activity is K+ 
dependent; utilizes NADP+ or NAD+ equally as coenzymes; expression is glucose repressed
Carbon source-responsive zinc-finger transcription factor, required for transcription of the glucose-repressed gene ADH2, of 
peroxisomal protein genes, and of genes required for ethanol, glycerol, and fatty acid utilization
Amino acid transport protein for valine, leucine, isoleucine, and tyrosine, low-affinity tryptophan and histidine transporter
Mitochondrial malic enzyme, catalyzes the oxidative decarboxylation of malate to pyruvate, which is a key intermediate in sugar 
metabolism and a precursor for synthesis of several amino acids
Cytosolic branched-chain amino acid aminotransferase; highly expressed during stationary phase and repressed during 
logarithmic phase
Aromatic aminotransferase, expression is regulated by general control of amino acid biosynthesis
3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase, catalyzes the formation of HMG-CoA from acetyl-CoA and acetoacetyl-
CoA; involved in the second step in mevalonate biosynthesis
Transketolase; catalyzes conversion of xylulose-5-phosphate and ribose-5-phosphate to sedoheptulose-7-phosphate and 
glyceraldehyde-3-phosphate in the pentose phosphate pathway; needed for synthesis of aromatic amino acids
Trans-aconitate methyltransferase, cytosolic enzyme that catalyzes the methyl esterification of 3-isopropylmalate, an intermediate 
of the leucine biosynthetic pathway, and trans-aconitate, which inhibits the citric acid cycle
Alcohol dehydrogenase type IV, dimeric enzyme demonstrated to be zinc-dependent despite sequence similarity to iron-activated 
alcohol dehydrogenases
Cytosolic aldehyde dehydrogenase, activated by Mg2+ and utilizes NADP+ as the preferred coenzyme; required for conversion of 
acetaldehyde to acetate; constitutively expressed
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GENE NAME SYSTEMATICNAME
BAT1 YHR208W
GRE3 YHR104W
EHT1 YBR177C
ADH5 YBR145W
ILV6 YCL009C
MAK3 YPR051W
ATF1 YOR377W
ILV2 YMR108W
LEU9 YOR108W
YPL113C YPL113C
AAD14 YNL331C
Alcohol acetyltransferase with potential roles in lipid and sterol metabolism; responsible for the major part of volatile acetate ester 
production during fermentation
Acetolactate synthase, catalyses the first common step in isoleucine and valine biosynthesis and is the target of several classes of 
inhibitors, localizes to the mitochondria; expression of the gene is under general amino acid control
Alpha-isopropylmalate synthase II (2-isopropylmalate synthase), catalyzes the first step in the leucine biosynthesis pathway; the 
minor isozyme, responsible for the residual alpha-IPMS activity detected in a leu4 null mutant
Putative dehydrogenase
Putative aryl-alcohol dehydrogenase with similarity to P. chrysosporium aryl-alcohol dehydrogenase; mutational analysis has not 
yet revealed a physiological role
FUNCTIONAL DESCRIPTION (BRIEF)
Mitochondrial branched-chain amino acid aminotransferase, homolog of murine ECA39; highly expressed during logarithmic 
phase and repressed during stationary phase
Aldose reductase involved in methylglyoxal, d-xylose and arabinose metabolism; stress induced (osmotic, ionic, oxidative, heat 
shock, starvation and heavy metals); regulated by the HOG pathway
Acyl-coenzymeA:ethanol O-acyltransferase that plays a minor role in medium-chain fatty acid ethyl ester biosynthesis; contains 
esterase activity; localizes to lipid particles and the mitochondrial outer membrane
Alcohol dehydrogenase isoenzyme V; involved in ethanol production
Regulatory subunit of acetolactate synthase, which catalyzes the first step of branched-chain amino acid biosynthesis; enhances 
activity of the Ilv2p catalytic subunit, localizes to mitochondria
Catalytic subunit of N-terminal acetyltransferase of the NatC type; required for replication of dsRNA virus
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CHAPTER 4 
Comparative transcriptomic responses of wine yeast strains in different 
fermentation media: towards understanding the interaction between 
environment and transcriptome during alcoholic fermentation 
 
4.1 Abstract 
System-wide ‘omics’ approaches have been widely applied in Saccharomyces cerevisiae. The large 
majority of such studies have been focusing on a limited number of laboratory strains to provide 
general insights into the nature of biological systems. More recently, industrial S. cerevisiae strains 
have become the target of such analyses, mainly to improve our understanding of biotechnologically 
relevant phenotypes that can not be adequately studied in laboratory strains. While such studies have 
provided significant insights, they have mostly, if not exclusively, been based on investigating single 
strains in a single medium. This experimental lay-out does not allow differentiating between generally 
relevant molecular responses and strain- or media-specific features. Here we analysed the 
transcriptomes of two phenotypically diverging wine yeast strains in two different fermentation media 
at three stages of wine fermentation. The data show that the intersection of transcriptome datasets from 
fermentations using either synthetic MS300 (simulated wine must) or real grape must (Colombard) can 
help to delineate relevant from ‘noisy’ changes in gene expression in response to experimental factors 
such as fermentation stage and strain identity. The differences in the expression profiles of strains in 
the different environments also provide some relevant insights into the transcriptional responses 
towards specific compositional features of the media. In a broader cellular context, the data also 
suggest that the synthetic must MS300 is a representative environment for conducting research on 
grape must fermentation and industrially relevant properties of wine yeast strains. 
 
4.2 Introduction 
Research on the model eukaryote, S. cerevisiae, has mainly been conducted using laboratory strains 
under laboratory conditions in laboratory media. Most approaches were designed to facilitate genetic 
and molecular analysis and were not representative of the natural or industrial ecological niches that 
provided the evolutionary framework for this species in the past centuries. As a probable consequence, 
laboratory conditions and strains appear unsuited for the analysis of many genes and their function/s, 
and in particular of many biotechnologically relevant phenotypes.  
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In the case of wine fermentation, some of the most obvious differences to standard laboratory 
conditions include very high sugar levels (20-30% w/v) of an equimolar mixture of glucose and 
fructose, a low pH (pH 3.0-3.8), self-anaerobic growth and nitrogen as the limiting nutrient for growth. 
In these conditions, metabolism is programmed to optimize yeast cells for fermentative dissimilation of 
the carbon source. During alcoholic fermentation yeast cells are also exposed simultaneously and 
sequentially to numerous stress conditions (Attfield, 1997; Bauer & Pretorius, 2000). The yeast must 
respond to fluctuations in dissolved oxygen concentration, pH, osmolarity, ethanol concentration, 
nutrient supply and temperature in order to survive. Not surprisingly, data suggest that the fermentation 
performance of industrial wine yeast strains is largely dependent on their ability to adapt to these 
changes (Ivorra et al., 1999).  
 
Analysis of the molecular adaptations and responses in such a complex system in the past had to use a 
reductionist, gene-by-gene approach. Large scale functional genomic analysis tools today open the way 
for new approaches to allow a holistic understanding of these molecular systems. Several such 
approaches have been undertaken to analyze wine yeast strains and wine fermentation conditions.  The 
synthetic wine must MS300 has been used to investigate transcriptional changes during fermentation of 
a single yeast strain (Rossignol et al., 2003). Other transcriptional studies of wine yeast have relied on 
different wine musts such as Riesling (Marks et al., 2003; Marks et al., 2008) and Muscat (Beltran et 
al., 2006) for fermentations of single strains only. These studies have identified differentially expressed 
transcripts in these specific strains in response to experimental factors such as temperature, nitrogen 
availability and fermentative stage. However, no attempt has been made to compare the effects that 
different grape-based or grape-like fermentation media have on the transcriptional responses of wine 
yeast strains, or to assess the effect of strain identity. It is therefore unknown to what degree the data 
derived from such studies are representative of wine fermentations in the broader context, and to what 
degree comparisons between transcript data from different fermentation media reflect biologically 
relevant responses to general fermentation conditions as opposed to media-specific responses.  
 
In a previous work (Rossouw et al., 2008), we have been able to show that complex molecular systems 
can be fruitfully analysed by taking a comparative approach. In this study, several phenotypically 
diverging wine yeast strains were compared on a transcriptomic and metabolomic level. These data 
allowed us to predict the impact of individual gene expression levels on a complex metabolic network 
in the conditions that were used to generate the initial data sets. To provide comparable datasets, all 
analyses were conducted in a well-defined synthetic medium that approximates conditions encountered 
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in grape must, and which has been used in many studies to provide conditions that are representative of 
wine fermentation. A question that requires further investigation is therefore whether data generated in 
such a system can serve as a general model and be extrapolated to events occurring in real grape must, 
a medium that is infinitely more complex and highly variable.    
 
In this study, we therefore conducted parallel fermentations with two phenotypically highly divergent 
commercial wine yeast strains, VIN13 and BM45, in two different media, namely the synthetic MS300 
and real Colombard must. The data show that the intersection of transcriptome datasets from both 
MS300 (simulated wine must) and Colombard fermentations can help to delineate relevant from 
‘noisy’ changes in gene expression in response to experimental factors such as fermentation stage and 
strain identity. Differences in the expression profiles of strains in different environments also provide 
some insights into the transcriptional responses towards specific compositional features of the media. 
In a broader cellular context, the data also show that the synthetic must MS300 is a representative 
environment for conducting research on grape must fermentation and industrially relevant properties of 
wine yeast strains. 
 
4.3 Methods 
4.3.1 Strains, media and culture conditions 
The two yeast strains used in this study are BM45 (Lallemand Inc., Montréal, Canada) and VIN13 
(Anchor yeast, South Africa). Both are diploid S. cerevisiae strains used in industrial wine 
fermentations. Yeast cells were cultivated at 30oC in YPD synthetic media 1% yeast extract (Biolab, 
South Africa), 2% peptone (Fluka, Germany), 2% glucose (Sigma, Germany). Solid medium was 
supplemented with 2% agar (Biolab, South Africa). 
 
4.3.2 Fermentation media 
One set of fermentation experiments was carried out with synthetic must MS300, which approximates 
to a natural must as previously described (Bely et al., 1990). The medium contained 125 g/L glucose 
and 125 g/L fructose, and the pH was buffered at 3.3 with NaOH. The second complementary set of 
fermentations was carried out with a 2008 Colombard must (pH 3.5) containing 108 g/L glucose and 
117 g/L fructose.  
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4.3.3 Fermentation conditions 
All fermentations were carried out under microaerobic conditions in 100ml glass bottles (containing 80 
ml of the medium) sealed with rubber stoppers with a CO2 outlet. The fermentation temperature was 
approximately 22oC and no stirring was performed during the course of the fermentation. Fermentation 
bottles were inoculated with YPD cultures in the logarithmic growth phase (around OD600 = 1) to an 
OD600 of 0.1 (i.e. a final cell density of approximately 106 cfu.ml-1). The cells from the YPD pre-
cultures were briefly centrifuged and resuspended in MS300 or Colombard must to avoid carryover of 
YPD to the fermentation media. The fermentations followed a time course of 14 days and the bottles 
were weighed daily to assess the progress of fermentation. Samples of the fermentation media and cells 
were taken at days 2, 5 and 14 as representative of the exponential, early logarithmic and late 
logarithmic growth phases respectively. 
 
4.3.4 Measurement of growth 
Cell proliferation (i.e. growth) was determined spectrophotometrically (PowerwaveX, Bio-Tek 
Instruments) by measuring the optical density (at 600 nm) of 200 µl samples of the suspensions over 
the 14 day experimental period. 
 
4.3.5 Analytical methods - HPLC 
Culture supernatants were obtained from the cell-free upper layers of the fermentation media. For the 
purposes of glucose determination and carbon recovery, culture supernatants and starting media were 
analyzed by high performance liquid chromatography (HPLC) on an AMINEX HPX-87H ion exchange 
column (at a temperature of 55 oC) using 5 mM H2SO4 as the mobile phase at a flow rate of 0.5 ml.min-
1. Agilent RID and UV detectors were used in tandem for peak detection and quantification. Analysis 
was carried out using the HPChemstation software package. 
 
4.3.6 Analytical methods - LCMS 
The amino acid composition of the grape must was determined by liquid chromatography mass 
spectrometry. Samples were analyzed using the EZ:Faast LCMS protocol (Phenomenex, UK). After 
solid phase extraction and derivatization the samples were subjected to LCMS analysis using the 
EZ:Faast column (method described by the EZ:Faast user’s guide). Labelled Homoarginine, 
Methionine-D3 and homophenylalanine were included as internal standards.  
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4.3.7 Analytical methods - GCMS 
Each 5 ml sample of synthetic must taken during fermentation was spiked with an internal standard of 
4-methyl-2-pentanol to a final concentration of 10 mg.l-1. To each of these samples 1 ml of solvent 
(diethyl ether) was added and the tubes sonicated for 5 minutes. The top layer in each tube was 
separated by centrifugation at 3000 rpm for 5 minutes and the extract analyzed. After mixing, 3 μl of 
each sample was injected into the gas chromatograph (GC). All extractions were done in triplicate. 
The analysis of volatile compounds was carried out on a Hewlett Packard 5890 Series II GC coupled to 
an HP 7673 auto-sampler and injector and an HP 3396A integrator. The column used was a Lab 
Alliance organic-coated, fused silica capillary with dimensions of 60 m × 0.32 mm internal diameter 
with a 0.5 μm coating thickness. The injector temperature was set to 200°C, the split ratio to 20:1 and 
the flow rate to 15 ml.min-1, with hydrogen used as the carrier gas for a flame ionisation detector held 
at 250°C.  The oven temperature was increased from 35°C to 230°C at a ramp of 3°C min 1.  
Internal standards (from Merck, Cape Town) were used to calibrate the machine for each of the 
compounds measured. 
 
4.3.8 General statistical analysis 
T-tests and anova analyses were conducted using Statistica (version 7). HCL and KMC clustering were 
carried out using TIGR MeV v2.2 (Ben-Dor et al., 1999). 
 
4.3.9 Microarray analysis 
Sampling of cells from fermentations and total RNA extraction was performed as described by Abbott 
et al., (2007). Probe preparation and hybridization to Affymetrix Genechip® microarrays were 
performed according to Affymetrix instructions, starting with 6 μg of total RNA. Results for each strain 
and time point were derived from 3 independent culture replicates. The quality of total RNA, cDNA, 
cRNA and fragmented cRNA were confirmed using the Agilent Bioanalyzer 2100.  
 
4.3.10 Transcriptomics data acquisition and statistical analysis 
Microarray data for the MS300 fermentations can be viewed at the GEO repository under the accession 
number GSE11651. The Colombard microarray outputs are available under the accession number 
GSE13695. Acquisition and quantification of array images and data filtering were performed using 
Affymetrix GeneChip® Operating Software (GCOS) version 1.4. All arrays were scaled to a target 
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value of 500 using the average signal from all gene features using GCOS. Genes with expression 
values below 12 were set to 12 + the expression value as previously described (Boer et al., 2003) in 
order to eliminate insignificant variations. 
 
Determination of differential gene expression between experimental parameters was conducted using 
SAM (Significance Analysis of Microarrays) version 2 (Tusher et al., 2001). The two-class, unpaired 
setting was used and genes with a Q value less than 0.5 (p < 0,0005) were considered differentially 
expressed. Only genes with a fold change greater than 2 (positive or negative) were taken into 
consideration. 
 
4.3.11 Analyses of multivariate data 
The patterns within the different sets of data were investigated by principal-component analysis (PCA; 
The Unscrambler; Camo Inc., Corvallis, Oreg.). PCA is a bilinear modeling method which gives a 
visually interpretable overview of the main information in large, multidimensional data sets. By 
plotting the principal components it is possible to view statistical relationships between different 
variables in complex data sets and detect and interpret sample groupings, similarities or differences, as 
well as the relationships between the different variables (Mardia et al., 1979).  
 
4.4 Results 
4.4.1 Composition of wine must 
The most relevant characteristics of the Colombard must, including pH (3.5) and sugar concentrations 
(108 g/L glucose and 117 g/L fructose) were determined. In addition, the amino acid concentrations of 
the must was determined by LCMS and compared to the composition of MS300 (Table 1), since amino 
acids are the primary precursors of many aroma compounds. 
 
The total amino acid content of the Colombard must is much lower than that of MS300 (approximately 
1.2 g.L-1 as opposed to 2.4 g.L-1). However, the fact that trypthophan and cystein are largely destroyed 
by the sample preparation procedure should be taken into consideration. Also, recoveries for sulfur-
containing amino acids such as tyrosine and methionine can be as low as 50 - 75%. Overall, the most 
significant differences in the amino acid concentrations of the two media were found for glutamine, 
arginine, leucine, glycine, threonine and methionine. 
 
 79
 
Table 1 Concentrations of the amino acids (in mg.L-1) in Colombard must in comparison to the 
standard MS300 composition. Amino acids that are present at concentrations below the 
detection limit are indicated by ‘bd’. The last column represents amino acids in the 
Colombard must as a percentage of the corresponding amino acids in MS300. 
 
Amino Acid
MS300
[mg/l]
Colombar
[mg/l] %
tyrosine 18.3 20.9 114.0
tryptophan 179.3 n/a n/a
isoleucine 32.7 20.9 63.9
aspartic acid 44.5 78.5 176.4
glutamic acid 120.4 76.7 63.7
arginine 374.4 67.6 18.1
leucine 48.4 18.4 38.0
threonine 75.9 41.6 54.8
glycine 18.3 9.4 51.3
glutamine 505.3 112.8 22.3
alanine 145.3 170.5 117.3
valine 44.5 55.4 124.5
methionine 31.4 2.5 8.0
phenylalanine 38.0 20.4 53.7
serine 78.5 90.7 115.5
histidine 32.7 39 119.2
lysine 17.0 bd 0.0
cystein 13.1 n/a n/a
proline 612.6 424 69.2  
 
4.4.2 Fermentation kinetics 
The BM45 and VIN13 strains generally displayed similar growth rates and primary fermentation 
kinetics such as fermentation rate, sugar utilization, ethanol production etc, regardless of the 
fermentation media (Figures 1 and 2). The strains followed typical wine fermentation patterns and all 
fermented to dryness within the monitored period.  
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Figure 1 CO2 release (frame A) and growth rate (frame B) during fermentation. Values are the average 
of 4 biological repeats ± standard deviation.  
 
Differences between the MS300 fermentations and the real wine must fermentations are evident for the 
total amount of ethanol and glycerol produced (Figure 2).  However, in terms of the yield (glycerol or 
ethanol produced per gram sugar consumed) these differences are negligible due to the slightly higher 
total sugar concentration at the start of the MS300 fermentations. 
 
 
Figure 2 Fermentation kinetics of the five yeast strains used in this study: Glucose utilization (A), 
fructose utilization (B), glycerol production (C) and ethanol production (D). All y-axis 
values are in g.l-1 and refer to extracellular metabolite concentrations in the synthetic must. 
Values are the average of 4 biological repeats ± standard deviation. 
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BM45 and VIN13 are widely used in the wine industry and are optimized for fermentation 
performance. As such, no vast differences in their primary fermentative capacity are expected. 
However, from an oenological perspective the strains differ with regard to several key areas, which will 
be covered in the following sections.  
 
4.4.3 Production of volatile aroma compounds 
Significant differences exist in the volatile aroma compound profiles produced by the VIN13 and 
BM45 strains, both in MS300 (Rossouw et al., 2008), as well as in real wine must (Table 2).  
 
Table 2 Volatile alcohols and esters present in the must at days 2, 5 and 14 of fermentation in VIN13 
and BM45. All values are expressed as mg.L-1 and are the average of 4 biological repeats ± 
standard deviation. Metabolites present at concentrations below the detection limit are 
indicated by “bd”. 
COMPOUND THRESHOLD ODOR VIN13 BM45 VIN13 BM45 VIN13 BM45
Ethyl Acetate 12 Apple, Pineapple, balsamic 35.18 ± 1.78 23.75 ± 1.18 46.1 ± 5.86 32.24 ± 3.36 48.12 ± 1.89 39.73 ± 2.3
Methanol 123.2 ± 12.7 120 ± 2 118.5 ± 20.9 78.92 ± 6.77 121.13 ± 11.39 111.81 ± 19.9
Propanol 306 Alcohol, ripe fruit, stupefying 17.23 ± 9.04 20.17 ± 6.02 31.07 ±  7.15 33.15 ± 1.26 86.95 ± 4.3 42.4 ± 1.84
Isobutanol 74 Alcohol, nail polish 19.22 ± 2.53 24.2 ± 0.63 30.7 ± 2.1 38.8 ± 1.12 36.24 ± 2.85 46.77 ± 3.58
Isoamyl Acetate 60 Solvent, marzipan, malt 0.85 ± 0.05 0.58 ± 0.02 1.03 ± 0.05 0.76 ± 0.02 0.93 ± 0.05 0.67 ± 0.03
Butanol 50 Medicinal, wine-like 0.49 ± 0.03 0.26 ± 0.01 0.80 ± 0.03 0.59 ± 0.02 0.92 ± 0.05 1.11 ± 0.02
Isoamyl alcohol 54.81 ± 4.54 52.98 ± 0.84 105.5 ± 9.78 90.1 ± 1.11 123 ± 7.6 112.4 ± 5.55
Ethyl hexanoate 0.67 Green apple, banana 0.78 ± 0.03 0.74 ± 0.01 0.75 ± 0.01 0.80 ± 0.02 0.68 ± 0.01 0.7 ± 0.02
Ethyl Caprylate 0.58 Sweet pear, banana 0.11 ± 0.01 0.13 ± 0.01 0.15 ± 0.01 0.2 ± 0.02 0.14 ± 0.01 0.2 ± 0.01
Acetic Acid Vinegar 460 ± 12 452 ± 12 698 ± 45 667 ± 18 694 ± 32 763 ± 34.6
Propionic Acid 2.49 ± 0.17 1.75 ± 0.01 4.21 ± 0.28 2.98 ± 0.09 4.3 ± 0.35 3.04 ± 0.18
Iso-Butyric Acid 8.1 Rancid butter/ cheese 0.62 ± 0.04 0.78 ± 0.02 0.88 ± 0.09 1.05 ± 0.03 0.794± 0.08 1.11 ± 0.08
Butyric Acid 2.2 Rancid cheese, sweet 0.79 ± 0.06 0.78 ± 0.01 0.97 ± 0.05 0.94 ± 0.01 0.96 ± 0.09 0.92 ± 0.01
Ethyl Caprate 0.5 Brandy, fruity, grape, floral 0.14 ± 0.01 0.1 ± 0.01 0.24 ± 0.02 0.15 ± 0.02 0.28 ± 0.01 0.26 ± 0.01
Iso-Valeric Acid 0.7 Rancid cheese, putrid bd bd bd bd 0.05 ± 0.01 bd
Hexanol 1 Herbaceous, peppery 0.31 ± 0.03 0.42 ± 0.01 0.34 ± 0.01 0.43 ± 0.01 0.25 ± 0.01 0.33 ± 0.02
Hexanoic Acid 8 Goat, sweaty 0.98 ± 0.06 1.2 ± 0.01 1.1 ± 0.02 1.2 ± 0.02 1.78 ± 0.22 1.07 ± 0.03
2-Phenyl Ethanol 200 Rose, honey 7.2 ± 0.75 9.3± 0.3 11.93 ± 0.27 11.58 ± 0.18 15.36 ± 0.84 13.32 ± 0.4
Octanoic Acid 10 Fatty, rancid, oily, soapy 1.36 ± 0.15 1.17 ± 0.03 1.65 ± 0.13 1.4 ± 0.06 1.76 ± 0.3 1.08 ± 0.04
Decanoic Acid 6 Fatty, rancid 0.24 ± 0.09 0.22 ± 0.02 0.75 ± 0.09 0.68 ± 0.13 2.27 ± 0.43 1.15 ± 0.06
DAY2 DAY5 DAY14
 
 
Importantly, the general pattern of aroma production was identical between the two media. The aroma 
compounds produced show an increase in concentration in the must over time, although the most active 
period of aroma compound accumulation appears to be during the active growth phase corresponding 
to the first five days of fermentation. The aroma compounds that are proportionally the most variable 
between VIN13 and BM45 by the end of fermentation are ethyl acetate, propanol, isobutanol, isoamyl 
acetate, propionic acid, isobutyric acid, hexanoic acid, octanoic acid and decanoic acid. This is similar 
to the trends observed for these two strains in the MS300 fermentations (Rossouw et al., 2008), 
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although the absolute concentrations of the aroma compounds produced vary in a noteworthy manner 
between the different media. This is to be expected considering that the metabolic pathways 
responsible for the production of the main aroma compounds are responsive to many factors, the most 
important of which is the availability of precursors such as the branched amino acids.  
 
4.4.4 Global gene expression profiles 
All aspects of the microarray workflow were compliant with MIAME standards. Variation between 
independent biological repeats was negligible and changes in gene expression during the course of 
fermentation matched up well with published data of a similar microarray analysis of the VIN13 strain 
(Marks et al., 2008). We are thus confident that both the Colombard and MS300 analyses are reliable, 
reproducible and comparable. Care was taken so synchronize the growth curves of the different 
fermentations so that sampling points correspond closely to one another  
 
For comparisons between any of the three time points approximately 500-1500 genes significantly 
increased or decreased in expression (2-fold or greater) for the BM45 and VIN13 strains in either the 
synthetic or real must. At each time point, the variation in gene expression between VIN13 and BM45 
(in the same medium) was in the range of 200-800 transcripts. 
 
4.4.5 Results of PCA analysis 
The patterns within the different sets of data were investigated by principal-component analysis (PCA). 
In terms of design, the samples represent the different fermentations (3 independent replicates for each 
of the two strains) at three different time points in two different fermentation media. The variables 
considered are the expression levels of the total gene set. 
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Figure 3 PCA analysis of whole transcriptome analysis for Colombar and MS300 fermentations. 
Components 1 and 2, and components 1 and 3, are plotted in frames A and B respectively. 
Strains can be identified as follows: MS300 VIN13 (green) and BM45 (light blue); 
Colombar VIN13 (blue) and BM45 (red). 
 
From frame A (Figure 3) it is clear that, not surprisingly, the primary experimental factor responsible 
for the variation in gene expression data is time, or rather the stage of fermentation. Three main clusters 
are evident along the first component axis corresponding to day2, day5 and day14 sample clusters, 
regardless of strain or must. PC1 accounts for 36% of the explained variance in the dataset, and is the 
main contributor to the PCA model. Within the broader time-point groupings the biological repeats of 
each strain cluster closely together, spreading out along the second component axis (accounting for 
19% of the explained variance). The third component (depicted in frame B) clearly divides all the 
 
B 
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samples into two medium-specific sub-groups. As this component only contributes 12% to the total 
explained variance, it would seem that the composition of the fermentation must is a lesser contributor 
to variance in a fermentation compared to the inherent genetic differences between the two strains and 
the stage of fermentation. The remaining six model components together only contribute a further 25% 
to explained variance. 
 
4.4.6 Differentially expressed genes 
A complete analysis was performed of the inter- and intra- strain genes with statistically significant 
changes in gene expression and a fold change greater than positive or negative 2 across strains, time 
points and fermentation media. In the case of the intra-strain comparisons between time points, the 
overlap between the significantly up/down –regulated genes was in the area of 50-75% when 
comparing the MS300 and Colombard outputs. In other words, 50-75% of the genes present in the 
MS300 VIN13 day 5 vs. day 2 list also featured on the corresponding analysis of the Colombard data. 
This was true for both the VIN13 and BM45 strains. However, for the inter-strain comparisons between 
VIN13 and BM45 at the three time points the intersection between gene lists was even greater: Less 
than 50 of the genes from the MS300 BM45 vs. VIN13 significance analysis were absent from the 
complementary Colombard analysis in the case of days 2 and 5. Only for day 14 were the differences 
between the inter-strain analyses greater, amounting to about one third of the differentially expressed 
genes. This is not surprising considering the variable responses of the BM45 and VIN13 strains to 
stress conditions that would be encountered towards the end of fermentation which are expected to be 
different in different musts. Overall though, comparative patterns of gene expression between different 
strains seem to be fairly reproducible regardless of the fermentation environment, particularly during 
the earlier parts of fermentation. 
 
4.4.7 Functional categorization of differentially expressed genes 
The genes that showed significant differences in expression between the MS300 and Colombard 
fermentations in any of the analyses (both inter- and intra- strain for VIN13 and/or BM45 at all time 
points) were extracted for further evaluation. This cumulative set amounted to approximately 1200 
genes showing greater than 2-fold changes (both positive and negative). These genes were divided into 
groups based on known or predicted function (Tables 3 and 4) in order to gain insight into the broader 
areas of yeast metabolism that are influenced by varying environmental conditions during fermentation. 
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Table 3 Categorization (GO function) of genes that are significantly decreased (greater than 2-fold) in 
expression in any of the Colombar samples in comparison to the corresponding MS300 
samples. ‘n’ represents the number of genes from the list in the category, while ‘t’ is the total 
number of genes in any given category. 
 
Biological Process Repressed genes in category from all Colombar vs MS300 frementations n t %
Nucleotide and nucleic acid metabolism
DEP1 MAK5 ADY2 PWP2 HCM1 STP4 NOP14 AIR2 YRB1 RRP8 CPR1 REF2 UME6 URH1 
NPL3 ADA2 PRP22 EDC2 SPT15 CCA1 ACT1 PUS2 NAB2 NUP49 SAE2 MPT5 EDC1 ADE3 
TAF1 OPI1 RPP1 RRP3 DBP8 SSL2 MRS1 DAL81 ZAP1 SIP4 MRS3 RPB4 RPA34 TAH11 
CCE1 MSN4 ABF1 RRN3 MRS4 PRP16 ACE2 CBF5 BUR2 CDD1 HAP1 NEJ1 YHC1 SFH1 
SEN1 RAD52 CAC2 DAT1 SPT21 CTL1 RGM1 SGS1 SKY1 RNT1 GCD10 RPC19 NRD1 SSK2 
DBP6 SPT20 HIR2 CDC21 NUP1 ADE2 GAC1 MBF1 DBP1 HHO1 TBF1 PRP46 RAD53 FCY1 
DPB2 ADE1 MTD1 ADE4 SER1 89 1046 8.5
Response to stress
UGA2 LRE1 HSP30 GPD1 RAD59 GRX3 LCD1 ISC1 RAD51 HSF1 RRD1 MGA2 GPX1 MNN4 
SIS2 HSP104 TSL1 SIP5 SIP18 HSC82 RAD50 WSC2 DDR2 POS5 HSP82 SKT5 HSP26 UBC4 
FAP7 HSP42 HSP78 GLC7 HSP12 HAC1 PHO4 YHB1 GRE3 CKA1 XBP1 DEF1 PSR1 TEN1
 PSR2 AHP1 SML1 HAL9 CRS5 IQG1 ATH1 49 199 24.6
Ribosome biogenesis and assembly
MAK5 PWP2 NOP14 RRP8 LOC1 NUP49 NOP7 RPP1 RRP3 DBP8 NMD3 RPF2 RLP24 RPL10 
CBF5 SEN1 YML025C RNT1 DBP6 BRX1 UTP5 SNU13 NOP16 MTR3 HCA4 MRT4 TOR2 DRS1 
SOF1 NOC3 GSP1 POP1 POP3 NOP58 NIP7 FHL1  36 165 21.8
C-compound and Carbohydrate metabolism
SHP1 SKT5 PGI1 GLK1 TPI1 SCS2 GLC7 SKN1 XKS1 SMI1 GRE3 GUT2 YJR096W 
IDP2 FBP1 PGM2 GLC8 IDH1 ZWF1 CIT1 22 415 5.3
Amino acid and derivative metabolism
GCV1 ARO3 ARG82 SER3 MET13 STR3 MUQ1 MET28 MAE1 MET1 MHT1 IDP2 SAM1 LEU3 
ARG80 ILV2 IDH1 MET2 CIT1 ARG1 MET16 21 149 14.1
Sulfur metabolism
CYS3 SAH1 CYS4 OPT1 MET3 ECM17 MET14 MET4 MET13 STR3 MET28 GTT1 GSH1 MET1 
GTT2 MHT1 SAM1 MET2 BIO5 MET16 20 44 45.5
Cell wall TIP1 BGL2 SPS100 CWP1 PIR3 PIR1 WSC3 7 38 18.4
Amino acid transport BAP2 TAT1 BAP3 GNP1 AGP3 MUP1 MUP3 7 23 30.4
Inorganic anion transport PHO88 SUL1 PHO89 FZF1 PHO84 YER053C YPR003C 7 15 46.7
Sulfur amino acid metabolism MET13 STR3 MET28 MET1 MHT1 SAM1 MET2 MET16 CYS3 SAH1 CYS4 MET3 MET14 MET4 14 29 48.3
Regulation of nitrogen and sulphur utilization UME6 MET32 GLN3 FZF1 DAL81 ABF1 6 29 20.7
Methionine metabolism MET13 STR3 MET1 SAM1 MET2 MET16 6 20 30.0
Nicotinamide metabolism PYC2 BNA3 UTR1 IDP3 YOR356W FDH1 6 25 24.0
Serine family amino acid metabolism CYS3 SAH1 CYS4 SER33 SER1 5 15 33.3
Cell adhesion FLO1 HSP12 AGA2 CKA1 4 11 36.4
Threonine metabolism GLY1 HOM3 HOM6 3 7 42.9
Pentose metabolism XKS1 GRE3 YJR096W 3 5 60.0
Glutathione metabolism GTT1 GSH1 GTT2 3 6 50.0  
 
The bulk of the genes that are decreased in expression in Colombard fermentations are related to 
nucleotide metabolism and various stress responses. The metabolism of specific amino acids such as 
serine and threonine are also influenced by differences in the fermentation media. Nitrogen and sulfur 
metabolism as well as numerous transport activities are also repressed in the Colombard must when 
compared to MS300. 
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Table 4 Categorization (GO function) of genes that are significantly increased (greater than 2-fold) in 
expression in any of the Colombar samples in comparison to the corresponding MS300 
samples. ‘n’ represents the number of genes from the list in the category, while ‘t’ is the total 
number of genes in any given category. 
 
Biological Process Overexpressed genes in category from all Colombar vs MS300 frementations n t %
C-compound and carbohydrate metabolism
BDH1 CHS2 CDC10 FEN1 AAD3 LYS21 STL1 MNN1 MIG2 LSC2 DOG1 HXT1 EGD2 SLN1 OST1 
INO1 PCK1 SNF7 YMR323W AAD14 FUN34 GPM3 ALG8 OST3 RKI1 OST2 EGD1 
YPL088W TAF14 BEM4 PCL8 TKL1 GPH1 33 415 8.0
Lipid, fatty-acid and isoprenoid metabolism
FEN1 DPP1 DPL1 GPI11 STE14 LPP1 GPI10 YGL144C CDC43 LAG1 ARD1 DOA1 YSR3 
ERG27 SEC59 SPO1 PDR16 ERG24 HES1 BTS1 IDI1 21 213 9.9
Amino acid metabolism
CHA1 LYS21 GLT1 PRO3 AUA1 LEU1 ARO2 LYS5 HIP1 BAT1 PHA2 YOR108W DFR1 FSH3 
PUT4 GDH1 DIP5 TKL1 18 204 8.8
Metabolism of vitamins, cofactors, and prosthetic g
PHO3 PHO5 ECM31 HEM13 YGL039W YGL157W PAN6 YJR142W COQ5 GSH2 THI80 HEM15 
DFR1 MET7 14 86 16.3
Nucleotide metabolism IMD1 YAR075W FUI1 YBR014C TRR2 URA1 IMD3 GUA1 AAH1 YOR071C DFR1 FSH3 SUV3 13 148 8.8
Steroid metabolism ERG4 ERG1 ATF2 OSH6 ERG6 ERG2 ERG12 ERG8 MVD1 ERG27 PDR16 ERG24 HES1 IDI1 ERG2 9 40 22.5
Nitrogen and sulfur metabolism GLT1 UGA4 AMD2 AUA1 GAT1 TRR2 GZF3 GDH1 8 67 11.9
Glycoprotein metabolism MNN1 OST1 SEC59 ALG8 OST3 OST2 6 64 9.4
Aromatic compound metabolism ARO2 URA1 AAH1 PHA2 DFR1 5 48 10.4
Phosphate metabolism PHO3 PHO5 DOG1 PHO90 TAF14 5 33 15.2
Amino-acid transporters AUA1 UGA4 HIP1 YOR071C PUT4 DIP5 5 25 20.0
Organic acid biosynthesis MRF1' YBR159W AYR1 ACS2 4 14 28.6
Organic anion transport CTP1 DAL5 BPT1 YHM2 4 10 40.0
Allantoin metabolism DAL1 DAL2 DAL3 3 5 60.0
Glutamine family amino acid biosynthesis GLT1 PRO3 GDH1 3 22 13.6
Nicotinamide adenine dinucleotide biosynthesis BNA1 BNA2 BNA5 3 8 37.5
GPI anchor metabolism GPI11 GPI10 GPI13 3 14 21.4
Glutamine family amino acid biosynthesis GLT1 PRO3 GDH1 3 22 13.6
UDP-N-acetylglucosamine metabolism QRI1 GNA1 2 2 100.0
Pentose-phosphate pathway RKI1 TKL1 2 9 22.2
Lysine metabolism LYS21 LYS5 2 9 22.2  
 
Lipid and carbohydrate metabolism head up the list of overexpressed genes in Colombard 
fermentations compared to MS300. Genes encoding several specific and non-specific amino acid 
transporters are also upregulated along with other genes involved in the synthesis of specific amino 
acids (ie glutamine and lysine). Proportionally large changes in gene expression within functional 
categories involved in steroid, allantoin, vitamin and cofactor metabolism give a clear indication of 
medium-specific effects on the transcriptional response of fermenting yeast. Strongly represented 
functional categories from the differential analysis will be investigated in more detail in the following 
sections. 
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4.4.8 Nitrogen and sulfur metabolism 
Nitrogen and sulfur metabolism feature on both the over- and under-expression lists, necessitating a 
more in-depth look at the genetic restructuring within this area during fermentation in different media 
(particularly in the context of amino acid metabolism). Expression data from genes involved in 
nitrogen and sulfur metabolism were subjected to hierarchical clustering (Figure 4). The closer the 
samples aggregate together, the stronger the statistical relationships between these samples. 
Accordingly, strains are primarily grouped together in a time-specific manner. Along the vertical plane, 
genes with similar expression patterns over time and between strains and media are grouped together. 
The length of the tree branched is inversely related to the strength of the statistical relationship between 
the genes (ie. the shorter the branch, the stronger the correlation).  
 
 
Figure 4 HCL clustering of transcripts encoding enzymes involved in nitrogen and sulfur metabolism 
(data log normalized to the relevant Day2 gene expression value). Red bars denote an increase 
in expression while green bars indicate a decrease in expression for a given gene. 
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In this figure, clear differences exist in the expression patterns of transcription factors-encoding genes 
such as ARG80 and ARG81, which are involved in the regulation of arginine-responsive genes along 
with the product of the ARG82 gene (El Alami et al., 2003). As another example, UGA3 encodes a 
transcriptional activator necessary for induction of gamma-aminobutyrate -dependent induction of 
genes such as UGA1, UGA2, UGA4 that are involved in glutamate degradation and intercellular 
nitrogen utilization and mobilization. Likewise, the DAL81 gene encodes a protein that acts as a 
positive regulator of genes in multiple nitrogen degradation pathways (Talibi et al., 1995). 
 
MET4 is another well-known transcriptional activator that is responsible for the regulation of the sulfur 
amino acid pathway (Thomas & Surdin-Kerjan, 1997). It requires different combinations of the 
auxiliary factors encoded by CBF1, MET28, MET31 and MET32, all of which fall into the same cluster 
depicted in Figure 4. On the enzymatic side, the proteins encoded by MET10 and ECM17 (sulfite 
reductase subunits), MET14 (an adenylylsulfate kinase), MET16 (a 3'-phosphoadenylsulfate reductase) 
and MET3 (an ATP sulfurylase) which collectively catalyze sulfate assimilation and are involved in 
sulfur amino acid metabolism (Thomas et al, 1990). Several of these genes are overexpressed at one or 
more stages in the Colombard fermentations as opposed to the corresponding MS300 fermentations. 
 
In terms of nitrogen metabolism, various genes involved in allantoin degradation such as DAL1, DAL2, 
DAL3, and DUR1,2 (Yoo et al., 1985; Buckholz & Cooper, 1991) are also represented in Figure 4 
because of increased expression in Colombard fermentations. Included in this category are also a large 
number of genes involved in amino acid metabolism. In general, most of the genes that stand out from 
the SAM analysis are involved in amino acid synthesis, uptake or catabolism of specific amino acids 
for nitrogen mobilization. Specific genes in this category will be considered in more detail later on in 
this paper. 
 
4.4.9 Expression of transporters genes 
Expression data from genes involved in transport activities were subjected to K-means clustering. 
Clusters showing variable expression patterns between Colombard and MS300 fermentations can be 
seen in Figure 5 below. 
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Figure 5 HCL clustering of transcripts in 3 clusters showing differential expression between different 
media for genes involved in amino acid metabolism (data log normalized to the relevant Day2 
gene expression value). Red bars denote an increase in expression while green bars indicate a 
decrease in expression for a given gene. 
 
The transport activities represented in Figure 5 are the most obvious manifestation of the compositional 
differences in the MS300 and Colombard fermentation media. Once again, amino acid transporters of 
varying affinities and specificities feature strongly in this figure, along with transporters for various 
inorganic (phosphate, iron, zinc, magnesium, copper, calcium, potassium) and organic substances 
(hexoses, allantoin, sterols, polyamines, myo-inositol).  
 
4.4.10 Enrichment of transcription factors 
The spheres of yeast metabolism related to nitrogen and sulfur uptake and utilization (including amino 
acid metabolism) were heavily impacted by differences in the composition of the fermentation media. 
Transcription factor enrichment analysis of these genes (from the significance analysis of Colombard 
vs. MS300 data) led to the identification of a few prominent transcription patterns that regulate the 
expression of these genes (Figure 6).  
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Figure 6 Expression patterns of genes encoding key transcription factors. 
 
The six transcription factor-encoding genes depicted in Figure 6 (namely GCN4, LEU3, GLN3, STP2, 
CBF1 and MET31) not only showed substantial changes in expression over time, but also between 
corresponding samples from the parallel Colombard and MS300 fermentations. These changes were 
not only related to the overall intensity of normalized gene expression (such as in the case of MET31 
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and GCN4) but also to the actual pattern of gene expression over time (GCN4, LEU3, GLN3, STP2). 
These differences were most pronounced during the earlier stages of fermentation. By day 14 (at the 
end of fermentation) the expression levels of the three key regulatory factors (GCN4, LEU3 and GLN3) 
were similar. The possible functional relevance of these transcription factors in the context of nitrogen 
and sulfur metabolism will be considered in the following section. 
 
4.4.11 Comparison of gene loading weights 
A principle aim of this study was to determine the comparability of the experimental must MS300 to 
real wine-making conditions. In particular, we were interested to see if predictive statistical models 
based on transcriptional information from MS300 studies could be reproduced in a real wine must 
background. In a previous paper (Rossouw et al., 2008) gene targets for genetic modification were 
identified based on the loading weights of individual genes in regression models. In these models the X 
variables were the expression levels of a selected set of genes related to aroma metabolism, and the Y 
variables were the concentrations of volatile aroma compounds in the must. Experimental validation 
proved that this approach indeed provided a predictive ability that was satisfactorily accurate (Rossouw 
et al., 2008).  
 
One of our key questions was whether the modeling capacity and predictability of such an approach 
was medium specific. To attend to this issue we constructed parallel PLS1 regression models using the 
aroma compound concentrations and gene expression values from the Colombard fermentations in the 
same manner as was done for the MS300 fermentations. To demonstrate the alignment of key model 
information we plotted the gene loading weights (for several important aroma compounds) of the 4 key 
genes considered in a previous study (Rossouw et al., 2008). The better the fit or overlap of these 
loading weights, the closer the alignment of model predictions from the two different experimental 
conditions (Figure 7). Clearly model alignments for three of the four genes are extremely close. The 
exception is AAD14, where only about three of the 11 loading weights are comparable in both 
fermentation conditions. 
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Figure 7 Gene loading weights for aroma compound models based on transcriptional data from MS300 
(solid gray lines) and colombard (dashed black lines) fermentations. 
 
4.5 Discussion 
4.5.1 General: MS300 versus Colombard 
The defined synthetic must MS300 and the natural Colombard must differ in terms of the exact balance 
of macro- and micro-nutrients available to the growing yeast. Yet despite these differences, inter-strain 
comparisons between VIN13 and BM45 at different stages of fermentation did not yield notable 
discrepancies in terms of significance outputs. The implication is thus that differences between strains 
(on a gene expression level) are an intrinsic feature that is not constrained or influenced by the 
nutritional environment of the yeast in a significant manner. The comparatively few differences that do 
exist in gene expression patterns (for any combination of intra- and inter-strain comparisons in the 
different media) are also mostly related to transport activities. On a metabolic level, central carbon 
metabolism, and more specifically fermentation pathways, were largely unaffected by medium identity 
(in terms of category percentages). 
 
Interestingly, the only pathways that showed significant differences between the two media can be 
directly related to metabolic requirements and media composition. In particular, pathways involved in 
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amino acid biosynthesis or degradation were notably impacted by the different media. Some stress 
response pathways and steroid metabolism were the other areas of yeast physiology that show varying 
genetic responses in the different fermentation media (Tables 3 and 4). 
 
MS300 appears thus a close enough an approximation to real wine must to be of benefit in comparative 
studies between, for example, different yeast species or strains, and possibly even different 
environmental factors. The PCA analysis (Figure 3) confirms that must composition is only the third 
most significant source of variation, after the stage of fermentation and strain identity factors. In light 
of this, the data produced or results inferred from studies in MS300 should in principle be transferable 
to real wine-making conditions to a large extent. Having a reliable and reproducible standard 
fermentation media available in the yeast research community is indeed advantageous in terms of 
knowledge-sharing and experimental comparability.  
In terms of the differences between media that can be directly aligned with media composition, the 
following observations appear of most relevance:  
 
4.5.2 Transport facilitation 
A large proportion of transcripts that were differentially expressed between corresponding samples in 
different fermentation media constituted very specific plasma membrane transport activities. While a 
large number of these transporters related to the uptake of amino acids (to be discussed in the following 
section) and other organic substances, a substantial amount of inorganic compound carriers also 
featured in the analysis (Figure 5). Most of the transport activities for the inorganic salts were increased 
in the Colombard fermentations (relative to MS300) at one or more time points during fermentation.  
 
AUS1 and PDR11 encode two transporters involved in sterol uptake (Wilcox et al., 2002), and showed 
expression increases of up to 20-fold in both VIN13 and BM45 fermentations in the Colombard must. 
The same trends were evident for other organic compound transporters, such as the high-affinity 
biotin/H+ symporter VHT1 as well as HNM1, a choline permease that is co-regulated with membrane 
lipid biosynthetic genes (Stolz et al., 2001). Two related genes, ITR1 and ITR2 (coding for myo-
inositol permeases; Nikawa et al., 1991) were also overexpressed in the Colombard fermentations, 
particularly at the end of fermentation. All these genes have a role to play in the metabolism of long-
chain fatty acids and are essential for anaerobic growth and cell membrane integrity. Their 
overexpression in the Colombard fermentations are likely related to simple differences in the 
availability of the target compounds in the different media. 
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Expression levels of several glycerol importers such as GUP1, GUP2 and SLT1 (Holst et al., 2000; 
Ferreira et al., 2005) were also increased substantially in the Colombard fermentations. Expression of 
the glycerol transporter genes is believed to be induced by osmotic shock, and differences in the 
concentrations of extracellular glycerol in the MS300 and Colombard fermentations (Figure 2) could 
account for the different transcriptional responses of the cells in this regard. 
 
The two major cell membrane sulfate permeases (SUL1 and SUL2; Smith et al., 1995) were highly 
underexpressed in the Colombard fermentations (up to 50-fold decrease), while the overexpression of 
the two ammonium permeases (MEP2 and MEP3;   Marini et al., 1997) were of the same magnitude 
(Figure 5; Tables 3 and 4). These vast transcriptional disparities reflect the cellular responses of the 
yeast to their different nutritional environments. 
 
Of the metal ion transporters, most of the differentially expressed transcripts were related to iron 
metabolism, including SIT1 (Lesuisse et al., 1998), FET3 (Askwith et al., 1994), FTR1 (Kwok et al., 
2006), ARN1 and ARN2 (Philpott et al., 2002). The expression of these genes is responsive to iron 
deprivation and extracellular iron concentrations. The SIT1, ARN1 and ARN2 gene products specifically 
recognize siderophore-iron chelates. Whereas these genes were overexpressed in the Colombard BM45 
and VIN13 strains throughout fermentation (Figure 5; Table 4), the FET3 and FTR1 genes (which 
encode high-affinity permeases for unbound ferrous iron) were highly repressed. These highly specific 
transcriptional responses demonstrate the tight control between transporter induction in response to not 
only iron availability, but also to the form in which the iron is present in the fermentation medium. In 
terms of other ionic compounds, only the transcription of a few inorganic phosphate transporters 
(PHO87, PHO84 and PHO90; Caspar et al., 2007) showed noteworthy differences in expression 
between fermentations in different media (Figure 5).  
 
4.5.3 Nitrogen, sulfur and amino acid metabolism 
Several differences in expression levels can be directly correlated to the different amino acid 
composition of the two media. Since the number of genes that can be discussed is large, only some 
examples are considered here. 
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 4.5.3.1 Amino acid transport 
Beginning with the uptake of amino acids from the media, it should be mentioned that all known 
amino-acid permeases in yeast belong to a single family of homologous proteins with a wide range of 
substrate specificities (Regenberg et al., 1999). Several transport proteins involved in amino acid 
uptake showed significant differences in expression levels between inter- or intra- strain comparisons 
of MS300 and Colombard analyses (Figure 5). Noteworthy genes from the underexpressed list (Table 
3) in Colombard versus MS300 fermentations include MUP1, MUP2, AGP3 and GNP1. 
  
 MUP1 and MUP2 both encode high affinity methionine permeases that are also involved in cysteine 
uptake (Isnard et al., 1996; Kosugi et al., 2001). As the Colombard must contains negligible levels of 
methionine (Table 1), the MUP genes are in all likelihood transcribed at lower levels in the yeast due to 
the near absence of their target metabolites.  
 
AGP3 encodes a low affinity, relatively non-specific general permease for most of the uncharged 
amino acids (Schreve & Garrett, 2004). The closely related GNP1 is more specific for Leu, Ser, Thr, 
Cys, Met, Gln and Asn (Zhu et al., 1996). This permease is transcriptionally induced by extracellular 
levels of the afore-mentioned amino acids, which may explain the discrepancies between the 
Colombard and MS300 expression levels (Tables 1 and 3). 
 
In terms of the genes overexpressed in Colombard must and related to amino acid uptake (Table 4), 
AUA1, HIP1, PUT4 and DIP5 are the most prominent candidates. AUA1 encodes a protein that is 
required for the negative regulation of GAP1 (Sophianopoulou & Diallinas 2003), which is a general 
amino acid permease (Regenberg et al., 1999). In light of the relative paucity of amino acids available 
to the yeast in the Colombard must it is economical for the cells to transcribe and translate specific 
transport activities for the few amino acids which are in fact abundant in the medium. This is clearly 
the case for the other three permeases: HIP1 codes for a histidine-specific permease (Tanaka & Fink, 
1985), which would enable the Colombard yeasts to take up the abundant histidine present in the 
medium (Table 1). Similarly, abundant proline is the likely reason for high expression levels of the 
PUT4 gene coding for a high-affinity proline permease (Lasko & Brandriss, 1981; Omura et al., 2005). 
And lastly, DIP5 expression mediates high-affinity and high-capacity transport of L-glutamate and L-
aspartate (Regenberg et al., 1998), both of which are present at high concentrations at the start of 
fermentation in the Colombard must (Table 1). 
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4.5.3.2 Amino acid biosynthesis 
Amino acid transporters and amino acid biosynthetic enzymes together account for the majority of the 
metabolic discrepancies between transcriptome data from strains under different fermentation 
conditions (Figures 4 and 5). Most of these differences can be accounted for directly by variation in 
medium composition. In further support of this argument one need only examine some of the 
biosynthetic enzymes that feature in the differential expression lists for Nitrogen and Sulfur 
metabolism (Figure 4, Tables 3 and 4).  
 
Genes that are overexpressed in the Colombard fermentations generally code for enzymes involved in 
the biosynthesis of specific amino acids that are lacking in the medium. For example, the low 
availability of the essential amino acid leucine in the Colombard must is reflected by an increase in the 
expression of LEU1, an isopropylmalate isomerase which catalyzes an important step in the leucine 
biosynthesis pathway (Baichwal et al., 1983; Friden & Schimmel, 1987). Likewise, LEU9 encodes an 
alpha-isopropylmalate synthase that is responsible for the first step in leucine biosynthesis (Casalone et 
al., 2000), and also shows increased expression levels in Colombard vs. MS300 fermentations (Table 
4). 
 
Lysine concentrations in the Colombard must were below detection, and thus we see a significant 
increase in the expression levels of key genes involved in the lysine biosynthesis pathway, namely 
LYS5 and LYS21 (Table 4; Ehmann et al., 1999) which are probably repressed in the MS300 cells due 
to feedback inhibition by the higher lysine levels (Feller et al., 1999). ARO2, TKL2 and PHA2 are all 
involved in the synthesis of precursors for the aromatic amino acids (Jones et al., 1991; Schaaff-
Gerstenschlager et al., 1993; Maftahi et al., 1995), which once again aligns well with the limited 
availability of these amino acids (most notably phenylalanine) in the Colombard must (Table 1). 
 
Similar observation can be applied to the catabolism of amino acids that are present in high 
concentrations. Indeed, only the CHA1 and FSH3 transcripts were overexpressed in the Colombard 
fermentations: These genes encode a serine deaminase and serine hydrolase respectively, both of which 
are involved in the degradation of L-serine for use as a nitrogen source (Petersen et al., 1988; Baxter et 
al., 2004). From Table 1 it is clear that this particular amino acid is also present at high concentrations 
at the start of fermentation and thus probably serves as a suitable source of nitrogen for the nitrogen- 
limited Colombard must. 
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4.5.3.3 Enrichment of transcription factors 
Most of the nitrogen or sulfur metabolising enzymes/ transporters discussed in the previous sections 
can be grouped under the effector systems of a few main transcription factors (refer to Figure 6). Most 
notable among these is probably GCN4, which codes for a key transcriptional activator of amino acid 
biosynthetic genes in response to amino acid starvation (Roussou et al., 1988). Expression levels of this 
gene were significantly and substantially elevated in the Colombard fermentations for both VIN13 and 
BM45, most likely due to the lower concentrations of free amino acids in this medium. The Gcn4p 
transcription factor targets the promoters of a large number of genes involved in amino acid 
metabolism in a highly specific manner (Natarajan et al., 2001). Indeed, it is reasonable to attribute a 
large proportion of the differentially expressed amino acid metabolizing genes to changes in the 
transcript abundance of this particular gene. 
 
Gcn4p in turn regulates the expression of another important transcription factor, namely Leu3p (Wang 
et al., 1999). The product of the LEU3 gene is involved in the specific regulation of the leucine -
isoleucine-valine pathways (Fridden & Schimmel, 1987; Zhou et al., 1987). The gene expression levels 
for this transcription factor show different trends for the MS300 fermentations (expression lowest early 
on in fermentation) as opposed to the Colombard fermentations (expression highest at earliest stage of 
fermentation). As the expression of this gene is under general amino acid control, the differences in the 
amino acid compositions of the fermentation media (and the rapid decline in amino acid availability in 
the Colombard must as fermentation progresses) accounts for these differences in expression profiles. 
 
Regarding the remaining four noteworthy transcription factors, GLN3 encodes the transcriptional 
activator responsible for nitrogen catabolite repression (Cox et al., 2002), STP2 is involved in inducing 
BAP gene expression in response to external amino acid availability (de Boer et al., 2000), while 
MET31 and CBF1 are both core components involved in the transcriptional regulation of sulfur amino 
acid metabolism (Thomas & Surdin-Kerjan, 1997).  
 
While the exact functionalities and interactions associated with these transcriptional regulators are not 
completely delineated, the large differences in the expression levels and patterns of these key 
modulators provide a legitimate explanation for the overarching differences in gene expression at the 
level of amino acid metabolism. Differences between Colombard and MS300 fermentations appear to 
be more pronounced during the earlier stages of fermentation. The overlap of transcription factor data 
at day 14 is most likely a reflection of the fact that the nutritional status of the fermenting cells are 
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similar in both media at this stage due to the exhaustion of free amino acids and macronutrients such as 
carbon, nitrogen and sulfur.  
 
4.6 Conclusions 
In general, the differences in the transcriptional responses of the VIN13 and BM45 strains in different 
fermentation can easily be accounted for by the compositional features of the different media (where 
this is known). This attests to the reliability and reproducibility of microarray analyses in batch 
fermentations and the interpretation of results regardless of minor variations in medium composition. 
As mentioned earlier, a key question was whether the modeling capacity and predictability of 
regression-based statistical approaches were largely independent of medium composition. Since this 
appears to be the case, the potential for integrative omics applications to be incorporated into reliable 
predictive models across the board, regardless of variation in specific environmental conditions, exists. 
Considering the analysis represented in Figure 7 it appears that this is indeed the case: The model 
predictions of gene loading weights for key aroma compounds were comparable in both the Colombard 
must and MS300 systems. 
 
In light of this, defined synthetic fermentation musts (such as MS300) are an invaluable component of 
systems biology approaches directed towards the study of industrial fermentation processes. 
Knowledge gained from ‘omic’ research in the field of fermentation science thus holds the potential to 
be relevant in industrial applications in spite of the relatively controlled experimental frameworks of 
laboratory research.  
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CHAPTER 5 
A comparative ‘omics’ approach to investigate differences in wine yeast 
physiology and metabolism during fermentation 
 
5.1 Abstract 
Commercial wine yeast strains of the species Saccharomyces cerevisiae have been selected to satisfy 
many different, and sometimes highly specific, oenological requirements. As a consequence, more than 
200 different strains with significantly diverging phenotypic traits are produced globally. This genetic 
resource has been rather neglected by the scientific community because industrial strains are less easily 
manipulated than the limited number of laboratory strains that have been successfully employed to 
investigate fundamental aspects of cellular biology. However, laboratory strains are unsuitable for the 
study of many phenotypes that are of significant scientific and industrial interest. Here we investigate 
whether a comparative transcriptomics and phenomics approach, based on the analysis of five 
phenotypically diverging industrial wine yeast strains, can provide insights into the molecular networks 
that are responsible for the expression of such phenotypes. For this purpose, some oenologically 
relevant phenotypes, including resistance to various stresses, cell wall properties and metabolite 
production of these strains were evaluated, and aligned with transcriptomic data collected during 
alcoholic fermentation. The data reveal significant differences in gene regulation between the five 
strains. While the genetic complexity underlying the various successive stress responses in a dynamic 
system such as wine fermentation reveal the limits of the approach, many of the relevant differences in 
gene expression can be linked to specific phenotypic differences between the strains. This is in 
particular the case for many aspects of metabolic regulation.  The comparative approach therefore 
opens new possibilities to investigate complex phenotypic traits on a molecular level. 
 
5.2 Introduction 
S. cerevisiae is a preferred model organism for studying eukaryotic cells. The haploid yeast genome is 
compact (12 - 13.5 megabases) and contains only around 6,000 protein encoding genes [17]. However, 
the functional analysis of the yeast genome remains a challenge, predominantly because many of the 
putative protein-encoding genes appear not amenable to classical genetic approaches. One possible 
reason is that most studies have been limited to a small number of laboratory strains. While these 
strains have been selected for their ease of use in laboratory conditions, they lack many of the 
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characteristics that are prominent in industrial isolates of this species. These industrial strains are 
highly diverse, since they have been selected for a large number of different and highly specific tasks. 
This geno- and phenotypic diversity represents a largely untouched genetic resource. Some of the 
challenges of large-scale functional genomics can therefore likely be met by including such strains in 
comparative ‘omics’ studies. Such approaches should contribute to building a comprehensive map of 
the yeast cell, including genome sequences and gene expression data, information on protein 
localization, structure, function and expression, and phenotypic descriptions [21; 25]. 
 
In commercial wine fermentations, the yeast species S. cerevisiae is the major role player. In excess of 
200 different strains of S. cerevisiae are produced and sold in the global fermentation industry. These 
wine yeast strains have been isolated and selected for optimized performance in certain key areas of 
oenological relevance. The specific phenotypic traits selected for include fermentative efficiency, 
general stress resistance, production of metabolites and in particular aroma compounds, cell wall 
adhesion properties and the ability to release enzymes of enological interest or mannoproteins [35]. 
Different varietals and styles of wine require specialized properties, explaining the significant 
phenotypic divergence between strains. Various research methodologies have been applied in an 
attempt to understand crucial aspects of wine yeast physiology. However, many important questions 
remain unanswered regarding the genetic and molecular regulation of most of these traits, which are 
mostly of a polygenic nature [32], and can not be fully understood through traditional approaches. 
 
In this paper, we investigate the potential of a comparative functional omics approach to correlate 
oenologically relevant phenotypes to specific gene expression patterns. The approach is based on the 
comparative analysis of physiological data and global gene expression data of five phenotypically 
diverging commercial wine yeast strains. Phenotypes investigated include general stress resistance, cell 
wall properties such as adhesion, and metabolic regulation and production. 
 
The ability of fermenting yeast cells to withstand certain stress factors is of extreme importance to the 
overall fermentation efficiency of the strains [26]. During the course of the wine fermentation process, 
S. cerevisiae cells are subjected to multiple severe stress conditions that affect their growth, viability 
and fermentative performance. These stresses include high osmotic pressure, acidity, nutrient 
deprivation, starvation and high alcohol concentration [2; 14; 20]. Some of these stresses occur 
sequentially, whereas others occur simultaneously [3].  This means that the genetic factors and 
regulatory networks involved in stress response pathways during fermentation are interwoven into 
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complex regulatory circuits with notable interplay/overlap between the various response pathways [18]. 
The predominant stress condition faced by yeast cells at the beginning of fermentation is probably the 
high sugar concentration, giving rise to high osmotic pressure, whereas towards the end of 
fermentation, the main stress factors are related to the high ethanol concentrations and depletion of 
essential nutrients.  
 
Several gene expressions studies of individual wine yeast strains have been undertaken in recent years 
to shed some light on the adaptation and stress tolerance mechanisms of industrial wine yeast strains. 
Ivorra et al. [26] and Zuzuarregui et al. [47] both evaluated expression levels of pre-selected 
representative genes involved in stress responses in several wine yeast strains during fermentation. 
Both studies indicated a good correlation between stress resistance and the ability to complete 
fermentations under suboptimal or optimal conditions. They also reported that a common pattern of 
stress response exists between efficient wine strains, providing the first prospects for the establishment 
of connections between gene expression and stress tolerance traits in wine yeast. 
 
Large scale transcriptome monitoring during alcoholic fermentation under conditions mimicking an 
enological environment has helped to elucidate the coordinated transcriptional reprogramming that 
takes place during alcoholic fermentation as changes in nutritional, environmental and physiological 
conditions occur [31; 39]. These approaches have helped to identify master regulatory pathways that 
play a key role in coordinating stress-induced changes in gene expression [39].  The data has also 
pointed to a group of genes designated as fermentation stress response (FSR) genes that are 
dramatically induced at various points during fermentation [31]. More specific transcriptional profiling 
of wine yeast strains has focused on cold stress [4] and the response to nitrogen availability [30]. 
 
Another important area of yeast performance relates to the ability of yeast cells to adhere to one 
another and settle out of suspension by the end of fermentation. Adhesion phenotypes such as 
flocculation and substrate adhesion are directly linked to cell wall properties and can have a major 
impact in biotechnological processes such as wine making [19]. Flocculation (the reversible, calcium-
dependent, non-sexual aggregation of yeast cells into 'flocs') in particular is a process of great 
importance to the fermentative characteristics of yeast strains (for a review, see Verstrepen et al., [43]). 
Several structurally related lectin-like proteins (flocculins), encoded by FLO genes [12], are 
responsible for different adhesion phenotypes, suggesting differential programs of pre- and post-
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transcriptional regulation a strong likelihood for this gene family (for a review, see Verstrepen et al., 
[44]. 
 
The last key area of yeast physiology investigated here relates to the general metabolic activity of the 
cells during fermentation, particularly in terms of the production of volatile flavour and aroma 
compounds. During fermentation, S. cerevisiae not only converts sugars to ethanol but also produces a 
number of long chain, complex alcohols and their corresponding acetate esters. These long chain and 
complex alcohols are the end products of amino acid catabolism [45]. Although the general sequence of 
biochemical reactions for these pathways is annotated to some degree [15], significant breaches exist in 
our current understanding of these pathways: There is almost no information available regarding the 
kinetics, substrate specificity or regulation of most of the enzymes involved in aroma compound 
production, and several reactions have not been attributed to a specific gene product. Because of these 
inherent complications a simplistic analysis of gene expression or protein activity in this important 
sphere of yeast metabolism is not yet feasible, and top-down set or graph analyses are needed to 
provide new insights.  
 
One such integrative metabolic and transcriptomic study of a wine yeast strain has been performed at 
different fermentation temperatures in order to correlate transcriptional changes with differences in the 
production of fatty acids and their corresponding esters [4]. Similar studies have been reported for 
transcriptome analysis in combination with targeted metabolome analysis in wine yeast [34]. Rossouw 
et al. [40] were able to align transcriptome data sets with the changes in exometabolome and to identify 
genes that impact on aroma compound metabolites. Theses approaches helped identify highly 
correlated gene expression subnetworks that could be linked to specific areas of fermentative 
metabolism related to the production of organoleptic compounds. 
 
In other areas of yeast metabolism, not much is known regarding the underlying molecular and 
biochemical reasons for the metabolic differences between different wine yeast strains. Differences in 
wine yeast metabolic activities will have a direct impact on the ability of the cells to tolerate biotic and 
abiotic stress conditions, as well as influence the likelihood of ‘stuck’ fermentations.  
 
One way to contextualize transcriptomic information is by integrating a priori knowledge of gene 
interaction and metabolic networks with the gene expression data, as described in Vemuri & Aristidou 
[42]. The combination of comparative microarray datasets with existing models of yeast metabolism 
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and interaction networks offers the potential for in silico evaluation of biologically relevant gene 
expression changes in the context of key areas of metabolism [16; 34].  
 
In this study, the phenotypic profile of five industrial wine yeast strains was established. These profiles 
were aligned with DNA microarray transcriptome datasets within the context and framework of 
existing interaction networks. The analyses shows that it is possible to pint-point specific genes and 
gene expression patterns that are related to areas which impact on yeast metabolism and general 
physiology, and more specifically areas that are of oenological relevance. In particular, we demonstrate 
that differences in gene expression patterns between strains can be linked to reporter metabolites 
around which significant metabolic and physiological changes can be grouped.  
 
5.3 Methods 
5.3.1 Strains. media and culture conditions 
The yeast strains used in this study are listed in Table1. All are diploid S. cerevisiae strains used in 
industrial wine fermentations. Yeast cells were cultivated at 30oC in YPD synthetic media 1% yeast 
extract (Biolab, South Africa), 2% peptone (Fluka, Germany), 2% glucose (Sigma, Germany). Solid 
medium was supplemented with 2% agar (Biolab, South Africa). 
 
Table 1 Yeast strains used in this study 
Strain Source/ Reference 
VIN13 Anchor Yeast, South Africa 
EC1118 Lallemand Inc., Montréal, Canada 
BM45 Lallemand Inc., Montréal, Canada 
285 Lallemand Inc., Montréal, Canada 
DV10 Lallemand Inc., Montréal, Canada 
 
5.3.2 Fermentation media 
Fermentation experiments were carried out with synthetic must MS300 which approximates to a 
natural must as previously described [5]. The medium contained 125 g/L glucose and 125 g/L fructose, 
and the pH was buffered at 3.3 with NaOH. 
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5.3.3 Fermentation conditions 
All fermentations were carried out under microaerobic conditions in 100 ml glass bottles (containing 80 
ml of the medium) sealed with rubber stoppers with a CO2 outlet. The fermentation temperature was 
approximately 22oC and no stirring was performed during the course of the fermentation. Fermentation 
bottles were inoculated with YPD cultures in the logarithmic growth phase (around OD600 = 1) to an 
OD600 of 0.1 (i.e. a final cell density of approximately 106 cfu.ml-1). The cells from the YPD pre-
cultures were briefly centrifuged and resuspended in MS300 to avoid carryover of YPD to the 
fermentation media. The fermentations followed a time course of 14 days and the bottles were weighed 
daily to assess the progress of fermentation. Samples of the fermentation media and cells were taken at 
days 2, 5 and 14 as representative of the exponential, early logarithmic and late logarithmic growth 
phases respectively. 
 
5.3.4 Growth measurement 
Cell proliferation (i.e. growth) was determined spectrophotometrically (PowerwaveX, Bio-Tek 
Instruments) by measuring the optical density (at 600 nm) of 200 µl samples of the suspensions over 
the 14 day experimental period. 
 
5.3.5 Analytical methods - HPLC 
Culture supernatants were obtained from the cell-free upper layers of the fermentation media. For the 
purposes of glucose determination and carbon recovery, culture supernatants and starting media were 
analyzed by high performance liquid chromatography (HPLC) on an AMINEX HPX-87H ion exchange 
column using 5 mM H2SO4 as the mobile phase at a flow rate of 0.5 ml.min-1 and a temperature of 55 
oC. Agilent RID and UV detectors were used in tandem for peak detection and quantification. Analysis 
was carried out using the HPChemstation software package. 
 
5.3.6 Enzymatic metabolite assays 
All enzymes and cofactors were obtained from Roche (Germany) or Sigma (Germany). Metabolite 
concentrations were determined using the enzymatic methods described by Bergmeyer and Bernt [7]. 
 
5.3.7 General statistical analysis 
T-tests and anova analyses were conducted using Statistica (version 7). HCL and KMC clustering were 
carried out using TIGR MeV v2.2 [6]. 
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5.3.8 Starvation assays 
Determination of cell viability/ survival upon macronutrient starvation was conducted using growth 
media limited for key macronutrients. The compositions of the four nutrient-depleted media are 
summarized in Table 2 below. 
 
Table 2 Media composition for carbon, nitrogen, sulfur and phosphorus starvation assays. 
- CARBON - NITROGEN - SULFUR - PHOSPHORUS
(NH4)2SO4 5 5
KH2PO4 3 3 3
MgSO4.7H20 0.5 0.5 0.5
K2SO4 5 2
NH4Cl 5
MgCl2 0.5
Glucose 50 50 50
g/L
 
 
5.3.9 Ca2+ - dependent flocculation assays 
Yeast colonies for each strain were inoculated (in quadruplicate) in test tubes containing 5 ml YPD 
media and grown to stationary phase. An aqueous solution of EDTA (pH 8.0) was then added to these 
cultures to a final concentration of 50 mM and the cultures agitated vigorously by vortexing at 
maximum speed setting. The OD600 was determined immediately by mixing 100 μl of the culture with 
900 μl of 50 mM EDTA. Ca2+ -dependent flocculation was then induced by spinning down 1 ml of the 
liquid cultures in a micro centrifuge, followed by washing in 1ml ddH2O and resuspension in 1 ml of 
40 mM CaCl2. The samples were then vigorously agitated as before and left undisturbed for 60 
seconds. A 100 μl sample was then taken from just below the meniscus in the micro centrifuge tube of 
each sample and mixed thoroughly with 900 μl of a 40 mM CaCl2 solution. A second 
spectrophotometric measurement was then taken at a wavelength of 600 nm as before. For more 
information see Bester et al. [8]. The extent of Ca2+ -dependent flocculation was then calculated by the 
following formula:  
Flocculation (%) = (A-B)/A × 100 
 
5.3.10 Cell surface hydrophobicity assays 
Yeast cultures grown overnight in YPD were diluted to a concentration of 0.5 X 107 cells in 2 ml of 
ddH2O. After centrifugation and removal of the supernatant, the cells were resuspended in 2 ml of 
buffer containing 22.2 g.l-1 K2HPO4, 7.26 g.l-1 KH2PO4; 1.8 g.l-1 urea and 0.2 g.l-1 MgSO4·7H2O. The 
absorbance of 1 ml of the cell suspension was determined spectrophotometrically at a wavelength of 
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660 nm (Reading A). To the remaining 1 ml cell suspensions, 100 μl of xylene was added to each 
sample and the samples vortexed vigorously for 30 seconds and left to stand for 15 minutes thereafter. 
The xylene layer was then removed from each tube and the absorbance of the remaining aqueous layer 
determined as before at 660 nm (Reading B). The modified hydrophobicity index (MHI) was defined as 
1 – (B/A). High MHI values are indicative of increased partitioning of cells towards the non-polar 
xylene phase, and thus of a hydrophobic yeast population [22]. 
 
5.3.11 Cell surface charge assays 
Yeast cultures grown overnight in YPD were diluted to a concentration of 0.5 X 107 cells in 1ml of 0.2 
M acetate buffer (pH 4.0), consisting of 4.1% acetic acid and 0.9% sodium acetate. Cells were washed 
three times in acetate buffer before final resuspension in acetate buffer containing alcian blue (0.015 
g.l-1). The cell suspensions were incubated at 120 rpm on a shaker for 5 minutes at room temperature. 
Samples were subsequently centrifuged at 4000 rpm for 5 minutes and the absorbance of the 
supernatant determined spectrophotometrically at 607 nm. The amount of alcian blue that remained 
bound to the cells was calculated using a standard curve set up by diluting the original 0.015 g.ll- alcian 
blue in acetate buffer. Data was expressed as μg of alcian blue bound per 0.5 X 107 cells (i.e. per 1 ml 
of OD600 = 0.5) [37].  
 
5.3.12 Mat formation 
To ability of yeast strains to form spreading growth mats (also referred to as biofilm formation) on 
plates was determined as described previously [38]. Ten μl of a yeast suspension grown overnight in 
liquid media was spotted in the centre of an YPD plate containing 0,3% (w/v) agar and incubated at 
23˚C. 
 
5.3.13 Heat shock 
Cells were grown continuously at 30oC to an OD600 of 1.0 before centrifugation and resuspension in an 
equal volume of ddH2O at a temperature of 55oC. The cell suspensions were then incubated at this 
temperature for 15, 40 and 45 minute periods and plated out in 10 μl serial dilution ranges on YPD 
plates and incubated for 24-48 hours at 30oC to assess for survival. 
 
5.3.14 Oxidative stress 
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Cells were grown to an OD600 of 1.0 as representative of the mid-exponential growth phase. Samples 
were plated out in 10μl serial dilutions on YPD plates containing 1 mM, 2 mM and 3 mM hydrogen 
peroxide and incubated at 30oC to detect the growth of tolerant cells. 
 
5.3.15 Osmotic and hypersaline stress 
Cells were grown to an OD600 of 1.0. Samples were then centrifuged to collect the cells and 
resuspended in equal volumes of 0.9% NaCL (osmo-neutral). Samples were plated out in 10 μl serial 
dilutions on YPD plates containing 1 M, 1.5 M and 2 M sorbitol, and incubated at 30oC for 24 – 48 
hours to assay for osmotic shock. For the hyper-saline stress, the same samples were plated out on YPD 
solid media containing 1 M, 1.2 M and 1.5 M sodium chloride (NaCl). 
 
5.3.16 Heavy metal (Copper) toxicity 
Mid-logarithmically-growing cells were collected by centrifugation, resuspended in slightly buffered 
ddH20 and spotted onto YPD plates containing 0.5 mM, 1 mM, 2 mM and 4 mM copper sulfate 
(CuSO4) respectively. 
 
5.3.17 Ethanol tolerance 
Yeast cells were grown to the mid-exponential growth phase before centrifugation to collect the cells. 
The cells were then resuspended in 20%, 25% and 30% ethanol solutions (v/v) and incubated at room 
temperature for 10 minutes. Serial dilutions of the ethanol-stressed cells were then spotted onto regular 
YPD plates to determine the relative survival rate of cells of the different strains. 
 
5.3.18 Microarray analysis 
Sampling of cells from fermentations and total RNA extraction was performed as described by Abbott 
et al. [1]. Probe preparation and hybridization to Affymetrix Genechip® microarrays were performed 
according to Affymetrix instructions, starting with 6 μg of total RNA. Results for each strain and time 
point were derived from 3 independent culture replicates. The quality of total RNA, cDNA, cRNA and 
fragmented cRNA were confirmed using the Agilent Bioanalyzer 2100.  
 
5.3.19 Acquisition of transcriptomics data and statistical analysis 
Microarray data can be viewed at the GEO repository under the accession number GSE11651. 
Acquisition and quantification of array images and data filtering were performed using Affymetrix 
GeneChip® Operating Software (GCOS) version 1.4. All arrays were scaled to a target value of 500 
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using the average signal from all gene features using GCOS. Genes with expression values below 12 
were set to 12 + the expression value as previously described [9] in order to eliminate insignificant 
variations. 
 
Determination of differential gene expression between experimental parameters was conducted using 
SAM (Significance Analysis of Microarrays) version 2 [41]. The two-class, unpaired setting was used 
and genes with a Q value less than 0.5 (p < 0,0005) were considered differentially expressed. Only 
genes with a fold change greater than 2 (positive or negative) were taken into consideration. 
 
Random forest analysis was carried out as described by Breiman [11]. Genes were differentially ranked 
according to their ability to discriminate between different time points (clamped strain data) and 
between different strains (clamped time data). The top 200 ORF’s for each analysis were considered for 
further in depth analysis and evaluation. 
 
5.3.20 Multivariate data analysis 
The patterns within the different sets of data were investigated by principal-component analysis (PCA; 
The Unscrambler; Camo Inc., Corvallis, Oreg.). PCA is a bilinear modeling method which gives a 
visually interpretable overview of the main information in large, multidimensional datasets. By plotting 
the principal components it is possible to view statistical relationships between different variables in 
complex datasets and detect and interpret sample groupings, similarities or differences, as well as the 
relationships between the different variables [29].  
 
5.3.21 Reporter metabolite analysis 
Microarray data were analysed using an algorithm that integrates the topology of the yeast metabolic 
graph to uncover the transcriptional regulatory architecture of the metabolic  pathways. The so called 
‘reporter metabolites’ are metabolites around which the most significant transcriptional changes can 
occur. The algorithm allows pair-wise and multiple comparisons to be performed using transcriptome 
data. Thus, multidimensional analysis of gene expression patterns at different times and between 
different strains is used first to score reporter metabolites. Based on the reconstruction of the metabolic 
network graphs it is possible to subsequently uncover highly correlated connected subgraphs 
(subnetworks) within the enzyme-interaction graph. For more information, see the original article by 
Patil & Nielsen [33]. 
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5.4 Results 
5.4.1 Strain physiology and fermentation kinetics 
All five commercial strains displayed comparable growth rates and primary fermentation kinetics such 
as fermentation rate, sugar utilization and ethanol production, while displaying significant differences 
with regard to the production of extracellular metabolites [40]. Additional phenotypic characterisation 
reveals significant differences in the general physiology of these strains. Such differences include (i) 
cell surface and adhesion properties related phenotypes such as flocculation, invasive growth and mat 
formation (Table 3), and (ii) the ability of the different strains to tolerate carbon, nitrogen, sulfur and 
phosphorous starvation (Figure 1) as well as key stress conditions such as oxidative, osmotic and 
ethanol stress (Figure 2).  
 
Table 3 Summary of cell wall properties and adhesion phenotypes of the five yeast strains. 
VIN13 EC1118 BM54 285 DV10
Flocculation %   3.63 ± 0.25 3.53 ± 0.55 12.17 ± 2.08 12.32 ± 2.75 5.85 ± 0.99
Modified Hydrophobicity Index (MHI) 0.037 ± 0.012 0.193 ± 0.031 0.555 ± 0.074 0.381 ± 0.042 0.155 ± 0.027
Cell surface charge index   25.4 ± 3.7 23.3 ± 2.4 26.5 ± 03.2 23.1 ± 2.2 28.1 ± 1.2
Mat formation   No No Yes Yes No  
 
With regard to cell surface properties, a general flocculation test revealed that the different strains 
showed significant variation in their inherent ability to flocculate in the presence of Ca2+. Flocculation 
was low in EC1118, VIN13, increased in DV10, and was highest for 285 and BM45. The flocculation 
percentages observed are however all much lower when compared to those obtained in similar 
conditions with laboratory yeast strains [8]. Besides flocculation ability, the cell surface hydrophobicity 
of the various strains also differed significantly from one another. The inter-strain trends observed were 
similar to those reported for the flocculation experiments. Furthermore only the BM45 and 285 strains 
showed the ability to form mats or ‘biofilms’ on semi-solid media. 
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Figure 1 Survival response of the five yeast strains subjected to starvation conditions. 
 
The strains showed varying responses to starvation for different macronutrients. Whereas all the strains 
responded similarly to phosphorous starvation, clear differences were evident for the survival rates of 
the five strains exposed to carbon, nitrogen and sulfur depleted media. Once again EC1118, VIN13 and 
DV10 displayed a close alignment in terms of survival rates, while BM45 and 285 exhibited close 
similarities to one another as well.  VIN13 coped best with nitrogen starvation stress, followed by 
EC1118 and DV10. BM45 and 285 were by far inferior in this regard. However, this pattern was 
completely reversed in the case of carbon and sulfur starvation, where these two strains displayed a 
better ability to survive under such conditions. 
 
Yeast survival during carbon starvation
Time (days)
20 25 30 35 40 45
%
 s
ur
vi
vi
ng
 c
el
ls
0
20
40
60
80
100
VIN13
EC1118
BM45
285
DV10
Yeast survival during nitrogen starvation
Time (days)
20 25 30 35 40 45
%
 s
ur
vi
vi
ng
 c
el
ls
0
20
40
60
80
100
120
VIN13
EC1118
BM45
285
DV10
Yeast survival during sulfur starvation
Time (days)
20 25 30 35 40 45
%
 s
ur
vi
vi
ng
 c
el
ls
0
20
40
60
80
100
VIN13
EC1118
BM45
285
DV10
Yeast survival during phosphorus starvation
Time (days)
20 25 30 35 40 45
%
 s
ur
vi
vi
ng
 c
el
ls
0
20
40
60
80
VIN13
EC1118
BM45
285
DV10
A B 
D C 
 119
 
Figure 2 Assays for heat shock, oxidative stress, osmotic and hypersaline stress, copper toxicity and 
ethanol tolerance for VIN13, EC1118, BM45, 285 and DV10. 
 
The strains showed varying tolerance to heat shock (Figure 2A), with the BM45 strain proving to be the 
least tolerant to this particular stress, followed by the DV10 strain. All three remaining strains showed 
similar degrees of tolerance to heat stress treatments. At 1mM concentrations of hydrogen peroxide, the 
strains 285 and BM56 showed the highest resistance to oxidative stress, followed by the DV10 strain 
(Figure 2B). The EC1118 and VIN13 strains were the least tolerant of oxidative stress conditions. 
Interestingly, the BM45 strain showed the lowest tolerance for high salt concentrations in the growth 
media, with all four of the other strains reacting similarly under these conditions (Figure 2D). However, 
all five strains responded with similar growth rates on the high sorbitol-concentration media (Figure 
2C). All five strains showed similar levels of tolerance to 20 % ethanol, but by 25 % ethanol, VIN13 
appears to be somewhat more tolerant than the rest (Figure 2F). Upon exposure to 30% ethanol, 
however, only the DV10 and VIN13 strains showed observable survival of cells. 
 
5.4.2 Global gene expression profiles 
All facets of the microarray analysis and processing were compliant with international MIAME 
standards. We believe that the analysis was reliable and reproducible based on the minor variation 
between independent biological repeats (Figure 3). Changes in gene expression during the course of 
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fermentation also agreed quite well with data from related microarray analysis for the EC1118 [39] and 
VIN13 strains [30].  
 
5.4.3 Outcomes of PCA analysis 
The overall structure in the comparative transcriptome datasets of the different strains was analyzed by 
principal-component analysis (PCA) of differentially expressed genes as identified from two-way 
ANOVA analysis (Fig. 3). In terms of design, the samples represent the different fermentations (3 
independent replicates for each of the five strains) at three different time points. The variables 
considered are the expression levels of the differentially expressed genes. 
 
 
Figure 3 PCA analysis showing components 1 and 2. Time points are indicated by D2 for day2, D5 for 
day5 and D14 for day14. Strains can be identified as follows: EC1118 (‘E’, purple); VIN13 
(‘V’, black); BM45 (‘B’, red); 285 (‘2’, blue); DV10 (‘D’, green). 
 
It is apparent that the primary experimental factor responsible for the variation in gene expression data 
is time, or rather the stage of fermentation. All samples group very well together in time-point specific 
clusters along the first component, or axes of variation. The second component neatly separates the 
main time point clusters into strain-specific sub-clusters. The PCA plot thus provides a succinct 
overview of the overall data structure and the relative relationship between the various strains. The fact 
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that distinct groupings are evident for biological repeats attests to the integrity of the microarray 
analyses. It is also evident (especially from second component) that certain strains are more similar in 
terms of their overall gene expression patterns. For instance, BM45 and 285 group closely together at 
all three time points, while EC1118 and DV10 also appear to group close together, with VIN13 in an 
intermediate position between the two aforementioned clusters. 
 
5.4.4 Significance and random forest analyses 
A large number of genes were significantly differentially expressed between different strains at the 
same time point ( ± 100-400) and within a particular strain at different time points during fermentation 
( ± 1000-2000). The only genes from these detailed results that will be considered in more detail later 
are those related to the GO process categories of energy and metabolism. 
 
Random forest analysis is a CART aggregation technique that can be applied to comparative 
microarray –type data in order to ‘rank’ genes in terms of their ability to discriminate between different 
‘classes’ or samples from different experimental conditions. The technique is essentially similar to the 
concept of biomarker identification and can be applied to discriminate between different experimental 
factors or conditions. In our research, we used the approach in order to identify genes with a strong 
discriminatory power, regardless of the absolute magnitude of fold change (which would otherwise 
obscure more subtle yet extremely relevant changes in the expression of certain genes). 
 
In the first case, genes are ranked in order of their ability to discriminate between different time points 
during fermentation (regardless of strain variability). In the second case, genes are ranked based on 
their ability to discriminate between different yeast strains regardless of growth cycles or fermentative 
stage. The top 200 ranked genes for both strain and time point discrimination were subject to functional 
categorization. The results of this functional enrichment of the ranked gene lists are summarized in 
Table 4.  
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Table 4 Functional categorization of the top 200 time point and strain discriminatory ORF’s (based on 
Random Forest analysis). 
 
MIPS Functional Category # selected / total
Genes from top 200 strain discriminatory list
TRANSPORT FACILITATION 21 /312
SEO1 YBR235W YBR293W AUT4 YCL073C ALR2 YFL054C AGP3 TPC1 TPO2 
MAL11 HXT9 MMP1 SUL2 CTR3 TOM37 PET8 ENB1 PDR5 YOR192C CTR1
CELL RESCUE, DEFENSE AND VIRULENCE 17 /278
TCM62 SIF2 YBR293W YCL073C YER187W PAU5 ALR2 DAK2 SNO3 TPO2 CPR2 
LCB3 HMS2 PAU4 QRI8 ENB1 PDR5
ION TRANSPORTERS 7 /78 SEO1 YBR235W ALR2 SUL2 CTR3 PDR5 CTR1
METABOLISM 43 /1066
PYC2 AAD3 MDH3 AAD4 THI13 APT2 CHO1 SER3 YFL052W DAK2 AGP3 AAD6 
YFR055W MIG2 UPF3 TPC1 MAL13 MAL11 YHR033W DOG2 AAP1 YIL172C MUC1 
YIR035C LCB3 HXT9 URA8 YJR149W PGU1 MTD1 MMP1 SUL2 PUT1 PUS5 HMG2 
GSF2 TOM37 GLO4 PDR5 YOR192C CAR1 PPT2 GPH1
Genes from top 200 time point discriminatory list
mRNA TRANSCRIPTION 29 /556
PRP45 HTB2 RTG3 ABD1 PRP9 MTF2 SUB2 SNU56 CFT1 SYF1 LRS4 SNU13 PRP22 
GLN3 ACA1 FLO8 CEG1 SIP2 DAL81 CTK2 CAF4 PRP16 PRP19 RGR1 HSH155 
PFS2 HAL9 RPB10 CET1
mRNA PROCESSING 16 /122
PRP45 ABD1 PRP9 MTF2 SUB2 SNU56 CFT1 SYF1 SNU13 PRP22 CEG1 PRP16 
PRP19 CEF1 PFS2 CET1
CELLULAR TRANSPORT 27 /494
CMD1 ARF2 YRB1 CAN1 SBH1 LEU5 VMA10 EPT1 YIL006W APL1 GAP1 COF1 
SED5 VPS34 GSP1 DIC1 ERV41 HXT2 LYP1 PEX15 ITR2 GYP1 SCD5 VMA4 RET3 
SAR1 SEC8
METABOLISM 49 /1066
IMD1 RTG3 RIB7 YBR159W DUR1,2 DUT1 PHO13 PDC2 EXG2 URH1 CAN1 PMI40 
ISC1 GLN3 ILV1 PYC1 ERG1 LAG1 LEU5 EPT1 DCD1 YHR155W YIL006W RNR3 
LYS12 DAL81 
DAL3 URA2 GAP1 RGR1 HMX1 THI7 VPS34 DIC1 NMD4 AMD1 IMD4 HXT2 ADH3 
ADE12 LYP1 ITR2 KTR1 TFC7 BTS1 YPL088W SPT14 PCL8 DPM1
 
 
As expected, the time point discriminatory data contain a large number of genes related to mRNA 
processing and general cell growth and maintenance. However, the most over-represented functional 
categories in the strain discriminatory sets are related almost entirely to transport facilitation and 
general metabolism. Only 12 of the 200 strain discriminatory ranks are essential genes: RFA1, RSM10, 
ALG13, BRR6, YGR277c, DSN1, PAM18, CFT2, RSC9, RNA14, YNL260c, and MED4. For the time 
point discriminatory rank set a total of 50 genes were essential, which is logical considering the 
involvement of fermentation stage-specific discriminators in processes such as growth and general cell 
cycle regulation. There was no overlap between the results of the different ranked lists. 
 
5.4.5 Glycolysis, fermentation and trehalose metabolism 
These areas of central carbon metabolism were over-represented in the SAM analysis outputs, which 
justified further investigation into the various genes coding for enzymes of the key central carbon 
metabolic pathways. In Figure 4, the overall change in gene expression over time and between strains is 
represented as a clustered heat map. The closer the samples aggregate together, the stronger the 
statistical relationships between these samples. Accordingly, strains are primarily grouped together in a 
time-specific manner. Along the vertical plane, genes with similar expression patterns over time and 
between strains are grouped together. The length of tree branches is inversely related to the strength of 
the statistical relationship between the genes (ie. the shorter the branch, the stronger the correlation).  
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Figure 4 HCL clustering of transcripts encoding enzymes involved in glycolysis, fermentation and 
trehalose metabolism (data log normalized to the day 2 gene expression average). Red bars 
denote an increase in expression while green bars indicate a decrease in expression for a given 
gene. 
 
It is interesting to note that for the first two time points there is the same clustering pattern for the 
different strains, whereas the strains segregated differently at the last time point. Nevertheless, the three 
strains EC1118, VIN13 and DV10 cluster closely together at all three time points. 
 
5.4.6 Reporter metabolite analysis 
This hypothesis-driven approach to interpreting microarray data aims to uncover the transcriptional 
regulatory architecture of metabolic networks. The reporter metabolites are those around which the 
most transcriptional changes occur, which implies that the levels of these metabolites are adjusted in 
response to the experimental factor/s in order to maintain metabolic homeostasis within the network. 
Differential comparisons were conducted within each strain, that is, day 2 vs. day 5 and day 5 vs. day 
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14 for VIN13, EC1118, BM45, 285 and DV10, respectively. The results for the top-scoring metabolites 
in the differential analysis can be viewed in the appendix to this chapter. 
 
For the first multiple analysis, all three time points were compared simultaneously for each individual 
strain. In the second case all strains were simultaneously compared with one another for each of the 
three time points. The statistically significantly reporter metabolites from these two analyses are 
summarized in Tables 5 and 6.  
 
Table 5 Multiple analysis across all strains for days 2, 5 and 14. 
 
Metabolite
Nr. of
neighbors Metabolite
Nr. of
neighbors Metabolite
Nr. of
neighbors
alpha,alpha-Trehalose 4 3-Phospho-D-glyceroyl phosphate 4 Hydrogen sulfide 4
3-Phospho-D-glyceroyl phosphate 4 NADPH 40 Sulfite 3
Biotin 3 Dolichyl beta-D-mannosyl phosphate 7 Intermediate_Methylzymosterol_I 2
Orthophosphate 67 NADP+ 43 Intermediate_Zymosterol_I 2
3-(4-Hydroxyphenyl)pyruvate 5 ATP 113 Aminoimidazole ribotide 2
3-Dehydrosphinganine 3 AMPM 6 1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate 2
Mannose-inositol-P-ceramide 3 alpha,alpha'-Trehalose 6-phosphate 4 Malate 8
alpha,alpha'-Trehalose 6-phosphate 4 Mannan 6 3'-Phosphoadenylylsulfate 2
7,8-Diaminononanoate 2 UMP 4 Acetoacetyl-CoA 2
Sulfite 3 D-Mannose 6-phosphate 5 O-Acetyl-L-homoserine 2
(R)-5-Diphosphomevalonate 2 GDP 16 (R)-3-Hydroxy-3-methyl-2-oxobutanoateM 2
Dethiobiotin 2 Pyrophosphate 60 (R)-2,3-dihydroxy-3-methylbutanoateM 2
Palmitoyl-CoA 2 3-Methyl-2-oxobutanoateM 2 Adenosine 3',5'-bisphosphate 3
Oxalosuccinate 2 dGDP 3 (S)-2,3-Epoxysqualene 2
NH3xt 3 (R)-Pantothenate 3 Chitosan 2
Acetoacetyl-CoA 2 Fecosterol 2 3-Phospho-D-glyceroyl phosphate 4
Inositol phosphorylceramide 3 1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide 4 CitrateM 5
PyruvateM 6 Malonyl-CoA 2 Adenosine 5
5-Phospho-alpha-D-ribose 1-diphosphate 17 AMP 38 gamma-L-Glutamyl-L-cysteine 2
Dolichyl phosphate 8 trans,trans-Farnesyl diphosphate 2 L-Lysine 4
DAY2 DAY5 DAY14
 
 
In this case, the analysis identifies the metabolites around which theoretically the most significant 
changes in gene expression/regulation occur when comparing all the different strains at each specific 
time point. Several interesting metabolites feature strongly in these interstrain comparisons: Trehalose 
and trehalose-6-P, mannose and mannose-6-p, as well as various reducing equivalents, important 
cofactors (ie biotin, pyrophosphate) and key compounds such as pyruvate and acetyl-CoA. These 
results agree quite well with the results of the random forest and significance analyses, as will be 
discussed shortly. 
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Table 6 Multiple analysis across all time points within each strain. 
Metabolite
Nr. of
neighbors Metabolite
Nr. of
neighbors Metabolite
Nr. of
neighbors
EC1118  Pyrophosphate 60 VIN13  dUMP 4 DV10  NADPH 40
NADPH 40 Pyrophosphate 60 5-Phospho-alpha-D-ribose 1-dipho 17
dUMP 4 GlutamateM 7 Biotin 3
Prephenate 3 5-Phospho-alpha-D-ribose 1-diphosphate 17 D-Fructose 2,6-bisphosphate 3
UDP 15 Dolichyl beta-D-mannosyl phosphate 7 Pyrophosphate 60
Isocitrate 5 2-OxoglutarateM 10 AMP 38
alpha,alpha-Trehalose 4 UDP 15 GlutamateM 7
D-Mannose 6-phosphate 5 AMP 38 dUMP 4
(S)-2,3-Epoxysqualene 2 alpha-D-Mannose 1-phosphate 2 NADP+ 43
Cytosine 5 Mannan 6 D-Mannose 6-phosphate 5
NADP+ 43 S-Adenosyl-L-methionine 14 UDPglucose 12
CYTSxt 4 Prephenate 3 UDP 15
ADxt 4 7,8-Diaminononanoate 2 ASNxt 4
GNxt 4 dADP 4 GLNxt 4
alpha-D-Mannose 1-phosphate 2 L-2-Aminoadipate 6-semialdehyde 2 Prephenate 3
BM45  Pyrophosphate 60 285  D-Fructose 2,6-bisphosphate 3
NADPH 40 Pyrophosphate 60
dUMP 4 dUMP 4
Prephenate 3 Prephenate 3
UDP 15 NADPH 40
Isocitrate 5 OxaloacetateM 5
alpha,alpha-Trehalose 4 ASNxt 4
D-Mannose 6-phosphate 5 GLNxt 4
(S)-2,3-Epoxysqualene 2 Biotin 3
Cytosine 5 alpha,alpha-Trehalose 4
NADP+ 43 GLYxt 4
CYTSxt 4 UDP 15
ADxt 4 NADP+ 43
GNxt 4 Ergosta-5,7,24(28)-trienol 2
alpha-D-Mannose 1-phosphate 2 ALAxt 5  
 
Table 6 indicates the reporter metabolites for each strain over the three time points. In other words, for 
each of the strains in the table, the transcriptional changes over time were substantially concerned with 
regulating the levels of the listed metabolites. In order to validate the assumptions derived from these 
analyses, several of the high-scoring metabolites were quantified experimentally in the same samples 
used for transcriptomic analysis. 
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Figure 5 Intracellular metabolite concentrations measured in the five strains at three time points 
corresponding to the transcriptional analysis. 
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Most metabolite levels followed the same general pattern of decrease as fermentation progresses 
(Figure 5).  One notable exception is trehalose, which showed an increase in intracellular concentration 
between days 2 and 5, with lower levels once again evident at day14 at the end of fermentation. 
Intracellular glucose-1-phosphate also showed a definite increase in intracellular levels from beginning 
to end of the fermentation cycle. In terms of inter-strain variations, no statistically significant 
differences were evident across strains for the metabolites phosphoenolpyruvate (PEP), pyruvate and 
UDP-glucose. Intracellular glucose and fructose concentrations were significantly higher in the BM45 
and 285 strains in the early stages of fermentation (days 2 and 5), while glucose-6-phosphate (and to a 
lesser extent glucose-1-phosphate and fructose-6-phosphate) concentrations were significantly lower in 
comparison to the EC1118 and VIN13. Intracellular trehalose levels were also consistently higher in 
EC1118, VIN13 and DV10 compared to BM45 and 285, particularly at days 2 and 5. 
 
5.5 Discussion 
5.5.1 Stress responses 
From our comparative transcriptome analysis it was evident that differences in the expression of genes 
involved in the various pathways involved in stress tolerance were substantial at all three time points 
considered. Clearly significant differences exist in the manner in which the five strains adapt to the 
changing fermentation environment at the molecular level. However, the problem from a data analysis 
perspective regarding these phenotypes is two-fold: Firstly, the genomic response programs for the 
different stress conditions share common effectors and regulators, making it difficult to attribute 
differences in gene expression levels to any specific stress tolerance phenotype. The second 
complication in the batch fermentation context is the fact that we have limited control and knowledge 
over the stress factors that are faced by the yeast at the specific time points at which transcriptomic 
analyses were conducted. There are thus inherent complications in terms of connecting differences in 
stress-related gene expression with stress responses and inherent phenotypic differences between the 
strains, as revealed by our analysis. 
 
Instead of a haphazard attempt to arbitrarily connect gene expression profiles with stress phenotypes 
we sought to explain some of these differences in light of the more concrete (and experimentally 
validated) metabolic differences between the strains. These links will be explored in more detail in the 
discussion of the reporter metabolite analysis. 
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5.5.2 Flocculation 
The flocculation response of yeast cells is a highly complex process, involving several interrelated 
signal transduction and stress response pathways as well as numerous structural proteins in the cell 
wall. Key components of this intricate system include not only the flocculation proteins themselves but 
also the enzymes responsible for the production and attachment of mannosyl residues to these structural 
proteins of the cell wall. Enzymes involved in the production of GPI anchors may also play a role in the 
covalent attachment and incorporation of flocculins and mannoproteins into the cell wall [28; 46].  
 
There is great diversity/variation in the inherent adhesion abilities of different yeast strains used in 
industrial wine fermentations. In terms of the five strains used in this study, BM45 and 285 are the 
strains with superior cell-cell and cell-substrate adhesion properties in comparison to the EC1118 and 
VIN13 strains (Table 3). In light of the results of our comparative transcriptomic profiling there may be 
several genetic factors responsible for these differences.  
 
5.5.2.1 Flocculin-encoding genes 
Although the ability of S. cerevisiae to adhere to other cells and one another is a component of complex 
developmental processes, one of the main requirements is the expression of various FLO genes, FLO1, 
FLO5, FLO10 and FLO11/ MUC1 [8; 10; 27; 43]. However, these genes are known to present strong 
strain-dependent variation in size and in their effectiveness to induce adhesion-related phenotypes [44] 
and their individual expression levels may not be accurately measured in current arrays because of 
significant sequence homology. More interesting from a phenotypic perspective should be the 
expression levels of transcriptional activators that are known to control general adhesion properties 
such as FLO8. Indeed, it has been well established that the expression levels of this gene directly 
correlate with flocculation and adhesion efficiency [8; 43; 44]. This gene showed significantly higher 
expression levels during early stationary phase in the BM45 strain compared to the weaker flocculating 
strains VIN13 and EC11118, correlating well with the observed difference in intrinsic flocculation and 
adhesion ability.   
 
5.5.2.2. Cell wall mannoproteins 
Several cell wall mannoproteins of the FIT and DAN families showed significant increases in 
expression in the BM45 and 285 strains in comparison to the rest. Most notable among these are FIT2, 
FIT3, DAN1, and DAN4. The FIT genes code for GPI-anchored cell wall mannoproteins that are 
involved in the uptake and retention of iron in the cell wall [36]. The regulation and roles of the DAN 
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family of mannoproteins are still poorly understood, although they are evidently required for anaerobic 
growth [13]. As mannoproteins, the FIT and DAN gene products are cell-wall bound and present 
mannose residues for selective binding by flocculation proteins of adjacent cells. The higher expression 
levels of genes in both the FIT and DAN families in the two strains with superior cell adhesion 
properties (BM45 and 285; Table 3) thus serve as a possible indicator of the potential involvement of 
these two gene families in establishing different adhesion phenotypes in wine yeast strains. 
 
5.5.3 Central carbon metabolism 
Our data show that a large proportion of differentially expressed transcripts are related to core 
metabolic activities of the fermenting yeasts (see Tables 2 and 3, Figure 4). Several enzymes involved 
in hexose metabolism, glycolysis, trehalose metabolism and redox balance are differentially expressed 
between strains at various stages of fermentation. The analysis of the gene expression levels within the 
framework of enzyme-enzyme and enzyme-metabolite interaction graphs (using the reporter metabolite 
approach) helped to pin-point areas of metabolism that could speculatively be related to strain-strain or 
time point variation.  
 
Trehalose, glucose-6-phosphate, glucose, UDP-glucose and fructose-6-phosphate scored high on the 
differential and multiple analyses across time points during fermentation (see table 6 and 
supplementary material. Indeed, these metabolites did show marked differences in concentration 
between time points (Figure 5). Trehalose was also a prominent inter-strain reporter for days 2 and 5, 
and once again experimentally determined trehalose levels were found to be significantly different 
between strains at these time points (Figure 5). This provides confidence that the outputs of the reporter 
analysis are biologically relevant and useful for an in silico interpretation of metabolic variation 
between different strains or key time points during fermentation. Several interesting features of these 
outputs will be discussed briefly in the following section. 
 
Trehalose and trehalose-6-phosphate appear numerous times in the multiple and differential reporter 
analyses, indicating that regulation of trehalose levels plays a key role throughout fermentation, both as 
a stress metabolite and as a key allosteric regulator of several important glycolytic enzymes. Trehalose-
6-P restricts sugar influx into glycolysis through inhibition of the hexokinases [23], and thus 
determines the flux through glycolysis and the provision of energy and intermediates for fermentation, 
glycerol metabolism and the OPP pathway. Changes in the expression of the genes involved in 
trehalose metabolism could potentially account for the metabolic restructuring that occurs in carbon 
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metabolism as fermentation progresses. For instance, expression levels of genes encoding TPS1, TPS2 
and TSL1 (involved in trehalose synthesis) increase sharply between days 2 and 5 of fermentation. This 
is mirrored by the experimentally determined increase in trehalose levels between these two time 
points. It would be anticipated that trehalose levels would continue to increase sharply towards the end 
stages of fermentation. Our observation of lower trehalose levels at the end of fermentation can be 
explained by trehalose mobilization at the final stage of fermentation when sugar exhaustion is 
imminent. This correlates well with the increasing expression levels of transcripts encoding 
intracellular trehalose-degrading enzymes (NTH1 and NTH2), as well as a decrease in the expression of 
TPS3, which encodes a positive regulator of the TPS1 and TPS3 encoded subunits. 
 
Trehalose concentrations are significantly higher in the EC1118, VIN13 and DV10 strains during 
exponential and early logarithmic growth in comparison to the BM45 and 285 strains. This propensity 
for comparatively greater trehalose accumulation could be an important contributing factor for the 
increased thermo-tolerance, ethanol and osmotic shock tolerance exhibited by these three strains in 
comparison to BM45 in particular [24]. 
 
The BM45 and 285 strains were characterized by significantly lower levels of intracellular hexose 
phosphates, and higher levels of fructose. This suggests a possible discrepancy in the phosphorylation 
efficiency of these strains, and may explain their generally lower fermentative rate, higher residual 
sugars at the end of fermentation and propensity for ‘stuck’ or sluggish fermentations. This apparently 
more ‘conservative’ phosphorylation and utilization of glucose and fructose by these two strains could 
explain why they showed a significantly higher survival rate under carbon starvation conditions in 
comparison to the other three strains.  
 
As mentioned earlier, trehalose-6-phosphate levels also play a key inhibitory role in the rate of hexose 
phosphorylation [23]. Both trehalose and trehalose-6-phosphate feature as strong reporters for the inter-
strain comparisons at day 2 and 5 (Table 5). It is thus tempting to speculate that the regulation of 
trehalose metabolism is a noteworthy area of divergence between wine yeast strains, and that this in 
turn has far-reaching effects on hexose phosphorylation and entry into glycolysis. Trehalose 
metabolism could thus potentially represent a type of overarching regulator with implications for the 
general fermentation phenotypes of different wine yeast strains. 
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Several other reporter metabolites are of interest in terms of their likely connection with fermentative 
phenotypes or relevant physiological traits. The presence of mannose in most of the top10 reporter 
metabolite lists for the intra-strain analysis (i.e. the time point differential data, Table 6) suggests a shift 
in the provision and availability of mannose residues for mannosylation of cell wall proteins as 
fermentation progresses. This could again point to protein mannosylation as an important area in terms 
of determining cell-cell adherence and aggregation during fermentation. Mannose residues or 
precursors thereof also feature heavily on the day 2 and day 5 inter-strain lists, suggesting that 
regulation of mannose metabolism differs between the strains in this study, at least partially accounting 
for their different cell wall properties and flocculation responses. 
 
Reducing equivalents like NADP and NADPH as well as related metabolites like glutamate and 
oxoglutarate (interconversion of these two metabolites is involved in regulating the intercellular 
NADP/NADH ratios) also stand out in this analysis. Changes in/maintenance of the ratios of these 
important reducing equivalents is a major area of metabolic adjustment during anaerobic fermentation 
due to the decreased availability of sugars (glucose) and the build-up of glycolytic intermediates and 
other potentially toxic products, e.g. acetaldehyde, as fermentation progresses.  
 
Prephenate (which is present in the top 15 reporters for each strain) is an intermediate in the 
biosynthesis of the aromatic amino acids phenylalanine and tyrosine. This suggests that large-scale 
changes in the expression of genes involved in this branch of amino acid metabolism occur during the 
course of fermentation. These aromatic amino acids are starting points for pathways that produce 
important aroma compounds in wine, namely 2-phenylethanol and 2-phenylethyl acetate [40]. The rate 
at which these volatile compounds appear in the must is high during the first few days of fermentation, 
decreasing substantially towards the end. This could reflect a reduced availability of the necessary 
precursors in the later stages of fermentation, as suggested by the reporter analysis. 
 
Fru-2,6-P2 also features in the DV10 and 285 strains for the intra-strain analysis. This metabolite is not 
just an intermediary metabolite of glycolysis, but like trehalose it is a very potent regulator of 
glycolysis by inhibiting Pfkp activity. This could potentially be related to the slowing in the rate of 
glycolysis as fermentation progresses. Biotin (also on the list for DV10 and 285) also exerts a marked 
effect upon the hexokinase activity of yeast, leading to a stimulation of the rate of glucose and fructose 
utilization. Once again this could contribute to the regulation of flux through glycolysis and related 
pathways etc during the course of fermentation. 
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The regulatory changes surrounding trehalose metabolism are different for the strains at especially day 
2 and also day 5. Likewise glycolytic metabolites like 3-Phospho-D-glyceroyl phosphate (just below 
the branch point between the glycerol pathway and the lower glycolysis) are also well represented in 
the analysis at days 2 and 5. This could indicate a difference in the way that the strains partition carbon 
towards glycerol production (to maintain NAD/NADH ratios) versus pyruvate production, leading 
ultimately to ethanol formation. In support of this concept, glycerol production was compared in the 5 
strains and there were indeed significant differences [40]. Such inherent differences in glycerol 
production by the different strains could account for their varying tolerance levels of osmotic stress 
conditions. 
 
NADP and NADPH are high scoring metabolites for the inter-strain comparisons at day 5. This could 
be the result of the differences in the dehydrogenase-catalysed reactions of the strains. The ratio of 
NADP and NADPH will impact on the production of a number of higher alcohols produced by the 
strains, and interestingly many of these alcohols differ significantly between strains [40]. The pathways 
leading to the production of these compounds contain several aldehyde/alcohol dehydrogenase 
catalysed steps. These enzymes can usually catalyze both the forward and reverse reactions and are 
very sensitive to NAD/NADH ratios. It is reasonable to speculate that differences in the directionality 
and flux through dehydrogenase-catalysed pathways in the different strains affects the overall 
regulation of NAD/NADH and NADP/NADPH levels in these strains, leading to differences in the 
cellular balance of reducing equivalents. Identification of the NADP/NADPH ratio as a key metabolic 
marker between different strains holds far-reaching implications for the overall regulation of metabolic 
networks in these strains. 
 
 (S)-2,3-Epoxysqualene, methylzymosterol and zymosterol (on the day14 list) are uncommon sterols 
that have hypothesized roles in membrane stabilization under high ethanol levels, which makes sense in 
light of the high ethanol concentrations at the end of fermentation. The reporter analysis identifies 
reactions related to the metabolism of these sterols as areas of variability between strains. It is tempting 
to speculate that this is one of the contributory factors for the differences in ethanol tolerance that was 
observed in our stress assays. 
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5.6 Conclusions 
The research presented here provides a base for further hypothesis-driven investigations into the role of 
various genetic systems in oenologically relevant phenotypes. By analyzing large comparative 
transcriptomic datasets of five industrial wine yeast strains we were able to identify various genes / 
gene sets that could be linked to relevant aspects of yeast performance in key areas related to 
flocculation, stress tolerance and metabolism. The study sheds light on some of the underlying 
molecular factors related to common inter-strain variations between strains, and also increased our 
understanding of metabolic changes that occur during fermentation under wine-making conditions. By 
using five yeast strains and three time points we were able to eliminate ‘noise’ and clearly distinguish 
between differences in gene expression that are related to strain identity alone, as opposed to the 
specific stage of fermentation. Strains such as BM45 and 285, which were similar in terms of their 
overall gene expression patterns (as can be seen from the PCA analysis in Figure 3) showed similar cell 
adhesion properties and stress tolerance properties (Table 3, Figure 1-2). The same is true for EC1118, 
DV10 and VIN13 (to a lesser extent). These strain groupings also hold for the profiles of exo-
metabolites produced [40], as well as for the concentrations of the nine key intercellular metabolites 
measured (Figure 5). By contextualizing the comparative transcriptome datasets within existing 
metabolic maps and applying the reporter metabolite algorithm we were able to pin-point some of the 
underlying molecular and genetic factors responsible for these important physiological trait differences 
between strains. Ultimately, the research presented in this paper provides new insights for targeted 
engineering strategies aimed at improving the performance of wine yeast strains.  
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Appendix 
Scored reporter metabolites for inter-strain differential analysis.  
DAY2-5
Nr. of
neighbors Z score DAY5-14
Nr. of
neighbors Z score
EC1118 D-Mannose 6-phosphate 5 2.94 D-Mannose 6-phosphate 5 3.70
dUMP 4 2.82 alpha-D-Glucose 6-phosphate 11 3.13
Pyrophosphate 60 2.57 (S)-2,3-Epoxysqualene 2 2.72
OxaloglutarateM 3 2.49 beta-D-Glucose 3 2.63
AMP 38 2.43 UDP 15 2.49
1,3-Diaminopropane 1 2.42 alpha,alpha-Trehalose 4 2.37
(3S)-3-Hydroxyacyl-CoA 1 2.42 Isocitrate 5 2.35
alpha-D-Mannose 1-phosphate 2 2.31 dUMP 4 2.29
D-Xylose-5-phosphate 4 2.26 alpha,alpha'-Trehalose 6-phosphate 4 2.20
dUTP 3 2.21 NADPH 40 2.17
tRNA(Arg) 2 2.19 Squalene 2 2.01
L-Arginyl-tRNA(Arg) 2 2.19 3-Dehydrosphinganine 3 2.00
Spermidine 3 2.10 Nicotinamide 1 2.00
alpha,alpha-Trehalose 4 2.08 NicotinamideM 1 2.00
2,5-Diamino-6-hydroxy-4-(5'-phosphoribosylamin 2 1.99 Palmitoyl-CoA 2 1.99
BM45 ALAxt 5 2.46 Acetyl-CoA 19 2.12
L-2-Aminoadipate 6-semialdehyde 2 2.44 L-Formylkynurenine 1 2.07
GLYxt 4 2.34 CARxt 1 2.03
AMP 38 2.20 Ethanol 5 1.88
(S)-LactateM 2 2.14 Urea 4 1.81
N6-(L-1,3-Dicarboxypropyl)-L-lysine 2 2.01 CoA 28 1.76
Carnitine 3 2.00 Guanosine 2 1.75
ASNxt 4 1.99 Inositol phosphorylceramide 3 1.73
GLNxt 4 1.99 Chorismate 5 1.72
L-Proline 3 1.98 Ceramide-3 2 1.68
5-O-(1-Carboxyvinyl)-3-phosphoshikimate 2 1.94 FMN 4 1.64
NH3xt 3 1.93 UREAxt 1 1.59
ARGxt 3 1.92 2-Aceto-2-hydroxy butyrateM 2 1.54
D-Ribulose 5-phosphate 4 1.91 2-AcetolactateM 2 1.54
Isocitrate 5 1.85 FAD 2 1.53
VIN13 dUMP 4 2.45 4-Hydroxybenzoate 9 2.63
D-Mannose 6-phosphate 5 2.34 Ceramide-3 2 2.46
L-Phenylalanine 6 2.27 CDP 4 2.43
dUDP 3 2.20 Anthranilate 4 2.41
NADHM 12 2.14 CoA 28 2.38
dGDP 3 1.97 Pyrophosphate 60 2.32
dADP 4 1.96 Acetyl-CoA 19 2.30
6-Phospho-D-gluconate 6 1.92 Malonyl-CoA 2 2.24
Isocitrate 5 1.92 Chorismate 5 2.24
D-Xylose-5-phosphate 4 1.88 Glutathione 10 2.16
dCDP 2 1.88 Inositol phosphorylceramide 3 2.11
alpha-D-Mannose 1-phosphate 2 1.87 CTP 8 2.11
L-Tyrosine 10 1.86 OxaloglutarateM 3 2.08
MalateM 5 1.85 tRNA(His) 1 2.04
UbiquinolM 9 1.84 L-Histidyl-tRNA(His) 1 2.04
DV10 alpha-D-Glucose 6-phosphate 11 2.63 Protoporphyrinogen IX 1 2.21
Xanthosine 5'-phosphate 7 2.61 beta-D-Glucose 3 2.17
tRNA(Lys) 1 2.37 MALxt 1 2.14
L-lysyl-tRNA(Lys) 1 2.37 2-Aceto-2-hydroxy butyrateM 2 2.05
D-Erythrose 4-phosphate 6 2.16 2-AcetolactateM 2 2.05
HomoisocitrateM 2 2.15 Malonyl-CoA 2 1.97
CitrateM 5 2.14 Oxygen 16 1.95
LipoamideM 1 2.10 1,3-beta-D-Glucan 7 1.94
S-AminomethyldihydrolipoylproteinM 1 2.10 Cytosine 5 1.79
URIxt 1 2.09 alpha-D-Glucose 30 1.77
alpha,alpha'-Trehalose 6-phosphate 4 2.03 Glycerone phosphate 7 1.70
L-2-Aminoadipate 6-semialdehyde 2 2.00 2-Hydroxybutane-1,2,4-tricarboxylate 1 1.68
AMP 38 1.95 dTDP 2 1.66
6-Phospho-D-gluconate 6 1.92 Methylglyoxal 1 1.65
UDPglucose 12 1.86 Ergosta-5,7,24(28)-trienol 2 1.55
285 NAD+M 17 2.95 (S)-Dihydroorotate 2 2.45
ATP 113 2.82 dUMP 4 2.33
NADP+ 43 2.79 C16_aldehydes 1 2.30
alpha,alpha-Trehalose 4 2.69 4-Hydroxybenzoate 9 2.21
AcetaldehydeM 3 2.58 alpha-D-Glutamyl phosphate 2 2.19
NADHM 12 2.56 CDP 4 2.17
beta-D-Fructose 6-phosphate 15 2.54 Dolichyl phosphate 8 2.09
Acetyl-CoA 19 2.49 3-Demethylubiquinone-9M 2 2.05
NADPH 40 2.45 Prephenate 3 2.00
Pyrophosphate 60 2.42 alpha,alpha'-Trehalose 6-phosphate 4 1.99
alpha,alpha'-Trehalose 6-phosphate 4 2.42 all-trans-Nonaprenyl diphosphate 7 1.97
ADP 82 2.39 L-Histidine 7 1.94
D-Fructose 2,6-bisphosphate 3 2.25 Phosphatidate 4 1.93
AMP 38 2.15 Pyrophosphate 60 1.91
Malate 8 2.10 N(pai)-Methyl-L-histidine 1 1.91  
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CHAPTER 6 
Transcriptional regulation and diversification of wine yeast strains 
 
6.1 Abstract 
Industrial wine yeast strains are geno- and phenotypically highly diversified, and have adapted to the 
ecological niches provided by industrial wine making environments. These strains have been selected 
for very specific and diverse purposes, and the adaptation of these strains to the oenological 
environment is a function of the specific expression profiles of their genomes. It has been proposed that 
some of the primary targets of yeast adaptation are functional binding sites of transcription factors (TF) 
and the transcription factors themselves. Sequence divergence or regulatory changes related to specific 
transcription factors would lead to far-reaching changes in overall gene expression patterns, which will 
in turn impact on specific phenotypic characteristics of different yeast species/strains. Variations in 
transcriptional regulation between different wine yeast strains could thus be responsible for rapid 
adaptation to different fermentative requirements in the context of commercial wine-making. In this 
study, we compare the transcriptional profiles of five different wine yeast strains in simulated wine-
making conditions. Comparative analyses of gene expression profiles in the context of TF regulatory 
networks provided new insights into the molecular basis for variations in gene expression in these 
industrial strains. We also show that the metabolic phenotype of one strain can indeed be shifted in the 
direction of another by modifying the expression of key transcription factors.  
 
6.2 Introduction 
The genus Saccharomyces can be divided into two major groups: sensu stricto and sensu lato (Barnett, 
1992). The sensu stricto yeasts include S. bayanus, S. cerevisiae, S. paradoxus, and S. pastorianus 
(Kurtzman & Robnett), but  S. cerevisiae is the species that is most widely used in the fermentation 
industry (oenology, bread-making and brewing).  S. cerevisiae has been studied at the genetic level 
since the 1930’s. Most of these studies were carried out using only a handful of strains (Mortimer et al., 
1957; Mortimer & Johnston 1986) that were selected for their ease of use in laboratory conditions. 
Thus the knowledge regarding the genetics and molecular biology of S. cerevisiae is based on a geno- 
and phenotypically narrow range of strains, while studies of natural populations and industrial strains 
of S. cerevisiae are very few (Liu et al., 1996; Mortimer 2000). 
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In contrast to the ‘laboratory’ yeast strains, industrial yeast strains are geno- and phenotypically highly 
diversified (Frezier & Dubourdieu, 1992; Schütz & Gafner, 1994). These strains have adapted to the 
ecological niches provided by industrial or semi-industrial environments. In the wine industry, a large 
number of such strains are commercially produced. Most of the strains were originally isolated from 
spontaneous wine fermentations (Johnston et al., 2000). Although the original or natural ecological 
niche of the species S. cerevisiae is still subject to conjectures, industrial environments have certainly 
provided much of the evolutionary framework for the strains that are currently used industry. These 
strains were all primarily all selected for their ability to completely ferment, or, in the language of 
wine, to ferment to dryness, very high levels (>200g/l) of initial sugars in a largely anaerobic 
environment. However, beyond this generic trait, strains have been selected for very specific and 
diverse purposes, for example to support the production of different styles of wine or to produce 
different aroma profiles. The strains represent therefore a wide range of phenotypic traits, which is 
reflected by significant genetic diversity.  
 
Most wine strains are diploid, which may confer an advantage in terms of rapid adaptation to variable 
external environments. It may also be a way to increase the dosage of some genes important for 
fermentation (Bakalinsky & Snow, 1990; Salmon, 1997). In addition to these changes, the subtelomeric 
chromosomal regions are subject to ongoing duplications and rearrangements via ectopic exchanges 
(Bidenne et al., 1992; Rachidi et al., 1999). Another possible mode of evolution of yeast in the genus 
Saccharomyces is the formation of interspecific hybrids, whereby haploid cells or spores of S. 
cerevisiae, S. bayanus and S. paradoxus mate with one another. The resulting genome plasticity 
resulting from these changes promote faster adaptation in response to environmental changes (Puig & 
Perez-Ortin, 2000) by providing important genetic diversity upon which natural selection mechanisms 
can operate. 
 
Obviously the adaptation of these strains to the oenological environment is a function of the specific 
expression profiles of their genomes. The availability of high quality sequence information offers 
opportunities for global transcriptomic, proteomic and metabolomic studies. Such approaches can 
correlate differences in fermentation phenotypes to gene expression and metabolic regulation. It has 
been proposed that some of the primary evolutionary targets of diversification are functional binding 
sites of transcription factors and the transcription factors themselves (Dermitzakis & Clark, 2002). In S. 
cerevisiae a large variety of sequence-specific transcription factors (TFs) regulate the expression of 
around 6000 protein-coding genes, ensuring the proper development and functioning of the organism. 
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Nucleotide substitutions, as well as short insertions and deletions involving a TF binding site, can be 
correlated with interspecies differences in the expression profiles of the corresponding genes 
(Dermitzakis & Clark, 2002), which in turn impacts on specific phenotypic differences between these 
related species. 
 
A recent study showed that although S. cerevisiae and S. mikatae are very similar in terms of 
nucleotide sequence, they are significantly different to one another and to other Saccharomyces species 
in terms of their TF profiles (Tsong et al., 2006; Borneman et al., 2007). It has been hypothesized that 
the extensive binding site differences observed between the different species reflect the rapid 
specialization of Saccharomyces for distinct ecological environments (Borneman et al., 2007). 
Variations in transcriptional regulation between related species could thus be responsible for rapid 
adaptation to different niches, or according to different fermentative requirements in the context of 
commercial wine-making. 
 
In this study, we compare the transcriptional profiles of five different wine yeast strains in simulated 
wine-making conditions: Detailed comparative analyses of gene expression profiles, particularly in the 
context of TF regulatory networks, provided new insights into the molecular basis for variations in 
gene expression in these industrial strains. A core issue pertained to whether the metabolic phenotype 
of one strain could be shifted in the direction of another by simply adjusting the expression of key 
transcription factors. This would credit sequence divergence or regulatory changes related to specific 
transcription factors as a major overarching theme responsible for the evolutionary adaptation of 
different Saccharomyces species, as well as different strains within a given species. This did indeed 
prove to be the case, shedding light on the mode of adaptation of industrial yeasts to environmental 
conditions. From a biotechnological point of view, the identification of key TF’s will enable targeted 
exploitation of yeast potential for improved fermentation performance.  
 
6.3 Methods 
6.3.1 Strains, media and culture conditions 
The yeast strains used in this study are listed in Table1. Yeast cells were cultivated at 30oC in YPD 
synthetic media 1% yeast extract (Biolab, South Africa), 2% peptone (Fluka, Germany), 2% glucose 
(Sigma, Germany). Solid medium was supplemented with 2% agar (Biolab, South Africa). 
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Table 1 Yeast strains used in this study. 
Strain Source/ Reference
VIN13 Anchor Yeast, South Africa
BM45 Lallemand Inc., Montréal, Canada
DV10 Lallemand Inc., Montréal, Canada
SOK2-VIN13 This study
RAP1-VIN13 This study  
 
6.3.2 Fermentation medium 
Fermentation experiments were carried out with synthetic must MS300 which approximates to a 
natural must as previously described (Bely et al., 1990). The medium contained 125 g/L glucose and 
125 g/L fructose, and the pH was buffered at 3.3 with NaOH. 
 
6.3.3 Fermentation conditions 
All fermentations were carried out under anaerobic conditions in 100 ml glass bottles (containing 80 ml 
of the medium) sealed with rubber stoppers with a CO2 outlet. The fermentation temperature was 
approximately 22oC and no continuous stirring was performed during the course of the fermentation. 
Fermentation bottles were inoculated with YPD cultures in the logarithmic growth phase (around 
OD600 = 1) to an OD600 of 0.1 (i.e. a final cell density of approximately 106 cfu.ml-1). The cells from the 
YPD pre-cultures were briefly centrifuged and resuspended in MS300 to avoid carryover of YPD to the 
fermentation media. The fermentations followed a time course of 14 days and the bottles were weighed 
daily to assess the progress of fermentation. Samples of the fermentation media and cells were taken at 
days 2, 5 and 14 as representative of the exponential, early logarithmic and late logarithmic growth 
phases respectively. 
 
6.3.4 Growth measurement 
Cell proliferation (i.e. growth) was determined spectrophotometrically (PowerwaveX, Bio-Tek 
Instruments) by measuring the optical density (at 600 nm) of 200 µl samples of the suspensions over 
the 14 day experimental period. 
 
6.3.5 Analytical methods - HPLC 
Culture supernatants were obtained from the cell-free upper layers of the fermentation media. For the 
purposes of glucose determination and carbon recovery, culture supernatants and starting media were 
analyzed by high performance liquid chromatography (HPLC) on an AMINEX HPX-87H ion exchange 
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column using 5 mM H2SO4 as the mobile phase. Agilent RID and UV detectors were used in tandem 
for peak detection and quantification. Analysis was carried out using the HPChemstation software 
package. 
 
6.3.6 Analytical methods – GC-FID 
Each 5 ml sample of synthetic must taken during fermentation was spiked with an internal standard of 
4-methyl-2-pentanol to a final concentration of 10 mg.l-1. To each of these samples 1 ml of solvent 
(diethyl ether) was added and the tubes sonicated for 5 minutes. The top layer in each tube was 
separated by centrifugation at 3000 rpm for 5 minutes and the extract analyzed. After mixing, 3 μl of 
each sample was injected into the gas chromatograph (GC). All extractions were done in triplicate. 
The analysis of volatile compounds was carried out on a Hewlett Packard 5890 Series II GC coupled to 
an HP 7673 auto-sampler and injector and an HP 3396A integrator. The column used was a Lab 
Alliance organic-coated, fused silica capillary with dimensions of 60 m × 0.32 mm internal diameter 
with a 0.5 μm coating thickness. The injector temperature was set to 200°C, the split ratio to 20:1 and 
the flow rate to 15 ml.min 1, with hydrogen used as the carrier gas for a flame ionisation detector held 
at 250°C.  The oven temperature was increased from 35°C to 230°C at a ramp of 3°C min 1.  
Internal standards (Merck, Cape Town) were used to calibrate the machine for each of the compounds 
measured. 
 
6.3.7 General statistical analysis 
T-tests and anova analyses were conducted using Statistica (version 7). HCL and KMC clustering were 
carried out using TIGR MeV v2.2 (Ben-Dor et al., 1999). 
 
6.3.8 Microarray analysis 
Sampling of cells from fermentation and total RNA extraction was performed as described by Abbott et 
al., (2007). For a complete description of the hybridization conditions, as well as normalization and 
statistical analysis, refer to Rossouw et al. 2008. Transcript data can be downloaded from the GEO 
repository under the following accession number: GSE11651. 
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6.3.9 Transcriptomics data analysis 
Determination of differential gene expression between experimental parameters was conducted using 
SAM (Significance Analysis of Microarrays) version 2 (Tusher et al, 2001). The two-class, unpaired 
setting was used and genes with a Q value less than 0.5 (p < 0,0005) were considered differentially 
expressed. Only genes with a fold change greater than 2 (positive or negative) were taken into 
consideration. 
 
Random forest analysis was carried out as described by Breiman (2001). Genes were differentially 
ranked according to their ability to discriminate between different time points (clamped strain data) and 
between different strains (clamped time data). The top 200 ORF’s for each analysis were considered for 
further in depth analysis and evaluation. 
 
Gene expression profiles were clustered using the Short Time Series Expression Miner (STEM; Ernst 
& Bar-Joseph, 2006).  
 
6.3.10 Multivariate data analyses 
The patterns within the different sets of data were investigated by principal-component analysis (PCA; 
The Unscrambler; Camo Inc., Corvallis, Oreg.). PCA is a bilinear modeling method which gives a 
visually interpretable overview of the main information in large, multidimensional datasets. By plotting 
the principal components it is possible to view statistical relationships between different variables in 
complex datasets and detect and interpret sample groupings, similarities or differences, as well as the 
relationships between the different variables (Mardia et al., 1979).  
 
6.3.11 Overexpression constructs and transformation of yeast cells 
All plasmids used in this study are listed in Table 2, and primers used for amplification of transcription 
factor-encoding genes are listed in Table 3. Standard procedures for the isolation of DNA were used 
throughout this study (Ausubel et al., 1994). Standard DNA techniques were also carried out as 
described by Sambrook et al., (1989). All enzymes for cloning, restriction digest and ligation reactions 
were obtained from Roche Diagnostics (Randburg, South Africa) and used according to supplier 
specifications. Sequencing of all plasmids was carried out on an ABI PRISM automated sequencer. All 
plasmids contain the dominant marker PhR conferring phleomicin resistance (PhR), and were 
transformed into host VIN13 and BM45 cells via electroporation (Wenzel et al., 1992; Lilly et al., 
2006).  
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Table 2 Plasmids constructed in this study. 
Plasmid Name Relevant genotype Reference
pDM-PhR-RAP1 2μ LEU2 TEF1P PhR322 TEF1T PGKP RAP1 PGKT This study
pDM-PhR-SOK2 2μ LEU2 TEF1P PhR322 TEF1T PGKP SOK2 PGKT This study  
 
Table 3 Primers used for amplification of target genes. 
Primer Name Sequence (5'-3')
PhR322F GATCCACGTCGGTACCCGGGGGATC
PhR322R GATCGCGATCGCAAGCTTGCAAATTAAAGCC
RAP1f TTAAGCGGCCGCATACGCAACCGCCCTACATAA
RAP1r TCTACATATGCGTGAATCAGTGAAATAAAGG
SOK2f TTAAGCGGCCGCTATAACCCTGGTAAGGTCCTT
SOK2r TCTACATATGGGCGGTAGGGTTTTGATTAA  
 
6.3.12 Quantitative real-time PCR analysis (QRT-PCR) 
RNA extractions from fermenting yeasts were carried out as per the microarray analyses. Primer design 
for QRT-PCR analysis was performed using the Primer Express software v. 3 (Applied Biosystems) 
and reagents were purchased from KAPA Biosystems. Spectral data were captured by the 7500 cycler 
(Applied Biosystems). Data analyses were conducted using Signal Detection Software (SDS) v. 1.3.1. 
(Applied Biosystems) to determine the corresponding Ct values and PCR efficiencies respectively for 
the samples analysed (Ramakers et al., 2003). The genes selected for QRT-PCR, as well as the primer 
sequences used for amplification are described in Table 4 below. 
   
Table 4 Target genes and primers for QRT-PCR. 
Gene ID Forward primer (5'-3') Reverse primer (5'-3')
ADH2 TTCAAGCCGCTCACATTCC CACAAGATTGGCGCGACTT
ALD4 TTGTGGGTGAGGCCATTACA ACCCTGTGAAGGCAACCTTTT
ARO10 AGTGTTGAATCAGCTGGCCTAAG CATAAGCGGCGTTCAGTTCAT
ATF2 GTTCGGCCTAAACGTTTGCT CCACGCTCATGTCCATGTTC
BAT1 CCATGTTCCGTCCGGATAAG CAAACAAATTCTAGCGGCAG
BAT2 AATCTGTTTGCCAACGTTCGA TGCTGGATCAGTTTCCCAATT
ERG10 CGTGCGGGTGCCAAAT CCATCTCTTTCGACACCATCAA
ERG13 GATCGGTCCTGATGCTCCAA CGTAGGCGTGTTCCATGTAAGA
HAT2 TGCCCGCAACCTTTCAA GGCCGCAAGGAGGTTTG
ILV3 CGTCCCAGGCCATGCTT CCCGACTTGAGGCTTCTTGA
RAP1 ATTGGATCCGAGTATGGTCGTT TCCGATGGCGCTGTGACT
SOK2 TCAACCTCTGATGCCCGTATC GCGGGTACGGCCACTGT
THI3 GGCGTGGCCGGATCTTA GGCGGCATACCCACTATGTG
YJL218W GGTCATCCAATTGACGTGGAA GGTCACAGGCATGGCATATTC  
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6.4 Results and Discussion 
6.4.1 General 
Three distinct industrial wine yeast strains were used to inoculate synthetic wine must fermentations. 
Samples were taken for transcriptomic analysis of all five strains at three important time points during 
fermentation: Day 2 (exponential growth phase), day 5 (early stationary growth phase) and day 14 (late 
stationary growth phase). Strains were monitored during the 14 day fermentation period in terms of 
their sugar utilization and production of ethanol, glycerol as well as volatile aroma compounds 
(Rossouw et al., 2008).  
 
The transcriptomic data was of a high quality and normalization proceeded according to standard 
Affymetrix operating procedures. Normalized expression values for the different strains and time 
points were analyzed by significance analysis (SAM, Tusher et al, 2001) and random forest analysis 
(Breiman, 2001). For the random forest analysis, the top 200 strain and time point –discriminatory 
genes were ranked and subjected to in-depth analyses, some of which have been presented in Chapter 
5. The primary focus of this publication relates to the transcriptional regulatory dimension of the data. 
 
6.4.2 Transcription factor enrichment 
Genes in the top 200 ranked lists for the strain and time ‘biomarkers’ were subjected to transcription 
factor enrichment to identify the main regulatory structures present in the data. From Table 5 it is clear 
that a few key transcription factors may account for the majority of genes responsible for the 
differential transcriptional response between strains and time points. 
 
Table 5 Top hits (% of total) for transcription factor enrichment analysis of random forest outputs. 
Yap1p Rap1p Arr1p Met4p Sok2p Rpn4p Ste12p Sfp1p Fhl1p Ino4p Swi4p
Time-specific ranks 24% 20% 17% 16% 15% 14% 13% 12% 11% 10% 10%
Yap1p Sok2p Met4p Rap1p Arr1p Ste12p Aft1p Rpn4p Ino4p Yap6p Phd1p
Strain-specific ranks 28% 27% 19% 17% 16% 14% 14% 13% 11% 11% 10%  
 
From the results of Table 6 it is also clear that differences in a few transcription factors account for the 
majority of highly discriminatory genes in the metabolism branch of the yeast data set. Most of the 
transcription factors listed in Tables 5 and 6 are involved in synchronization of stress responses, 
regulation of carbon utilization and cell wall properties. All these responses are highly integrated and 
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connected in the yeast system as a whole, necessitating further analysis of the top scoring transcription 
factors.  
 
Table 6 Top hits (% of total) for transcription factor enrichment analysis of random forest outputs in 
MIPS functional category of metabolism. 
 
Yap1p Sok2p Arr1p Gcn4p Ste12p Met4p Rap1p Tec1p Rpn4p Swi4p Adr1p
Time-specific ranks 39% 26% 26% 24% 22% 20% 17% 17% 15% 13% 13%
Yap1p Sok2p Arr1p Met4p Gcn4p Aft1p Ino4p Rpn4p Nrg1p Yap6p Rap1p
Strain-specific ranks 50% 42% 32% 26% 24% 21% 21% 21% 18% 18% 18%  
 
Of the 18 transcrption factors listed in Tables 5 and 6, 12 showed no differences in expression levels 
and patterns over the time points considered in this study. Hypergeomtric distribution analysis grouped 
these 12 transcription factors into five clusters based on gene expression patterns over time. The 
expression clusters are summarized in Figure 1 below.  
 
 
Figure 1 Hypergeometric distribution of transcription factors into 5 main expression profiles using 
STEM analysis. 
 
The remaining six transcription factors (notably some of the top-scoring candidates of the TF 
enrichment) showed significant differences between strains in terms of relative transcript abundance 
and expression patterns over time (Figure 2). 
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Figure 2 Expression patterns of genes encoding key transcription factors. 
 
Interestingly, strains with similar physiological properties regarding metabolite profiles and cell wall 
properties also have similar profiles for the expression patterns of the transcriptional regulators in 
Figure 2 (i.e. EC1118 and DV10, as well as BM45 and 285). These 6 transcription factors play 
important roles in numerous aspects of cellular metabolism and regulation, though their specific 
functions are not fully characterized, and information regarding regulatory networks and specific 
targets is rather unclear. Yap1p is induced in response to oxidative stress conditions (Okazaki et al., 
2007) and is believed to regulate the expression of a several genes involved in protein mannosylation as 
well as the invasive growth response (Haugen et al., 2004; Thorsen et al., 2007). Yap6p is involved in 
a variety of stress-related programs, including the response to DNA damage and oxidative, osmotic and 
toxic metal stresses (Tan et al., 2008). Three other key transcription factor –encoding genes in the 
enrichment analysis, namely SOK2, PHD1 and STE12 show variable expression patterns between 
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strains (Figure 2). Their protein products are all involved in pseudohyphal growth and regulation of key 
mannoproteins such as Flo11p (Gimeno & Fink, 1994; Pan & Heitman, 2000), as well as a host of 
other metabolic processes. Rap1p is a multipurpose DNA-binding protein that functions in 
transcriptional activation, silencing and replication in yeast. Genes containing Rap1p binding sites 
include genes encoding proteins involved in amino acid biosynthesis and regulation of carbon 
metabolism (Yarragudi et al., 2007). 
 
6.4.3 Overexpression of selected transcription factors  
To determine whether the different expression patterns of these key regulators could be reconciled with 
the metabolic and phenotypic differences observed in the strains, we selected two of these genes, 
namely SOK2 and RAP1, for overexpression analysis. The SOK2 gene was cloned from the BM45 
strain and over-expressed in VIN13, while the RAP1 gene cloned from DV10 was over-expressed in 
BM45. Our goal was to elevate the expression levels of these transcription factors in the target strains 
to more closely match the expression levels observed in the ‘donor’ strains (Figure 2). 
 
Figure 3 clearly shows that the expression levels of SOK2 and RAP1 in the transformed strains were 
successfully and significantly increased in comparison to their respective controls. To assess whether 
the overexpression of these factors had the expected impact on genes under their control, several target 
genes of Sok1p and of Rap1p (Table 7) were also selected for expression analysis using real-time PCR. 
ERG10 and THI3 were included as negative controls.  
 
 
Figure 3 Relative gene expression (normalized to PDA1 expression) of RAP1, SOK2 and selected 
target genes. Values are the average of three biological repeats ± standard deviation. 
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Both negative controls (THI3 and ERG10) showed no change in expression for the two transformants. 
Most of the known target genes of the two transcription factors (Table 7) were increased in expression 
as expected, roughly in keeping with the magnitude of the expression change of the overexpressed 
transcription factor in question. Only ARO10 did not show any increase in both the RAP1 and SOK2 
overexpression strains. 
 
Table 7 Sok2p and Rap1p activity with reference to the target genes in figure 4. Transcription factor 
activity is based on reported interaction studies by Vachova et al. (2004), Chua et al. (2006), 
Workman et al. (2006), Kasahara et al. (2007) and Yarragudi et al. (2007). 
 
SOK2 RAP1
ADH2 √ X
ALD4 √ √
ARO10 √ √
ATF2 √ √
BAT1 √ X
BAT2 √ √
ERG10 X X
ERG13 X √
HAT2 X √
ILV3 √ X
THI3 X X
YJL218W X √
RAP1 X n/a
SOK2 n/a √  
 
6.4.4 Fermentation properties of the overexpressing strains 
The three original strains, as well as the two transformants were inoculated into synthetic wine must 
and the fermentations monitored over the characteristic 14 day fermentation period (Figure 4). All 
fermentations completed to dryness and the levels of ethanol and glycerol production were similar for 
the two transformed strains and their respective controls. 
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Figure 4 Fermentation kinetics of the 3 yeast strains and two transformants relevant to this study: 
Glucose utilization (A), fructose utilization (B), glycerol production (C) and ethanol 
production (D). All y-axis values are in g.l-1 and refer to extracellular metabolite 
concentrations in the synthetic must. Values are the average of 4 biological repeats ± standard 
deviation. 
 
One way to easily assess the general fermentative phenotype of the transformed strains on a metabolic 
level is to measure the production of volatile aroma compounds such as higher alcohols and esters, 
considering that these exo-metabolites largely represent the ‘end-products’ of alcoholic fermentation. 
The metabolism of these secondary metabolites also show more variation between different strains in 
comparison to the more tightly regulated pathways related to primary fermentative metabolism (Figure 
4). The concentrations of 22 exo-metabolites were measured at days 2, 5 and 14 of fermentation, in 
keeping with our original sampling scheme. The results are summarized in tables 8-10 below. 
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Table 8 Volatile alcohols and esters present in the fermentation media at day 2 of fermentation. All 
values are expressed as mg.L-1 and are the average of 4 biological repeats ± standard 
deviation. Metabolites present at concentrations below the detection limit are indicated by 
“bd”. Values in bold indicate a statistically significant increase in concentration for a given 
metabolite relative to the untransformed control, whereas values in italics indicate a decrease 
in concentration. 
 
 
DAY2 VIN13 BM45 DV10 SOK2 RAP1
Ethyl Acetate 5.53 ± 1.40 7.60 ± 0.71 8.10 ± 2.13 5.70 ± 1.20 6.14 ± 2.16
Propanol 33.24 ± 4.38 32.81 ± 1.18 28.39 ± 5.21 34.25 ± 3.19 27.25 ± 1.37
Isobutanol 5.78 ± 0.71 9.26 ± 0.70 6.20 ± 1.62 8.71 ± 0.74 8.20 ± 1.70
Isoamyl Acetate 0.10 ± 0.11 0.18 ± 0.11 0.17 ± 0.17 0.31 ± 0.02 0.24 ± 0.11
Butanol 0.16 ± 0.2 bd bd 0.41 ± 0.12 bd
Isoamyl alcohol 32.58 ± 5.74 37.80 ± 2.90 32.78 ± 3.61 37.27 ± 3.82 35.85 ± 3.30
Ethyl Hexanoate bd bd 0.17 ± 0.17 bd bd
Hexanol bd bd bd bd bd
Ethyl Caprylate 0.05 ± 0.04 0.10 ± 0.02 0.11 ± 0.03 0.09 ± 0.01 0.11 ± 0.03
Acetic Acid 449.5 ± 17.8 715.3 ± 18.9 618.4 ± 15.4 525.2 ± 26.2 658.8 ±  7.0
Propionic Acid 2.23 ± 0.15 2.04 ± 0.19 2.38 ± 0.31 2.47 ± 0.18 2.15 ± 0.23
Iso-Butyric Acid 0.78 ± 0.04 0.79 ± 0.06 0.80 ± 0.06 0.71 ± 0.02 0.68 ± 0.04
Butyric Acid 0.55 ± 0.04 0.58 ± 0.05 0.67 ± 0.02 0.52 ± 0.01 0.57 ± 0.01
Ethyl Caprate 0.08 ± 0.016 0.12 ± 0.04 0.10 ± 0.02 0.09 ± 0.02 0.16 ± 0.06
Iso-Valeric Acid 0.45 ± 0.03 0.47 ± 0.08 0.38 ± 0.06 0.37 ± 0.01 0.33 ±  0.04
Diethyl Succinate bd bd bd bd bd
Valeric Acid bd bd bd bd bd
2-Phenylethyl Acetate bd bd bd bd bd
Hexanoic Acid 0.73 ± 0.03 0.94 ± 0.13 1.39 ± 0.07 0.85 ± 0.07 1.05 ± 0.15
2-Phenyl Ethanol 6.42 ± 0.47 9.64 ± 0.35 7.49 ± 0.50 7.11 ± 0.69 7.57 ±  0.78
Octanoic Acid 0.76 ± 0.15 1.25 ± 0.64 3.05 ± 0.92 1.14 ± 0.26 1.03 ± 0.10
Decanoic Acid 2.54 ± 0.19 2.73 ± 0.12 3.33 ± 0.09 2.34 ± 0.26 2.95 ± 0.38  
 
Table 9 Volatile alcohols and esters present in the fermentation media at day 5 of fermentation. All 
values are expressed as mg.L-1 and are the average of 4 biological repeats ± standard 
deviation. Metabolites present at concentrations below the detection limit are indicated by 
“bd”. Values in bold indicate a statistically significant increase in concentration for a given 
metabolite relative to the untransformed control, whereas values in italics indicate a decrease 
in concentration. 
 
DAY5 VIN13 BM45 DV10 SOK2 RAP1
Ethyl Acetate 19.74 ± 2.48 20.52 ± 1.13 28.38 ± 1.69 22.52 ± 2.65 19.38 ± 0.95
Propanol 70.22 ± 2.34 48.65 ± 3.43 66.88 ± 5.64 82.06 ± 4.97 44.66 ± 3.02
Isobutanol 12.97 ± 1.95 20.14 ± 1.96 16.42 ± 1.81 18.17 ± 1.84 17.29 ± 1.55
Isoamyl Acetate 0.30 ± 0.09 0.36 ± 0.02 0.38 ± 0.09 0.70 ± 0.17 0.36 ± 0.04
Butanol 0.59 ± 0.09 0.52 ± 0.03 0.69 ± 0.05 0.88 ± 0.04 0.58 ± 0.04
Isoamyl alcohol 78.74 ± 4.54 85.54 ± 4.69 95.87 ± 7.52 106.80 ± 8.47 89.53 ± 2.01
Ethyl Hexanoate 0.11 ± 0.18 0.16 ± 0.16 0.18 ± 0.05 0.15 ± 0.01 0.10 ± 0.08
Hexanol bd  bd bd bd bd
Ethyl Caprylate 0.11 ± 0.04 0.14 ± 0.00 0.15 ± 0.03 0.12 ± 0.01 0.10 ±  0.01
Acetic Acid 792.6 ± 16.4 1131.1 ± 44.0 1093.2 ± 81.7 1047.3 ± 72.87 1159.9 ± 113.6
Propionic Acid 4.58 ± 0.42 2.62 ± 0.10 5.05 ± 0.39 6.56 ± 0.44 2.78 ± 0.28
Iso-Butyric Acid 0.83 ± 0.03 0.90 ± 0.05 0.89 ± 0.06 0.87 ± 0.05 0.81 ± 0.06
Butyric Acid 0.65 ± 0.08 0.68 ± 0.04 0.80 ±0.08 0.67 ± 0.05 0.71 ± 0.05
Ethyl Caprate 0.24 ± 0.05 0.30 ± 0.04 0.46 ± 0.03 0.35 ± 0.03 0.33 ± 0.07
Iso-Valeric Acid 0.65 ± 0.07 0.62 ± 0.09 0.64 ± 0.06 0.66 ± 0.04 0.50 ± 0.06
Diethyl Succinate 0.03 ± 0.05 0.10 ± 0.00 0.11 ± 0.01 0.14 ± 0.03 0.15 ± 0.00
Valeric Acid 0.02 ± 0.03 0.02 ± 0.02 0.05 ± 0.00 0.06 ± 0.01 0.07 ± 0.00
2-Phenylethyl Acetate 0.01 ± 0.67 0.03 ± 0.60 0.03 ± 0.04 0.04 ± 0.00 0.02 ± 0.01
Hexanoic Acid 1.11 ± 0.17 1.37 ± 0.28 2.19 ±0.24 1.40 ± 0.16 1.56 ± 0.32
2-Phenyl Ethanol 10.74 ± 0.68 12.66 ± 0.66 13.52 ± 1.25 14.62 ± 0.84 13.10 ± 2.10
Octanoic Acid 1.38 ± 0.08 1.34 ± 0.21 2.65 ± 0.12 1.65 ± 0.13 1.28 ± 0.09
Decanoic Acid 2.80 ±0.17 2.98 ± 0.39 4.50 ± 0.29 3.28 ± 0.21 3.80 ± 0.14  
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Table 10 Volatile alcohols and esters present in the fermentation media at day 14 of fermentation. All 
values are expressed as mg.L-1 and are the average of 4 biological repeats ± standard 
deviation. Metabolites present at concentrations below the detection limit are indicated by 
“bd”. Values in bold indicate a statistically significant increase in concentration for a given 
metabolite relative to the untransformed control, whereas values in italics indicate a decrease 
in concentration. 
 
DAY14 VIN13 BM45 DV10 SOK2 RAP1
Ethyl Acetate 31.39 ± 0.66 27.11 ± 2.85 33.18 ± 0.43 28.09 ± 1.41 23.88 ± 0.99
Propanol 76.48 ± 3.09 45.60 ± 1.21 69.52 ± 5.30 83.37 ± 6.25 41.53 ± 4.01
Isobutanol 19.00 ± 1.74 25.88 ± 2.81 21.27 ± 3.07 24.96 ± 0.53 22.42 ± 1.65
Isoamyl Acetate 0.34 ± 0.04 0.43 ± 0.03 0.43 ± 0.11 0.73 ± 0.02 0.40 ± 0.04
Butanol 1.07 ± 0.07 0.58 ± 0.06 0.87 ± 0.06 1.33 ± 0.04 0.70 ± 0.05
Isoamyl alcohol 106.8 ± 9.37 104.61 ± 3.42 113.69 ± 11.49 132.74 ± 7.57 108.09 ± 7.01
Ethyl Hexanoate 0.22 ± 0.19 0.35 ± 0.01 0.39 ± 0.03 0.36 ± 0.01 0.19 ±  0.02
Hexanol bd bd bd 0.01 ± 0.01 0.35 ± 0.02
Ethyl Caprylate 0.15 ± 0.02 0.24 ± 0.04 0.29 ± 0.03 0.26 ± 0.02 0.23 ± 0.05
Acetic Acid 926.9 ± 50.2 1154.6 ± 112.7 1261.0 ± 47.1 1182.9 ± 87.8 1263.2 ± 85.9
Propionic Acid 6.05 ± 0.48 2.81 ± 0.17 8.01 ± 0.22 7.93 ± 0.63 5.07 ± 0.42
Iso-Butyric Acid 0.76 ± 0.03 0.96 ± 0.07 1.02 ± 0.10 0.96 ± 0.04 0.86 ± 0.03
Butyric Acid 0.49 ± 0.04 0.61 ± 0.04 0.75 ± 0.01 0.59 ± 0.02 0.63 ± 0.06
Ethyl Caprate 0.32 ± 0.04 0.43 ± 0.04 0.59 ± 0.04 0.47 ± 0.05 0.50 ± 0.09
Iso-Valeric Acid 0.84 ± 0.01 0.79 ± 0.09 0.91 ± 0.12 0.87 ± 0.04 0.67 ± 0.07
Diethyl Succinate bd bd 0.05 ± 0.05 0.07 ± 0.03 0.11 ± 0.04
Valeric Acid bd bd 0.01 ± 0.01 bd 0.22 ± 0.15
2-Phenylethyl Acetate 0.03 ± 0.02 0.04 ± 0.01 0.04 ± 0.01 0.06 ± 0.00 0.02 ± 0.01
Hexanoic Acid 1.53 ± 0.08 2.56 ± 0.60 3.28 ± 0.51 2.28 ± 0.28 2.76 ± 0.30
2-Phenyl Ethanol 13.68 ± 0.88 15.16 ± 0.74 16.07 ± 0.69 20.43 ± 1.54 12.93 ±  0.83
Octanoic Acid 1.15 ± 0.06 1.13 ± 0.19 1.93 ± 0.15 1.31 ± 0.11 1.25 ± 0.29
Decanoic Acid 2.18 ± 0.04 1.95 ± 0.16 3.45 ± 0.12 2.38 ± 0.11 2.34 ± 0.21  
 
Clearly significant differences exist in the production of volatile aroma compounds at all three stages of 
fermentation considered. The differences were most pronounced for the SOK2 transformant, but 
significant differences were also evident for the RAP1 overexpressing strain. By the end of 
fermentation, more than half of the aroma compounds measured were present at substantially elevated 
concentrations in the SOK2 overexpressing strain in comparison to VIN13. In the case of the RAP1 
transformant, 5 compounds were significantly increased, and 2 compounds decreased with reference to 
the control BM45 strain (Table 10).  
 
In terms of the specific metabolites affected, most of the changes can be related to the (potentially) 
increased expression levels of the target genes of Sok2p and Rap1p in the aroma compound –producing 
pathways. For instance, the putative Sok2p –mediated activation of all the enzymes involved in the 
valine degradation pathway (BAT1-2; Váchová et al., 2004; PDC1, 5 & 6; Borneman et al., 2006) 
accounts for the dramatic increase in the two immediate end-products of this pathway, namely 
isobutanol and isobutyric acid (Table 8). Likewise, activation of ALD4-6 by Sok2p (Chua et al., 2006; 
Borneman et al., 2006) could explain the increase in acetic acid concentrations (Tables 8-10) in the 
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SOK2 overexpressing strain (acetate is the direct product of the reaction catalysed by these three 
aldehyde dehydrogenase isomers). Numerous other correlations can be found between Sok2p target 
genes and corresponding increases in the specific products of reactions catalysed by these genes, i.e. 
ARO10 (Chua et al., 2006) and the compounds 2-phenylethanol and isoamyl alcohol (Tables 9 and 10). 
The same observations can be made regarding the RAP1 –overexpressing strain: For example, one of 
its target genes, ERG13 (Kasahara et al., 2007) is involved in the production of diethyl succinate, with 
is present at much higher concentrations at the end of fermentation in the transformed strain compared 
to the reference BM45 strain (Table 10).  
 
6.4.5 Results of multivariate analysis 
Our original question pertained to whether the metabolic phenotype of one strain could be shifted in the 
direction of another by adjusting the expression of a key transcription factor. This would suggest that 
changes in the regulation/expression of specific transcription factors could be responsible for major 
phenotypic divergence and adaptation of different Saccharomyces species or different strains within a 
species. To address this issue we followed a multivariate approach to present the overall structure of 
the collective dataset in a qualitative manner. The results of the PCA analysis are depicted in frames A-
C of figure 5 below. 
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Figure 5 Principal component analysis of aroma compound concentrations. Components 1 and 2 are 
represented by frame A, components 1 and 3 by frame B, and components 2 and 4 by frame C 
respectively. 
 
B 
A 
C 
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From the PCA analysis it is clear that major shifts have occurred in the metabolite profiles of the two 
transformed strains in comparison to the BM45 and VIN13 reference strains (Figure 5). By day 2 of 
fermentation the differences between the sample groupings of the SOK2 -overexpressing VIN13 and 
the reference VIN13 strain is negligible. The same is true of the RAP1 -overexpressing strain and its 
control BM45 strain. However, by day 5 of fermentation the two transformed industrial strains form 
clearly disparate clusters that are separated from their control samples along the first three principal 
components or axes of variation. The same is true for day 14, where the distances between distinct 
sample groupings are even greater for four principal components (accounting for 85% of the explained 
variance). 
 
As can be seen from frames A and B of Figure 5, the overall exo-metabolite composition of the RAP1 –
overexpressing strain has shifted from the BM45 control strain in the direction of the DV10 target 
strain for days 5 and 14 of fermentation. Yet although large distances separate the SOK2 –
overexpressing samples from the control VIN13 cluster, the shift did not appear to approximate to the 
target BM45 cluster in a reliable manner, sometimes even shifting in the complete opposite direction 
(for components three and four, for example).  
 
6.4.6 Closing remarks 
To conclude, although the moderation of key transcription factor expression levels in a particular wine 
yeast strain can indeed alter metabolism in a large-scale manner, the changes are somewhat 
unpredictable and do not always align with preconceived expectations. This is not surprising, given the 
complexity of cellular metabolic regulation, particularly aroma compound metabolism: Various factors 
such as the prevailing redox balance, the concentration of intermediates and flux through upstream and 
downstream pathways affect the rates and directionality of the many promiscuous enzymes which 
catalyze the reactions of higher alcohol and ester synthesis. This of course makes a direct and 
quantitative prediction of the role and metabolic impact of a single transcription factor largely 
unfeasible for the time being. Yet despite these layers complexity, we were still able to moderate 
metabolism in a fairly defined manner (qualitatively) by moderating transcription factor expression 
levels in a strategy based on evaluation of high quality comparative gene expression data. 
 
Lessons from nature have shown us that micro-evolution, which has presumably provided us with the 
plethora of Saccharomyces strains known today, implements this technique of transcription factor 
moderation, or binding site alteration, in order to effect a large-scale rewiring of metabolic and 
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regulatory circuits in the cell. The possibility thus exists to modify or enhance industrial wine yeasts in 
a holistic manner by carefully selecting and modifying high-level master regulatory systems, instead of 
instituting numerous single gene changes at the effector level. 
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CHAPTER 7 
Comparative transcriptomic and proteomic profiling of industrial wine 
yeast strains 
 
7.1 Abstract 
7.1.1 Background 
The geno- and phenotypic diversity of commercial Saccharomyces cerevisiae wine yeast strains 
provides an opportunity to apply the system-wide approaches that are reasonably well established for 
laboratory strains to generate insight on the functioning of complex cellular networks in industrial 
environments. We have previously shown that a comparative analysis of the transcriptome and 
exometabolome of five phenotypically divergent wine yeast strains allows the establishment of a 
statistically robust omics matrix to correlate changes in gene expression and exometabolome, including 
a predictive capability regarding impacts of genetic perturbations on complex metabolic network. 
However, transcriptomic data sets do not provide an accurate reflection of changes at the proteome 
level. Here, we extend the comparative approach to include a proteomic analysis of two of the 
previously analysed wine yeast strains.  
 
7.1.2 Results 
An iTRAQ-based approach was used to investigate protein levels in two industrial wine yeast strains at 
three different time points of alcoholic fermentation in synthetic wine must. The data show that 
differences in the transcriptomes of the two strains at a given time point rather accurately reflect 
differences in the corresponding proteomes, providing strong support for the biological relevance of 
comparative transcriptomic data sets in yeast. In line with previous observations, the alignment proves 
less accurate when assessing intrastrain changes at different time points. In this case, differences 
between transcriptome and proteome appear strongly dependent on the GO category of the 
corresponding genes. The data in particular suggest that metabolic enzymes and the corresponding 
genes appear strongly correlated over time and between strains, suggesting a strong transcriptional 
control of such enzymes. The data also allow the generation of hypotheses regarding the molecular 
origin of significant differences in phenotypic traits between the two strains.   
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7.1.3 Conclusion 
The data suggest that the comparative approach provides more robust and biologically more 
meaningful data sets than can be derived from single strain approaches. The interstrain comparison of 
transcriptomic and proteomic data sets reveal intrinsic molecular differences between strains that in 
many cases can be directly correlated to relevant phenotypes, and are therefore well suited to the 
analysis of complex phenotypes. Wine yeast strains appear furthermore ideally suited for such 
approaches, and offer the additional advantage that data sets can be directly analysed for 
biotechnological relevance. 
 
7.2 Background 
Saccharomyces cerevisiae has long been a model organism to investigate the biology of the eukaryotic 
cell. The yeast genome, which is compact and contains only around 6000 protein-encoding genes, was 
completely sequenced in 1996 [1], but nearly 10% of putative proteins remain without predicted 
functions. The majority, if not all of these remaining gene products are non-essential in laboratory 
conditions and the deletion of these genes in most cases does not lead to a detectable phenotype.  
 
A major limitation of most current approaches in this regard is that research is conducted using a 
limited number of laboratory yeast strains which, while displaying characteristics that are useful for 
genetic and molecular analyses, represent limited genetic and phenotypic diversity. These laboratory 
strains are furthermore significantly different from the strains that are used for industrial and 
commercial purposes. Industrial environments however constitute much of the evolutionary framework 
of the species S. cerevisiae in the past centuries, and many genes that can not be related to a specific 
function in laboratory strains may be related to specific phenotypes in industrial strains. Such strains 
may therefore be better suited for the analysis of complex genetic and molecular networks and of their 
phenotypic relevance or biological meaning. The recent sequencing of a wine yeast strain [2] already 
showed that at least 27 new genes were present in the genome sequence of this strain in comparison to 
the standard S288c laboratory strain, and that a large number of other significant differences exist 
between these genomes. Furthermore, different wine yeast strains exhibit great variation in 
chromosome size and number, as well as ploidy, and cover a wide range of phenotypic traits, many of 
which are absent in laboratory yeast [3]. 
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Large-scale gene expression analysis with microarrays is one of the most powerful and best developed 
genomics methodologies that can be applied to yeast. Transcript levels of predicted genes can be 
measured simultaneously, under any selected condition and at specific time points, to identify sets of 
genes whose expression levels are induced or repressed relative to a reference sample [4]. 
Transcriptome analysis of wine yeast strains has already proven useful to analyse the broad genetic 
regulation of fermentative growth in wine environments, and has allowed identification of stress 
response mechanisms that are active in these conditions [5;6;7]. Rossouw et al. [8] showed that a 
comparative analysis of transcriptome and exometabolome could be used to identify genes that are 
involved in aroma metabolism and to predict some of the impacts. While of great usefulness, 
transcription data alone are of limited value since they can not be directly correlated with protein levels 
and, a forteriori, with in vivo metabolic fluxes [9;10;11]. All omics datasets would indeed be 
significantly strengthened by combination with other layers of the biological information transfer 
system [12;13]. 
 
A current bottleneck of such systems biology approaches is that most ‘omics’ tools are not developed 
to the same degree as transcriptomics. In particular, genome-scale protein quantification faces 
significant challenges, but methods for determining relative levels of protein between samples have 
been developed [14]. Two-dimensional (2D) gel electrophoresis has been and continues to be employed 
to separate complex protein mixtures, and is frequently combined with in-gel tryptic digestion and 
mass spectrometry for the identification of proteins [15]. In general, most yeast proteomic studies to 
date have been conducted using this 2D gel electrophoresis technology [16;17;18;19].   In wine yeast, 
the 2D gel approach coupled to mass spectrometry has been used to study post-inoculation changes in 
protein levels [20], as well as the proteomic response of fermenting yeast to glucose exhaustion [21]. 
While over 1400 soluble proteins of yeast have been identified using 2D analyses, this approach has 
not addressed the issue of quantification in a satisfactory manner, and also suffers from the relatively 
low number of proteins which are identified in a single analysis, including the under-representation of 
low-abundance and hydrophobic proteins [22;23]. 
 
To overcome some of these limitations, whole proteome analysis can also be implemented by a high-
throughput chromatography approach in combination with mass spectrometry [24]. The separation of 
peptides from complex protein digests is usually achieved by 2 dimensional nano-liquid 
chromatography-mass spectrometry (LC/MS) [25]. A total of 1504 yeast proteins have been 
unambiguously identified in a single analysis using this 2D chromatography approach coupled with 
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tandem mass spectrometry (MS/MS) [26]. Advances in LC/MS –based proteome analysis, in 
combination with advances in computational methods, have led to a more comprehensive identification 
and accurate quantification of endogenous yeast proteins [27;28]. Yet most of the above-mentioned 
studies were carried out with laboratory yeast strains, mostly under confined experimental conditions 
limited to steady, exponential growth rates. No such studies have been conducted using different wine 
yeast strains at different stages of the normal growth cycle. 
 
In our study we made use of such a chromatography-coupled mass spectrometry approach for the 
comparative analysis of wine yeast strains. To enable relative quantification between samples, we 
employed the 8-plex iTRAQ labeling strategy. The strategy enables relative quantification of up to 
eight complex protein samples in a single analysis using isobaric tags [29]. In short, unlabelled protein 
samples are trypsin digested, then labeled using isobaric tags (the eight reporter ions) and subsequently 
separated by liquid chromatography followed by tandem MS (MS/MS). The covalently bound isobaric 
tags have the same charge and overall mass, but produce different low mass signatures upon MS/MS, 
thus enabling relative quantification between different samples in a single analysis [30]. 
 
In this paper, we extend the comparative omics approach by aligning the transcriptomes and proteomes 
of two industrial wine yeast strains. The transcriptomes of these strains, generated at the same time 
points in the same conditions, have been analysed previously [8]. Our data show that differences in 
transcript levels of the two strains at a given time point are a reasonably accurate reflection of 
differences in the corresponding protein levels. This provides strong support for the biological 
relevance of comparative transcriptomic data sets in yeast, showing that intrinsic differences between 
strains may form a more reliable platform for analyses of biologically relevant and meaningful genetic 
features of a system. Interstrain comparative transcriptome and proteome analyses (as opposed to single 
strain analyses) appear to substantially increase our ability to provide a biologically relevant 
interpretation of omic data sets and to understand metabolic and physiological changes that occur 
during wine fermentation. Such combinatorial comparative approaches should ultimately enable 
accurate model-building for industrial wine yeast and facilitate the generation of intelligent yeast 
improvement strategies. 
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7.3 Materials & Methods 
7.3.1 Strains, media and culture conditions 
Two yeast strains were used in this study, namely VIN13 (Anchor Yeast, South Africa) and BM45 
(Lallemand Inc., Canada). Both are diploid Saccharomyces cerevisiae strains used in industrial wine 
fermentations. Yeast cells were cultivated at 30oC in YPD synthetic media 1% yeast extract (Biolab, 
South Africa), 2% peptone (Fluka, Germany), 2% glucose (Sigma, Germany). Solid medium was 
supplemented with 2% agar (Biolab, South Africa).  
 
7.3.2 Fermentation medium 
Fermentation experiments were carried out with synthetic must MS300 which approximates to a 
natural must as previously described [31]. The medium contained 125 g/L glucose and 125 g/L 
fructose, and the pH was buffered at 3.3 with NaOH. 
 
7.3.3 Fermentation conditions 
All fermentations were carried out under microaerobic conditions in 100 ml glass bottles (containing 80 
ml of the medium) sealed with rubber stoppers with a CO2 outlet. The fermentation temperature was 
approximately 22oC and no stirring was performed during the course of the fermentation. Fermentation 
bottles were inoculated with YPD cultures in the logarithmic growth phase (around OD600 = 1) to an 
OD600 of 0.1 (i.e. a final cell density of approximately 106 cfu.ml-1). The cells from the YPD pre-
cultures were briefly centrifuged and resuspended in MS300 to avoid carryover of YPD to the 
fermentation media. The fermentations followed a time course of 14 days and the bottles were weighed 
daily to assess the progress of fermentation. Samples of the fermentation media and cells were taken at 
days 2, 5 and 14 as representative of the exponential, early logarithmic and late logarithmic growth 
phases. 
 
7.3.4 Microarray analyses 
Sampling of cells from fermentation and total RNA extraction was performed as described by Abbott et 
al. [32]. For a complete description of the hybridization conditions, as well as normalization and 
statistical analysis, refer to Rossouw et al. [8]. Transcript data can be downloaded from the GEO 
repository under the following accession numbers: GSE11651. 
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7.3.5 Protein extraction 
General chemicals for sample preparation were acquired from Merck. Samples of the cells were taken 
from the fermentations (at days 2, 5 and 14) by centrifugation and weighed after washing with ddH2O. 
The pellets were sonicated using a Soniprep 150 probe sonicator on ice in 30 second bursts, then spun 
at 16000 g, and the supernatants collected. Protein content was assayed by the EZQ method 
(Invitrogen) and aliquots containing 50 μg of total protein underwent reduction (incubation with 10 
mM DTT at 56°C for one hour) and alkylation (incubation with 30 mM iodoacetamide at pH 8.0 in the 
dark for one hour) and were then quenched with further DTT.  Samples were subsequently digested by 
incubation with 2 ug of trypsin (Promega, Madison, Wisconson, USA) at 37°C overnight.   The 
resulting peptides were desalted on 10 mg Oasis SPE cartridges (Waters Corporation, Massachusetts, 
USA) and completely dried down using a speed vacuum concentrator (Thermo Savant, Holbrook, NY, 
USA).   
 
7.3.6 iTRAQ labeling 
Dried protein digests were re-constituted with 30 μL of dissolution buffer from the iTRAQ Reagent 
Multi-Plex Kit (Applied Biosystems, Foster City, CA, USA) and labelled with 8-plex iTRAQ reagents 
according to the manufacturer’s instruction.  Labelled material from six different samples were then 
combined, acidified, desalted as above, concentrated to approximately 50 μL, and finally diluted to 250 
μL in 0.1% formic acid. 
 
7.3.7 HPLC method 
Pooled samples were fractionated in an on-line fashion on a BioSCX II 0.3 x 35 mm column (Agilent 
Technologies, Santa Clara, CA, USA) using ten salt-steps; 10, 20, 40, 60, 80, 100, 140, 200, 260 and 
500 mM KCl.  Peptides were captured on a 0.3 x 5 mm PepMap cartridge (LC Packings, Dionex 
Corporation, Sunnyvale, CA, USA) before being separated on a 0.3 x 100 mm Zorbax 300SB- C18 
column (Agilent). The HPLC gradient between Buffer A (0.1% formic acid in water) and Buffer B 
(0.1% formic acid in acetonitrile) was formed at 6 ul/min as follows: 10% B for the first 3 min, 
increasing to 35%B by 80 min, increasing to 95% B by 84 min, held at 95% until 91 min, back to 10% 
B at 91.5 min and held there until 100 min. 
 
7.3.8 MS conditions 
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The LC effluent was directed into the Ionspray source of QSTAR XL hybrid Quadrupole- Time-of -
Flight mass spectrometer (Applied Biosystems) scanning from 300-1600 m/z.  The top three most 
abundant multiple charged peptides were selected for MS/MS analysis (55-1600 m/z). The mass 
spectrometer and HPLC system were under the control of the Analyst QS software package (Applied 
Biosystems). 
 
7.3.9 Data analyses 
All of the datafiles from each 2D LC-MS/MS experiment were searched as a set by ProteinPilot 2.0.1 
(Applied Biosystems) against a yeast protein database from Stanford University’s Saccharomyces 
Genome Database (5884 sequences, downloaded November 2008). The data was also searched against 
the same set of sequences in reverse to estimate the False Discovery Rate for each run, which was 
below 0.3% for all three runs. 
 
7.3.10 Network analyses 
Microarray data were normalized with the GCRMA method [33].  Ratios of the RNA levels for each 
gene at each time point comparing BM45 to VIN13 were subsequently created from the means of 
technical replicates performed for each strain.  If the resulting ratio was less than one it was 
transformed by taking its negative inverse in order to express relative expression levels on the same 
scale.  Ratios for protein levels between BM45 and VIN13 were similarly created.  Ratios of the RNA 
and protein levels were also created to show the differences between time points within each strain. 
XML files for the KEGG pathway database [34;35;36] were downloaded, parsed and used to create an 
undirected graph consisting of nodes representing pathways and nodes representing gene products 
which participate in said pathways.  Edges were created between the gene product nodes and each of 
the pathway nodes in which they are thought to participate.  A neighborhood walking algorithm was 
implemented in order to extract subgraphs corresponding to all of the gene products and their 
associated pathways for which we had ratios for both protein and RNA levels.  Given that the proteins 
identified by iTRAQ varied across each time point (within and between each strain) this subgraph 
extraction was done separately for each time point. 
The resulting subgraphs were visualized with Cytoscape v 2.6.1 [37;38].    Pathways representing 
differences between strains as well as reasonable concordance in the regulation of RNA and protein 
levels were subsequently selected.  An unweighted force directed layout algorithm was applied to the 
selected subgraphs and finally the order of gene product nodes around pathway nodes was manually 
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adjusted to be consistent across time points.  Manual node order adjustment was necessary due to the 
variation in protein data identified by iTRAQ from time point to time point. 
The resulting visually mapped subgraphs provide an effective visualization method with which to 
observe the ratios of RNA and proteins involved in specific pathways simultaneously and as such, give 
further insight into the differences in metabolic regulation between strains and time points for both 
types of molecules. 
All programming required for ratio creation, data parsing, graph creation and neighborhood walking 
was implemented in Perl. 
 
7.4 Results & Discussion 
7.4.1 Transcriptome data 
Transcriptome data was acquired (using the Affymetrix platform) at three time points during 
fermentation, namely day 2 (exponential growth phase), day 5 (early stationary phase) and day 14 (late 
stationary phase) at the end of fermentation. The data were evaluated more comprehensively in a 
previous publication [8] and will not be the focus of the research presented here. Complete 
transcriptomic datasets are available at the GEO repository under the accession number GSE11651. 
 
7.4.2 Interstrain alignment of the transcriptome and proteome  
Protein abundance data for the BM45 and VIN13 strains were also generated at the same three time 
points. Three repeats each for both strains were combined for each time point in a single 8-plex iTRAQ 
analysis. In other words, the repeats for BM45 and VIN13 were pooled for comparative analyses in 
three sets according to time points (i.e. all day 2 samples together, all day 5 samples together and all 
day 14 samples together). A total of 436 proteins were unambiguously identified. Not all of these 
proteins were identified for both strains across all three time points, but for each time point at least 300 
common proteins were quantified for the three BM45 and VIN13 samples.  
 
To get an impression of the general data structure and overall alignment of transcript and protein data 
when comparing the two strains at each time point, we first calculated the ratios in the concentrations 
of identified proteins and the ratios of the corresponding gene expression values between the two 
strains. As a broad measure of alignment, we used the ratio of these protein and transcript comparisons 
(Figure 1). In these representations, values of above 1.5 and below 0.67 represent cases were the 
difference in fold change between protein concentration and transcription levels between the two 
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strains are higher than a factor of 1.5, meaning that for these genes transcript and protein levels show 
relatively large differences between strains. For day 2, only 37 of the 300 protein-mRNA ratios differed 
by a fold change of more than 1.5 (i.e. a ratio of more than 1.5 or less than 0.67). This means that 
interstrain comparisons at a given time point are reliable as gene expression and protein abundance data 
align with a close to 90% overlap within the 1.5 fold change threshold. The same observation holds for 
the day 5 analysis, where once again only ± 13% (38 out of 300) of the protein-mRNA pair ratios 
differed by a fold change of 1.5 or greater.  
 
By day 14 of fermentation the close alignment of transcript and protein ratios diverges somewhat. Here 
114 of the 311 protein-mRNA pairs show discrepancies in the comparative ratios between BM45 and 
VIN13. The poor alignment at this stage of fermentation can probably be explained by the fact that 
active fermentation has stopped, and cells are exposed to severe stress in the form of high ethanol 
levels and nutrient depletion. At this stage, active transcription is at a minimum, except for those genes 
related to the mobilization of reserve nutrients or tolerance of the severe stress conditions faced as the 
cells slow down metabolically. The levels of accumulated proteins still present at this point may thus 
bear limited correlation to the levels of mRNA in the cells. 
 
 
 
Figure 1 Distribution of the different protein-transcript pairs across the spectrum of ratios determined 
in our analysis for days 2 (frame A), 5 (frame B) and 14 (frame C) of the BM45 vs. VIN13 
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comparative analysis. For the intrastrain analysis, the distribution of protein-transcript ratios 
for day 5 compared to day 2 can be seen in frame D (for BM45) and frame E (for VIN13). 
 
In Figure 1 the general alignment of all the log2-transformed protein-mRNA ratios is represented as a 
distribution curve. Log2-transformed ratios close to zero indicate very strong agreement between the 
protein levels and gene expression levels for comparisons between strains. Hence the steeper the 
gradient of the slopes of the Gaussian-shaped curves, the closer the alignment of transcript and protein 
datasets as a whole. 
 
For the interstrain analysis at specific time points, there is clearly a significant peak for days 2 and 5 
around the optimal alignment point of zero, with sharp declining slopes in the direction of the two-fold 
change indicators (namely values of 1 and -1). The narrow peaks for these two days are a clear 
indicator of the close alignment of protein and transcript datasets. The opposite is clearly true for day 
14 (frame C), where no classic Gaussian distribution is evident, but rather a segmented pattern of 
increase and decrease across the wide range of protein-transcript ratios.  
 
7.4.3 Intrastrain comparison of the evolution of transcriptome and proteome 
In order to compare peptide signal areas between different runs (i.e. for comparisons between different 
time points for either VIN13 and BM45) the data were normalized as follows: All of the iTRAQ 
signals for peptides that are not shared among multiple detected proteins and that have a confidence 
score of at least 1.00 were selected. The area for each label in these peptides was calculated as a 
percentage of the total iTRAQ signal for each of the labels. This final transformed value is more 
conducive for comparisons across multiple iTRAQ experiments. The agreement among the replicates 
when expressed as a % of total signal as per our calculations was very good, and enabled intra-strain 
comparisons across time points to be made. 
 
When the analysis of transcript versus protein ratios was applied to the intra-strain analysis at different 
time points, the result indicates a largely random distribution of protein-transcript ratios (Figure 1). 
Although only the day5 vs. day2 analysis is shown, the results for the day14 vs. day5 analysis were no 
different. The intra-strain comparisons clearly do not conform to any normal distribution curve when 
applying the stringent criteria used for the transcript-protein alignment in this case. It must be kept in 
mind that in this analysis a large positive or negative change in the expression of a particular gene, 
along with a moderate change in the corresponding protein levels (in the same direction) would fall 
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outside of the threshold applied here for a good alignment. However, such an alignment would in many 
cases be considered a good fit from a biological perspective. 
 
To overcome the inherent stringency of this form of analysis, and considering the breakdown of 
correlation between transcripts and protein levels observed for the intra-strain analysis, we decided to 
use trends in transcript and protein levels as a second criterion. This assessment is much less stringent 
since it only queries whether up or down changes in transcript levels over the time points investigated 
here would generally correlate with similar trends on the protein level. In this case, ratios where both 
transcript and protein were less than one or both greater than one were considered aligned (+). Inverse 
ratios (i.e. one ratio less than one and the other greater than one) constituted a negative result (non-
aligned). 
 
Using this approach, the alignment of protein vs. transcript data for the VIN13 and BM45 strains 
between time points (i.e. day 5 vs. day 2, day 14 vs. day 5) was only around 60% for all three 
comparisons. Considering that a random sample would yield 50%, this value is surprisingly low, but in 
line with previous reports. Even when protein-transcript pairs for only the top 50 genes in terms of the 
magnitude of increase/decrease in expression were evaluated, the trend analysis did not improve in any 
noteworthy manner: For day 5 vs. day 2 in both strains, the alignment value increased slightly to 65-
68%, but for day 14 vs. day 5 there was in fact a decrease to close to 50%, much lower than the 60% 
value calculated for the entire gene.  This is surprising, since the transcript levels of these genes were 
changed by at least 1.8 fold (and up to 32 fold), and such significant changes would be expected to 
reflect on the proteome level. It is noteworthy that 2-fold is a threshold value that is frequently used in 
transcriptomic analysis to differentiate significant from non-significant changes. 
 
There are several possible explanations for this discordant alignment of transcript and protein levels for 
the intrastrain comparisons. Firstly, our transcriptome and proteome data were generated at the same 
stage of fermentation. However, the proteome at a specific time point is a reflection of previous rather 
than concomitant transcript levels. In other words, it would be expected that a particular transcriptomic 
dataset should be more closely aligned with proteomic data that are generated at a later time point, i.e. 
after the translation and post-translational modification workflow has responded to the earlier changes 
in transcription levels. Secondly, the time points assessed here represent very different environmental 
conditions within a dynamically changing system, whereas the comparison of different strains at the 
same time points de facto normalises for the environmental background. These findings help to explain 
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our observation that the predictive capacity of the omics matrix that was derived from the alignment of 
transcriptome and exometabolome data sets [8] was statistically mainly reliant on inter-strain, and 
much less on intra-strain comparisons.   
 
Our dataset also confirms previous observations [27;39] that transcriptomic and proteomic datasets are 
frequently difficult to align across different time points and need to be interpreted with caution. This is 
particularly the case when only a single strain is analysed, as any changes at the transcript level might 
be specific to the strain in question, and not represent a generally relevant response. In this sense, 
transcriptome comparisons of different strains under the same experimental conditions (regarding time 
point, medium composition etc.) might represent a more reliable system for inferring biological 
meaning, since only the genetic background will provide the basis for differences in physiological or 
phenotypic changes. Using different strains in comparative transcriptome analyses represents an 
inherent control system that is self-standardized to limit ‘noisy’ outputs.  
 
7.4.4 Functional categorization of expressed proteins 
For comparisons within a single experiment, the ratios of BM45 vs. VIN13 for both expressed genes 
and proteins were determined and compared. To facilitate evaluation of the data, the protein-mRNA 
pairs were categorized according to GO classification terms. The proteins identified in our analysis can 
reasonably be considered as representative of the entire proteome as all functional categories are well 
represented (i.e. approximately 160 proteins involved in energy and metabolism, 25 in cell cycle 
regulation, 35 in cellular transport, 35 in cell rescue and defense, 80 in protein synthesis and 25 in 
transcription). Furthermore, no bias towards any generic protein feature such as concentration or 
hydrophobicity profiles were obvious in the data. In this section, two relevant categories are further 
discussed as examples: Energy and metabolism as well as cell rescue and defense (Tables 1 and 2). 
Ratios above 1.3 and below 0.77 are indicated in bold font to represent relatively large increases or 
decreases in the abundance of transcript or protein for BM45 in comparison to VIN13. Missing values 
indicate that no data was acquired for a particular protein at that time point.  
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Table 1 GO category of energy and metabolism for protein-mRNA pairs at days 2, 5 and 14. Transcript 
ratios are indicated by (G) and protein ratios by (P). Values are the average of three repeats.  
 
Gene name ORF Functional description (brief)
BM45 vs 
VIN13 (P)
BM45 vs 
VIN13 (G)
BM45 vs 
VIN13 (P)
BM45 vs 
VIN13 (G)
BM45 vs 
VIN13 (P)
BM45 vs 
VIN13 (G)
ACC1 YNR016C acetyl-CoA carboxylase 1.38 1.22 1.15 1.06 1.27 1.16
ACO1 YLR304C aconitate hydratase 1.10 0.93 1.01 0.88
ACS2 YLR153C  acetyl-coenzyme A synthetase 1.43 1.38 1.20 0.99 0.47 1.46
ADE1 YAR015W phosphoribosylamidoimidazole-succinocarboxamide synthase 0.68 1.04
ADE12 YNL220W  adenylosuccinate lyase 1.04 0.91 0.88 0.99
ADE13 YLR359W  adenylosuccinate lyase 1.01 0.69 0.63 1.05
ADE17 YMR120C  5-aminoimidazole-4-carboxamide ribotide transformylase 1.00 0.77 0.78 0.96 0.67 0.99
ADE2 YOR128C phosphoribosylaminoimidazole carboxylase 0.82 0.94
ADE3 YGR204W C1-tetrahydrofolate synthase (trifunctional enzyme) 0.85 0.84 1.06 0.81 1.25 0.90
ADE4 YMR300C amidophosphoribosyltransferase 1.00 0.54
ADE5,7 YGL234W 7 phosphoribosylamine-glycine ligase 1.04 0.80 1.14 0.98 0.84 1.12
ADH1 YOL086C alcohol dehydrogenase I 1.00 0.91 0.93 0.82 1.16 0.91
ADH3 YMR083W alcohol dehydrogenase III 0.91 0.95
ADK1 YDR226W adenylate kinase, cytosolic 0.99 0.71 1.07 1.04 0.68 0.89
ALD6 YPL061W  aldehyde dehydrogenase, cytosolic 1.27 1.51 0.72 3.72
ADO1 YJR105W strong similarity to human adenosine kinase 0.87 1.12
APE2 YKL157W aminopeptidase yscII 0.86 0.87
ARG1 YOL058W argininosuccinate synthetase 0.69 0.80 0.35 0.84
ARG4 YHR018C arginosuccinate lyase 0.73 0.72
ARO1 YDR127W arom pentafunctional enzyme 0.78 0.70 0.72 0.67
ARO2 YGL148W chorismate synthase 1.10 1.07
ARO3 YDR035W 2-dehydro-3-deoxyphosphoheptonate aldolase 1.09 1.15 0.67 1.20 0.72 1.09
ARO4 YBR249C 2-dehydro-3-deoxyphosphoheptonate aldolase 0.99 0.88 0.90 1.03 0.68 0.92
ARO8 YGL202W aromatic amino acid aminotransferase I 0.95 0.94 0.74 0.91
ASN1 YPR145W asparagine synthetase 0.92 0.93 1.57 0.97 1.06 0.95
ATP1 YBL099W  F1F0-ATPase complex, F1 alpha subunit 1.07 0.70 0.94 0.94 0.78 0.99
ATP14 YLR295C YLR295C 1.06 0.86
ATP16 YDL004W YDL004W 1.07 0.92 0.84 0.94
ATP2 YJR121W  F1F0-ATPase complex, F1 beta subunit 0.97 0.87 0.88 0.96 0.60 1.06
ATP4 YPL078C  F1F0-ATPase complex, F0 subunit B 1.06 1.12
BAT1 YHR208W branched chain amino acid aminotransferase 0.90 0.85 0.60 0.74 0.80 0.78
BGL2 YGR282C endo-beta-1,3-glucanase of the cell wall 0.96 1.12 0.94 0.89 1.19 0.91
CDC19 YAL038W  pyruvate kinase 0.89 0.98 0.96 0.85 1.16 0.94
CIT1 YNR001C citrate (si)-synthase, mitochondrial 1.21 0.89 2.00 1.15
COR1 YBL045C  ubiquinol--cytochrome-c reductase 44K core protein 0.99 0.81 1.15 0.91
COX4 YGL187C  cytochrome-c oxidase chain IV 0.91 1.18 1.67 0.96
CPA2 YJR109C arginine-specific carbamoylphosphate synthase, large chain 1.54 0.96 0.96 0.97
CYS3 YAL012W cystathionine gamma-lyase 1.43 1.22 1.85 1.35 1.85 1.39
CYS4 YGR155W cystathionine beta-synthase 1.18 1.08 1.23 1.25 0.87 1.32
DLD3 YEL071W  D-lactate dehydrogenase 3.45 1.24 2.26 1.39
DAK1 YML070W dihydroxyacetone kinase, induced in high salt 1.01 1.11
DPM1 YPR183W dolichyl-phosphate beta-D-mannosyltransferase 0.91 0.64
DYS1 DYS1 deoxyhypusine synthase 0.99 0.89 0.36 0.93
ECM17 YJR137C  involved in cell wall biogenesis and architecture 0.91 1.05 1.33 0.79 1.92 0.73
EGD1 YPL037C GAL4 DNA-binding enhancer protein 1.25 0.81 1.06 0.90
EGD2 YHR193C alpha subunit of the nascent polypeptide-associated complex 0.95 0.71 1.02 0.83 0.65 0.80
EMI2 YDR516C 6c strong similarity to glucokinase 1.17 0.90
ENO1 YGR254W enolase I (2-phosphoglycerate dehydratase) 0.80 1.11 0.98 0.77 1.19 0.89
ENO2 YHR174W enolase II (2-phosphoglycerate dehydratase) 0.93 0.87 0.41 0.83 0.77 0.88
ERG1 YGR175C squalene monooxygenase 1.22 1.10 1.02 0.93 0.44 0.98
ERG10 YPL028W  acetyl-CoA C-acetyltransferase, cytosolic 1.14 1.33 1.05 1.05
ERG13 YML126C  3-hydroxy-3-methylglutaryl coenzyme A synthase 1.22 1.23 0.29 1.19
ERG20 YJL167W  farnesyl-pyrophosphate synthetase 1.08 0.98 0.49 0.97
ERG6 YML008C S-adenosyl-methionine delta-24-sterol-c-methyltransferase 0.97 1.12 1.43 0.04 0.75 1.05
EXG1 YLR300W exo-beta-1,3-glucanase (I/II), major isoform 0.98 1.33 1.26 0.76 0.99 1.04
FAS1 YKL182W fatty-acyl-CoA synthase, beta chain 1.16 1.13 1.05 0.94 1.14 1.03
FAS2 YPL231W fatty-acyl-CoA synthase, alpha chain 1.07 1.11 1.09 1.08 1.19 1.07
FBA1 YKL060C fructose-bisphosphate aldolase 0.96 0.97 0.92 0.91 1.22 0.90
FUR1 YHR128W uracil phosphoribosyltransferase 2.03 0.91
GAD1 YMR250W similarity to glutamate decarboxylases 0.61 0.79
GAS1 YMR307W glycophospholipid-anchored surface glycoprotein 0.92 0.96
GDB1 YPR184W similarity to human 4-alpha-glucanotransferase 0.80 0.98
GDH1 YOR375C glutamate dehydrogenase (NADP+) 0.96 0.79 1.71 0.86 1.03 0.93
GFA1 YKL104C glucosamine--fructose-6-phosphate transaminase 1.02 1.08 1.09 1.17
GLK1 YCL040W aldohexose specific glucokinase 0.84 1.26 0.93 0.79 1.10 0.91
GND1 YHR183W 6-phosphogluconate dehydrogenase 1.10 0.93 1.37 1.06 1.47 1.10
GPD1 YDL022W glycerol-3-phosphate dehydrogenase (NAD+) 1.01 1.00 1.04 0.87 0.69 0.99
GPD2 YOL059W glycerol-3-phosphate dehydrogenase (NAD+) 1.22 4.23 0.59 1.26
GPH1 YPR160W glycogen phosphorylase 1.19 0.81 0.58 0.87 1.21 1.00
GPM1 YKL152C phosphoglycerate mutase 0.91 1.08 0.93 0.93 1.17 0.88
GRE3 YHR104W aldose reductase 1.43 1.65 1.18 1.42
GSY2 YLR258W UDP-glucose--starch glucosyltransferase, isoform 2 0.43 0.95
GSY2 YLR258W  UDP-glucose--starch glucosyltransferase, isoform 2 0.43 0.95
GUA1 YMR217W GMP synthase (glutamine-hydrolyzing) 0.58 1.12
HEM13 YDR044W  coproporphyrinogen III oxidase 0.74 0.51 0.62 0.69
HIS1 YER055C ATP phosphoribosyltransferase 1.14 0.98 1.12 0.78
HIS3 YOR202W imidazoleglycerol-phosphate dehydratase 0.88 0.69
HIS4 YCL030C phosphoribosyl-ATP pyrophosphatase 0.98 1.16 0.94 0.98 1.17 0.97
HOM2 YDR158W aspartate-semialdehyde dehydrogenase 0.96 0.99 0.69 0.90 0.65 0.89
DAY2 DAY5 DAY14
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Gene name ORF Functional description (brief)
BM45 vs 
VIN13 (P)
BM45 vs 
VIN13 (G)
BM45 vs 
VIN13 (P)
BM45 vs 
VIN13 (G)
BM45 vs 
VIN13 (P)
BM45 vs 
VIN13 (G)
HOM6 YJR139C homoserine dehydrogenase 0.89 1.16 1.28 1.13
HOR2 YER062C DL-glycerol phosphatase 2.25 1.09
HXK1 YFR053C hexokinase I 0.98 0.72 1.03 0.91 1.45 0.99
HXK2 YGL253W hexokinase II 0.90 0.72 1.75 1.24 1.37 1.10
HXT3 YDR345C low-affinity hexose transporter 0.90 1.31 1.64 0.84
HYP2 YEL034W translation initiation factor eIF5A.1 0.96 1.44 1.05 1.06
ILV1 YER086W anabolic serine and threonine dehydratase precursor 1.16 0.91 0.61 1.09
ILV2 YMR108W acetolactate synthase 0.90 0.91 0.96 0.85
ILV3 YJR016C dihydroxy-acid dehydratase 0.58 0.65 0.59 0.62 0.54 0.64
ILV5 YLR355C ketol-acid reducto-isomerase 1.09 0.87 1.05 0.92 0.28 0.98
ILV6 YCL009C acetolactate synthase, regulatory subunit 0.97 1.09 0.54 0.75
IMD2 YHR216W IMP dehydrogenase 2.07 0.93 1.70 0.53 1.72 1.83
IMD3 YLR432W strong similarity to IMP dehydrogenases 1.33 1.17
IMD4 YML056C strong similarity to IMP dehydrogenases 0.88 0.53 0.81 0.81
INO1 YJL153C myo-inositol-1-phosphate synthase 1.01 2.92
IPP1 YBR011C inorganic pyrophosphatase, cytoplasmic 0.80 0.91 0.90 0.96 0.68 0.85
KGD1 YIL125W 2-oxoglutarate dehydrogenase complex E1 component 1.44 0.91
KGD2 YDR148C 2-oxoglutarate dehydrogenase complex E2 component 1.44 0.90
LEU2 YCL018W beta-isopropyl-malate dehydrogenase 0.98 1.13 0.61 0.73 0.73 0.87
LEU4 YNL104C 2-isopropylmalalate synthase 1.01 0.92 0.72 0.79
LPD1 YFL018C dihydrolipoamide dehydrogenase precursor 1.19 1.15
LSC1 YOR142W succinate-CoA ligase alpha subunit 0.46 0.98
LYS1 YIR034C saccharopine dehydrogenase 1.35 1.27 0.97 0.77 0.53 1.01
LYS12 YIL094C  homo-isocitrate dehydrogenase 1.04 0.81 1.12 1.14 0.56 1.11
LYS20 YDL131W  homocitrate synthase 0.93 0.92 1.09 0.80 1.20 0.85
LYS4 YDR234W homoaconitase 0.84 0.55 0.88 1.13 0.23
LYS9 YNR050C saccharopine dehydrogenase 0.88 0.80 1.17 0.98 1.20 1.00
MAE1 YKL029C malic enzyme 1.03 0.57 1.24 1.19 1.09 1.18
MCR1 YKL150W  cytochrome-b5 reductase 0.97 0.98 0.97 0.98
MDH1 YKL085W malate dehydrogenase precursor 1.30 1.03 1.08 1.04
MET10 YFR030W  sulfite reductase flavin-binding subunit 1.11 0.94
MET17 YLR303W  O-acetylhomoserine sulfhydrylase 1.26 0.96 1.06 1.35 1.86 1.47
MET22 YOL064C  protein ser/thr phosphatase 1.23 1.18
MET3 YJR010W sulfate adenylyltransferase 0.95 1.07 1.60 1.04 1.70 1.07
MET6 YER091C 5-methyltetrahydropteroyltriglutamate methyltransferase 1.35 1.10 1.02 1.35 0.90 1.42
MIR1 YJR077C phosphate transport protein 0.92 0.91 1.12 0.85
NCP1 YHR042W NADPH-cytochrome P450 reductase 0.81 1.15
OYE2 YHR179W  NADPH dehydrogenase 0.91 0.93 1.12 0.81 2.00 0.88
PDA1 YER178W pyruvate dehydrogenase alpha chain precursor 0.76 1.03 0.79 0.91
PDC1 YLR044C pyruvate decarboxylase, isozyme 1 1.01 0.98 1.02 0.91 1.27 0.93
PDC5 YLR134W pyruvate decarboxylase, isozyme 2 0.94 0.30 0.75 0.39 0.76 0.52
PDC6 YGR087C pyruvate decarboxylase 3 0.91 1.09
PDI1 YCL043C protein disulfide-isomerase precursor 0.91 1.08 1.14 0.81 1.08 0.81
PDX3 YBR035C pyridoxamine-phosphate oxidase 1.18 1.06 0.95 1.02
PFK1 YGR240C 6-phosphofructokinase, alpha subunit 1.05 1.07 1.18 1.08 1.63 1.25
PFK2 YMR205C 6-phosphofructokinase, beta subunit 1.01 0.78 1.07 1.02
PGI1 YBR196C glucose-6-phosphate isomerase 1.12 1.11 1.11 1.08 1.88 1.17
PGK1 YCR012W phosphoglycerate kinase 0.85 1.05 0.90 0.88 1.18 0.93
PGM2 YMR105C phosphoglucomutase, major isoform 1.21 1.82 0.82 0.80
PSA1 YDL055C mannose-1-phosphate guanyltransferase 0.82 0.80 1.66 0.68 1.93 0.81
PYC2 YBR218C pyruvate carboxylase 2 0.37 0.94 0.38 0.91
QCR7 YDR529C  ubiquinol--cytochrome-c reductase subunit 7 0.67 0.66 1.04 0.80 1.39 0.77
RHO1 YPR165W GTP-binding protein of the rho subfamily 0.91 0.83 1.22 0.84
RHR2 YIL053W DL-glycerol phosphatase 0.78 0.59 0.54 0.84
RIB3 YDR487C 3,4-dihydroxy-2-butanone 4-phosphate synthase 0.76 0.99 0.95 0.81 0.56 0.62
RNR2 YJL026W ribonucleoside-diphosphate reductase, small subunit 0.83 0.55 0.54 1.38 0.66 0.77
RNR4 YGR180C ribonucleotide reductase small subunit 0.76 0.60 0.56 0.84 0.67 0.79
RPP1B YDL130W F1 ATPase stabilizing factor, 10 kDa 0.74 0.81
SAH1 YER043C S-adenosyl-L-homocysteine hydrolase 1.05 0.94 0.96 1.12 0.48 1.07
SAM1 YLR180W S-adenosylmethionine synthetase 1 1.09 1.37
SAM2 YDR502C S-adenosylmethionine synthetase 2 1.04 1.00 1.14 1.05 1.72 1.19
SEC53 YFL045C  phosphomannomutase 0.97 1.02 0.69 1.06
SER1 YOR184W phosphoserine transaminase 1.13 1.17 0.75 0.97
SER33 YIL074C  3-phosphoglycerate dehydrogenase 1.38 1.09 1.24 1.11
SHM2 YLR058C serine hydroxymethyltransferase 1.14 0.79 0.78 0.98 0.26 0.97
STM1 YLR150W specific affinity for guanine-rich quadruplex nucleic acids 0.91 1.33 0.84 1.09
TAL1 YLR354C transaldolase 1.08 0.94 1.15 1.09 1.27 1.16
TDH1 YJL052W glyceraldehyde-3-phosphate dehydrogenase 1 0.70 1.01 0.98 0.64
TDH3 YGR192C glyceraldehyde-3-phosphate dehydrogenase 3 1.33 0.88 0.76 1.03 1.25 1.06
THR1 YHR025W homoserine kinase 0.92 0.50 1.00 2.06 0.66 1.00
THR4 YCR053W threonine synthase (o-p-homoserine p-lyase) 1.08 0.93 0.92 1.11
THS1 YIL078W threonyl tRNA synthetase, cytosolic 0.97 1.11
TKL1 YPR074C transketolase 1 1.06 0.95 1.13 1.08 1.13 1.11
TPI1 YDR050C triose-phosphate isomerase 1.26 0.89 0.98 1.11 1.14 1.05
TPS1 YBR126C alpha,alpha-trehalose-phosphate synthase 1.10 1.42 0.91 0.97 1.08 1.10
TRP5 YGL026C tryptophan synthase 0.96 0.99 1.01 0.93 0.83 0.96
TRR1 YDR353W thioredoxin reductase (NADPH) 0.96 1.31
TSL1 YML100W alpha,alpha-trehalose-phosphate synthase 0.72 3.55 0.97 0.98
URA2 YJL130C multifunctional pyrimidine biosynthesis protein 1.24 0.79 1.16 1.38
YDL124W YDL124W similarity to aldose reductases 1.07 1.30
YEL047C YEL047C soluble fumarate reductase 0.82 1.07
YPR1 YDR368W strong similarity to aldo/keto reductase 0.86 0.87 0.61 0.94
DAY2 DAY5 DAY14
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As can be seen from Tables 1 and 2, and as would be expected when considering the overall good 
alignment presented for the inter-strain comparisons at similar time points, the relative over- or 
underexpression of genes generally coincides with a similar trend in the protein abundance data 
(particularly for the first two time points during fermentation). 
 
Table 2 GO category of cell rescue and defense for protein-mRNA pairs at days 2, 5 and 14. Transcript 
ratios are indicated by (G) and protein ratios by (P). Values are the average of three repeats.  
 
Gene name ORF Functional description (brief)
BM45 vs 
VIN13 (P)
BM45 vs 
VIN13 (G)
BM45 vs 
VIN13 (P)
BM45 vs 
VIN13 (G)
BM45 vs 
VIN13 (P)
BM45 vs 
VIN13 (G)
AHP1 YLR109W  alkyl hydroperoxide reductase 1.20 1.06 1.07 1.10 1.21 1.02
CCS1 YMR038C  copper chaperone for superoxide dismutase SOD1P 1.05 1.06 1.11 1.03
CPR1 YDR155C  cyclophilin (peptidylprolyl isomerase) 1.12 1.01 1.00 0.93 1.07 0.91
DAK1 YML070W  dihydroxyacetone kinase, induced in high salt 1.01 1.11
DDR48 YMR173W  heat shock protein 0.95 1.19 0.88 0.73 0.75 0.69
GPD1 YDL022W  glycerol-3-phosphate dehydrogenase (NAD+) 1.01 1.00 1.04 0.87 0.69 0.99
GRE3 YHR104W  aldose reductase 1.43 1.65 1.06 1.70 1.18 1.42
GRX1 YCL035C  glutaredoxin 0.83 0.64 1.08 0.56
GRX5 YPL059W  member of the subfamily of yeast glutaredoxins 1.08 0.69 1.21 0.84
HMF1 YER057C  heat-shock induceable inhibiter of cell growth 0.75 1.11 0.88 0.78
HOR2 YER062C  DL-glycerol phosphatase 2.25 1.09
HSP104 YLL026W  heat shock protein 0.95 1.38 0.80 0.92 1.30 1.15
HSP12 YFL014W  heat shock protein 5.01 1.17 1.01 2.18 0.97 1.96
HSP26 YBR072W  heat shock protein 1.56 2.65 0.99 1.20 1.09 1.18
HSP30 YCR021C  heat shock protein 0.87 1.29 1.25 1.55
HSP60 YLR259C  heat shock protein 0.75 0.66 0.91 0.68 1.19 0.79
HSP78 YDR258C  heat shock protein 0.89 1.38 0.73 0.66 1.51 0.96
HSP82 YPL240C  heat shock protein 0.70 0.75 0.84 0.74 1.19 0.84
JLP1 YLL057C  similarity to E.coli dioxygenase 1.46 2.23
LAP3 YNL239W  member of the GAL regulon 0.97 1.22
MET22 YOL064C  protein ser/thr phosphatase 1.23 1.18
MRH1 YDR033W  membrane protein related to HSP30P 1.15 1.13 0.90 0.93 1.03 1.17
NCP1 YHR042W  NADPH-cytochrome P450 reductase 0.81 1.15
PRE1 YER012W  20S proteasome subunit 0.68 1.34
PRX1 YBL064C  similarity to thiol-specific antioxidant enzyme 0.99 0.98 0.98 0.89
SOD1 YJR104C  copper-zinc superoxide dismutase 0.94 1.02 0.96 0.89 1.02 0.81
SSA1 YAL005C  heat shock protein of HSP70 family 0.84 0.80 1.23 1.35
SSC1 YJR045C  mitochondrial heat shock protein 0.79 0.63 0.92 0.79 1.49 0.81
SSE1 YPL106C  heat shock protein of HSP70 family 1.02 0.92 0.85 1.02 1.48 1.02
SSZ1 YHR064C  protein involved in pleiotropic drug resistance 0.99 0.87 0.91 1.01 0.47 1.04
STI1 YOR027W  stress-induced protein 0.84 0.79 1.36 0.97
TPS1 YBR126C  alpha,alpha-trehalose-phosphate synthase 1.10 1.42 0.91 0.97 1.08 1.10
TRX2 YGR209C  thioredoxin II 1.09 0.79 1.43 0.74
TSA1 YML028W  thiol-specific antioxidant 0.91 1.06 0.98 0.98 0.61 0.93
YGP1 YNL160W  secreted glycoprotein 1.01 1.34 1.27 1.10
YDJ1 YNL064C  mitochondrial and ER import protein 0.87 0.54
YHB1 YGR234W  flavohemoglobin 0.39 0.77 0.58 0.40 0.26 0.40
DAY2 DAY5 DAY14
 
 
The same functional categories were also analysed for the intrastrain data. Surprisingly, when 
considering the rather poor general alignment of changes in transcript and protein levels in this case, 
gene expression and protein levels also aligned well for the specific functional categories of amino acid 
metabolism and fermentative metabolism, suggesting a strong transcriptional control of such metabolic 
enzymes (Table 3).  
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Table 3 Relative protein and transcript ratios for day 5 versus day 2 in both VIN13 and BM45 
for genes involved in fermentation and amino acid metabolism. Transcript ratios are 
indicated by (G) and protein ratios by (P). Matching trend alignments are indicated by 
‘+’ while opposite trends in transcript and protein levels are indicated by ‘Negative’. 
Values are the average of three repeats. 
 
Gene name ORF BM45 (P) BM45 (G) VIN13 (P) VIN13 (G) BM45 Trend VIN13 Trend
ACS2 YLR153C 0.29 0.41 0.27 0.47 + +
ARO3 YDR035W 0.39 0.90 0.48 1.53 + Negative
ARO4 YBR249C 0.41 0.24 0.44 0.24 + +
ASN1 YPR145W 0.65 0.39 0.65 0.23 + +
BAT1 YHR208W 0.75 0.44 0.98 0.63 + +
GDH1 YOR375C 0.60 0.18 0.69 0.08 + +
GPD1 YDL022W 1.53 1.49 1.63 1.43 + +
GPH1 YPR160W 2.41 0.93 3.07 1.32 Negative +
ILV3 YJR016C 0.76 0.39 0.78 0.42 + +
ILV5 YLR355C 0.70 0.62 0.69 0.52 + +
LEU2 YCL018W 1.88 0.26 2.32 0.49 Negative Negative
LYS12 YIL094C 0.22 0.34 0.24 0.24 + +
LYS21 YDL131W 0.25 0.28 0.31 0.27 + +
LYS4 YDR234W 0.22 0.68 0.28 0.42 + +
LYS9 YNR050C 0.66 0.11 0.61 0.07 + +
PDC1 YLR044C 0.60 0.91 0.62 0.87 + +
PFK1 YGR240C 0.60 0.90 0.59 0.82 + +
PFK2 YMR205C 0.67 0.69 0.64 0.50 + +
PGM2 YMR105C 1.27 1.31 1.59 2.91 + +
SAM2 YDR502C 0.26 0.86 0.27 0.74 + +
SHM2 YLR058C 0.56 0.30 0.61 0.30 + +
TDH1 YJL052W 1.34 0.95 1.38 0.98 Negative +
TDH3 YGR192C 0.45 0.68 0.41 0.79 + +
THR1 YHR025W 0.22 0.35 0.35 0.18 + +
TPI1 YDR050C 0.68 0.87 0.68 0.79 + +
TPS1 YBR126C 0.72 1.93 0.83 3.01 Negative Negative
TRP5 YGL026C 0.37 0.48 0.37 0.48 + +
TSL1 YML100W 3.55 2.13 2.71 7.83 + +  
 
Other categories showed almost no relationship between changes in transcript and protein levels. As an 
example, Table 4 shows data for the GO category of transcription and cell cycle control. The difference 
in the alignment of protein and transcript data between different functional categories becomes quite 
apparent when contrasting the results depicted in Tables 3 and 4. Transcriptomic data thus appears to 
be reasonably representative of protein levels for metabolic enzymes, but not for most other GO 
categories such as general cell maintenance and growth. 
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Table 4 Relative protein and transcript ratios for day 5 versus day 2 in both VIN13 and BM45 for 
the GO categories of transcription and cell cycle control. Transcript ratios are indicated by 
(G) and protein ratios by (P). Positive trend alignments are indicated by ‘+’ while opposite 
trends in transcript and protein levels are indicated by ‘Negative’. Values are the average of 
three repeats. 
 
Gene name ORF BM45 (P) BM45 (G) VIN13 (P) VIN13 (G) BM45 Trend VIN13 Trend
TRANSCRIPTION NOP1 YDL014W 0.74 0.39 0.69 0.19 + +
SUB2 YDL084W 1.36 0.72 1.34 0.52 Negative Negative
HTA1 YDR225W 0.47 1.09 0.43 0.97 Negative +
NPL3 YDR432W 0.83 1.53 0.85 1.00 Negative +
SNU13 YEL026W 1.45 0.85 1.73 0.65 Negative Negative
PAB1 YER165W 0.90 0.55 1.06 0.55 + Negative
ARC1 YGL105W 1.26 0.32 1.86 0.22 Negative Negative
ADE3 YGR204W 0.22 0.81 0.24 0.64 + +
EGD2 YHR193C 1.41 0.39 1.61 0.27 Negative Negative
DED1 YOR204W 0.29 2.72 0.29 3.33 Negative Negative
NOP58 YOR310C 0.02 0.50 0.01 0.32 + +
EGD1 YPL037C 0.62 0.30 1.03 0.23 + Negative
RPO26 YPR187W 0.60 0.76 0.70 0.37 + +
CELL CYCLE YBR109C CMD1 7.75 0.83 9.03 0.81 Negative Negative
YDL126C CDC48 4.40 1.47 4.44 1.18 + +
YFL014W HSP12 5.63 1.77 12.68 2.06 + +
YFL039C ACT1 1.37 0.85 1.40 0.90 Negative Negative
YGL106W MLC1 1.93 0.71 2.30 0.37 Negative Negative
YGR180C RNR4 0.45 0.39 0.44 0.42 + +
YJL026W RNR2 0.87 0.25 0.91 0.26 + +
YLR075W RPL10 0.95 0.69 1.10 0.74 + Negative
YPL240C HSP82 0.50 5.52 0.45 4.97 Negative Negative  
 
7.4.5 Correlations between protein levels and phenotype 
The differences in protein abundance between the two strains can tentatively be correlated to specific 
phenotypic differences (where these are known). For instance, the significantly lower levels of several 
heat shock proteins, such as Hsp60, Hsp82 and Ddr48 in BM45 in comparison to VIN13 (Table 2) 
could account for the generally lower tolerance of this strain to various stress conditions, including heat 
stress, since these proteins have been shown to directly impact on this phenotype  [40;41]. Similarly, 
lower levels of antioxidant proteins such as Tsa1 and Yhb1 (Table 2) could also explain the increased 
susceptibility of BM45 to oxidative stress in comparison to VIN13 [42]. Lower Erg13, Erg20 and Erg6 
protein abundances (Table 1) in BM45 vs. VIN13 could also account for the lower ethanol and osmotic 
shock tolerance of BM45, given that these proteins are involved in the production of a variety of sterols 
with roles in cell membrane stabilization [43;44]. 
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Figure 2 Network visualization of protein and gene expression ratios in metabolic hubs linked to the 
metabolism of various amino acids. The pathway networks for BM45 vs. VIN13 day 2, 5 and 
14 are presented in frames A, B and C, respectively. Frame D depicts the changes in gene and 
protein levels for day 5 versus day 2 in VIN13. Visual mapping was used to represent the 
ratios of RNA and proteins as follows: RNA ratios are represented by a linear colour scale 
A
B
C
D
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assigned to the interior of each node and protein ratios are represented by a linear colour scale 
assigned to the border of each node. Both of the linear colour scales are constructed such that 
the maximum intensity is set to correspond to ratios equal to or above a positive or negative 2 
fold difference between strains, or between time points within each strain.  The blue scale 
represents negative ratios while the red scale represents positive ratios.  White indicates a 
ratio of 1.0, i.e. no difference for that molecule.  
 
On the metabolic front, the data indicate why the alignment of exometabolome and transcriptome data 
has previously proven successful. Indeed, differences in the ratios of several proteins involved in the 
synthesis of the aromatic amino acids (namely Aro1, Aro3, Aro4 and Aro8; Table 1) are reflected by 
differences in the concentrations of the end-products of these pathways [8]. Likewise, Bat1 is involved 
in catalyzing the first transamination step of the catabolic formation of fusel alcohols via the Ehrlich 
pathway [45]. Differences in Bat1 expression (Figure 2; Table 1) has proven to effect large changes in 
higher alcohol production by wine yeast strains [8]. BAT1 gene expression and Bat1 protein levels are 
quite notably concordant (Figure 2), and the decrease in expression for BM45 relative to VIN13 agrees 
with metabolite data showing significantly lower propanol, butanol and methanol production by BM45 
in comparison to VIN13 [8].  In fact, this close alignment between transcript and protein levels appears 
to be the case for almost all of the gene-protein pairs linked to the metabolism of the amino acids 
shown in Figure 2, both at days 2 and 5, and even 14. From Figure 2 it is clear that there is a direct 
correlation between transcript and protein abundance in central metabolic pathways, (such as those 
pathways related to amino acid metabolism in this example). 
 
Amino acid metabolism is of particular interest from a wine-making perspective as amino acids serve 
as the precursors of important volatile aroma compounds. For instance, sulfur-containing amino acids 
such as methionine (and cysteine to a lesser extent) are the precursors for the volatile thiols that are 
significant aroma compounds in wine [46]. The branched chain amino acids such as valine, leucine and 
isoleucine on the other hand, serve as the precursors for various higher alcohols. Of the enzymes 
involved in branched chain amino acid metabolism, BAT1 has been discussed above.  
 
Other genes that encode enzymes in this pathway and that were identified in our previous study [8] for 
their strong statistical link between expression levels and the production of specific aroma compounds 
include LEU2, encoding a beta-isopropylmalate dehydrogenase that catalyzes the third step in the 
leucine biosynthesis pathway [47]. Expression of this gene showed a significant statistical correlation 
with compounds such as isobutanol [8], and as can be seen from Figure 2, the relative transcript and 
protein abundance ratios align well for this gene.  
 184
 
Of the genes involved in the metabolism of isoleucine and valine (precursors for higher alcohol 
synthesis), the ILV gene family (ILV1, ILV2, ILV3, ILV5, and ILV6) encode isoforms of 
acetohydroxyacid reductoisomerases involved in branched-chain amino acid biosynthesis [48]. 
Expression of the ILV gene isoforms showed strong positive correlations with many higher alcohols 
analysed in a previous study, and expression differences between BM45 and VIN13 once again align 
with differences in the exo-metabolite profiles of these two strains as reported by Rossouw et al. [8]. 
The ILV gene versus protein ratios are also well-aligned, again confirming the tight, concordant 
regulation of transcript levels and enzyme abundance in key metabolic pathways. 
 
In terms of intrastrain comparisons between time points, the alignment of changes in transcription and 
protein abundance is also good when considering metabolic pathways such as those of amino acid 
metabolism (Figure 2D). Although the intensity of the fold change differs for mRNA and proteins, the 
overall trends match up well. From Figure 2D, it can be seen that there is a general down-regulation of 
transcripts (and their corresponding proteins) involved in amino acid metabolism as fermentation 
proceeds from the exponential growth phase (day 2) to early stationary phase (day 5). This is to be 
expected, as day 5 heralds a fermentative phase characterized by continued high rates of fermentative 
metabolism associated with a significant reduction in growth and biomass formation.  
 
7.5 Conclusions 
Although our coverage of the yeast proteome was only around 5%, the identified proteins were 
distributed over all functional categories. This suggests that the protein abundance data present a 
sufficient coverage of the proteome to assess the biological relevance and reliability of the 
transcriptome data. In our study, the alignment of relative protein abundance ratios with gene 
expression data was accurate for data generated within a single iTRAQ experiment. This was mostly 
true for the early stages of fermentation (days 2 and 5) when active cell growth and metabolism is 
occurring. Also, alignment of protein and transcript levels within metabolic pathways specifically 
proved to be extremely reliable. In the case of data comparisons across different iTRAQ experiments 
the quality of gene expression to protein correlations deteriorates substantially. The reason for this 
observation is that the alignment of transcript and protein datasets across specific time points is 
naturally problematic due to the lag time between the expressed transcriptome and later changes in the 
protein profile. Clearly transcriptomic studies involving analyses across different time points are 
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fraught with significant complication and therefore may be more difficult to interpret in a biologically 
meaningful manner. On the other hand, comparison of transcription patterns in the context of different 
genetic backgrounds appears to provide a reliable indication of the real molecular responses of the cells 
to underlying genetic differences. 
 
Overall, the close alignment of transcript and protein ratios in particularly interstrain comparisons gives 
us great confidence in the quality and usability of our transcript data. Most notably, the concordance of 
gene and protein levels of enzymes involved in metabolism confirms transcriptional control of at least 
some of the important metabolic pathways in yeast. This implies that transcriptomic data can 
theoretically be applied to evaluate and model certain aspects of yeast metabolism with relative 
confidence. The agreement of protein abundance ratios between strains with the phenotypic 
characteristics of these strains further strengthens our belief that the ‘omic’ datasets we have generated 
provide valuable and reliable insights into the fundamental molecular mechanisms at work in industrial 
wine yeast strains during alcoholic fermentation.  
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CHAPTER 8 
General Discussion 
 
The main goal of this project was to investigate the genetic factors underlying different fermentation 
phenotypes and physiological adaptations of industrial wine yeast strains. Five industrial wine yeast 
strains were phenotypically characterized and compared in terms of their fermentation capacity and 
physiology, and subjected to transcriptional and exo-metabolomic profiling during alcoholic 
fermentation in simulated wine-making conditions. Two of these strains were further characterized in 
real grape must and on a proteomics level to assess to what degree the transcriptomic data provide 
meaningful information regarding protein levels and changing environmental conditions. 
 
Characterization of the five strains showed that there were significant differences in the complement of 
volatile aroma compounds produced by these strains. Other noteworthy differences were also identified 
experimentally, including (i) the ability of the different strains to tolerate key stress conditions such as 
oxidative, osmotic and ethanol stress, (ii) adhesion properties related phenotypes such as flocculation, 
invasive growth and mat formation, (iii) responses to starvation for different macronutrients such as 
carbon, nitrogen, sulfur and phosphorous and (iv) intracellular concentrations of key glycolytic 
metabolites.  
 
The gene expression profiles of the five strains were systematically analyzed at three time points during 
fermentation, corresponding to the exponential, early stationary and late stationary growth phases. As a 
means to contextualize our data we evaluated the gene expression levels within the framework of 
enzyme-enzyme and enzyme-metabolite interaction graphs (using the reporter metabolite approach). 
This approach helped to pin-point specific areas of metabolism that accounted for inter-strain or time 
point variation.  
 
We were also interested to see whether we could predict the impact of specific genes of known or 
unknown function on the yeast metabolic network by combining whole transcriptome and partial exo-
metabolome analysis. To address this issue the matrix of gene expression data (from the five strains at 
the three time points) was integrated with the concentrations of volatile aroma compounds measured at 
the same time points. Using the relatively unbiased approach of regression modeling we were able to 
identify several candidate genes for aroma profile modification. Overexpression of a few of these target 
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genes and analysis of the data did indeed show a statistically significant correlation between the 
changes in the exo-metabolome of the overexpressing strains and the changes that were predicted based 
on the unbiased alignment of transcriptomic and exo-metabolomic data. Considering the complexity of 
the system, the success rate of this approach was quite satisfactory, suggesting that a comparative 
transcriptomics and metabolomics approach can be used to identify the metabolic impacts of the 
expression of individual genes in complex systems. 
 
One of the major challenges of large-scale functional genomics in wine yeast is the fact that the 
specific strain, the time point during fermentation, as well as the composition of the fermentation media 
and other abiotic factors (i.e. temperature) all contribute to the transcriptomic response of the yeast 
population to its ‘environment’. We therefore conducted parallel transcriptomic analyses with two wine 
yeast strains in two different fermentation media, namely MS300 and Colombard must, in order to 
delineate relevant and ‘noisy’ changes in gene expression in response to experimental factors such as 
fermentation stage and strain identity. We were also interested to see if predictive statistical models 
based on transcriptional information from MS300 studies could be reproduced in a real wine must 
background.  
 
Multivariate analysis of gene expression data derived from this study showed that the composition of 
the fermentation must is a lesser contributor of variance in a fermentation compared to both strain 
identity and the time point during fermentation. Moreover, inter-strain comparisons at different stages 
of fermentation did not yield notable discrepancies in terms of significance outputs. We demonstrated 
that the alignment of exometabolic model information from the MS300 and Colombard datasets was 
very close, which suggested that integrative ‘omics’ applications can be incorporated into reliable 
predictive models across the board, regardless of variation in specific environmental conditions. This 
finding validated the suitability of the widely-used synthetic must MS300 as a representative 
experimental media for conducting research on wine yeast genetics, biochemistry and physiology. 
 
Another important aspect to consider in systems biology research relates to the alignment of different 
‘omics’ datasets, or the degree to which the different levels of the cellular information transfer system 
compare with one another. Obviously protein levels are a much stronger indicator of the real cellular 
response to a particular perturbation/ experimental factor. Since most of our analyses and deductions 
were based on gene expression data, it was important to see how protein expression levels aligned with 
our transcriptomic analysis.  
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For the proteomic analysis two strains were considered at the same three time points, namely day 2, 
day 5 and day 14. A total of approximately 450 proteins were unambiguously identified. We found that 
alignment of transcript and protein ratios were extremely high for comparisons between the two strains. 
This observation provides strong support for the biological relevance of comparative transcriptomic 
datasets in yeast. However for the intrastrain comparisons (between time points) the close alignment of 
transcript and protein ratios falls apart. This confirms previous observations (de Groot et al., 2007; de 
Godoy et al., 2008) that transcriptomic and proteomic datasets are frequently difficult to align across 
different time points and need to be interpreted with caution.  
 
In this context of time point comparissons, differences between transcriptome and proteome appear 
strongly dependent on the GO functional category of the corresponding genes. Our data suggest that for 
most categories, such as cell cycle control, transcription, translation etc., there is almost no correlation 
between trends in transcript levels and proteins over time. However, metabolic enzymes and the 
corresponding genes appear strongly correlated over time and between strains, suggesting a strong 
transcriptional control of such enzymes. The implication is thus that transcriptomic data can 
theoretically be applied to evaluate and model certain aspects of yeast metabolism with relative 
confidence. 
 
The large comparative datasets also allow for the generation of hypotheses regarding the molecular 
origin of significant differences in phenotypic traits between the different strains: By enrichment of 
differentially expressed gene datasets for specific transcription factors (TFs) we were able to identify 
key transcription factors showing significant differences in their expression patterns between the 
different strains. These transcription factors together accounted for the majority of differentially 
expressed genes in the interstrain comparisons. It has been proposed that some of the primary targets of 
yeast adaptation are functional binding sites of transcription factors and the transcription factors 
themselves. Variations in transcriptional regulation between different wine yeast strains could thus be 
responsible for the rapid adaptation to different fermentative requirements in the context of commercial 
wine-making.  
 
We hypothesized that much of the transcriptional and metabolic variation encountered among the 
different wine yeast strains in use today could be explained by adaptation mediated by changes in the 
expression/regulation of certain key transcription factors. Changes in the expression of these ‘master 
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controllers’ can lead to large-scale changes to the fermentation phenotypes of the different yeast 
strains. By overexpressing two of these transcription factors we did indeed observe far-reaching 
changes in cellular metabolism, particularly a modified aroma compound metabolism. We also showed 
that the metabolic phenotype of one strain could indeed be made more similar to another strains by 
modifying the expression of these transcription factors. These observations therefore provide some 
insights into the mechanisms of adaptation and micro-evolution of wine yeast strains. 
 
On the whole, our transcriptomic data align well with previous studies conducted using similar strains 
(Rossignol et al., 2003; Marks et al., 2008). The one drawback of these previous transcriptomic studies 
in wine yeast is that only single strains were considered in each analysis. By using several 
phenotypically divergent commercial wine yeast strains we were able to generate a more robust dataset. 
Such a comparative approach provided more biologically meaningful data than would have been 
derived from single strain approaches. The interstrain comparison of transcriptomic and proteomic 
datasets revealed intrinsic molecular differences between strains that in many cases could be directly 
correlated to relevant phenotypes. Our multi-strain, multi-layered ‘omic’ approach was therefore well 
suited to the analysis of complex phenotypes such as aroma compound production, stress tolerance, 
flocculation, etc. 
 
There are very few published proteomic studies for wine yeast strains, and even fewer for proteomics 
in conjunction with transcriptional analysis (Trabalzini et al., 2003; Salvadó et al., 2008). Our study is 
the first of its kind in terms of combing transcriptome and proteome analysis for different strains across 
time points. Ultimately, the agreement of protein abundance ratios between strains with the phenotypic 
characteristics of these strains further strengthens our belief that the ‘omic’ datasets we have generated 
provide valuable and reliable insights into the molecular mechanisms at work in industrial wine yeast 
strains during alcoholic fermentation. 
 
However, the major shortfall in our research is the limited nature of our proteomic dataset. The 450 
proteins that we have identified represent less than 10% of the whole yeast proteome. Future directives 
would obviously include the generation of a more comprehensive protein dataset, considering that 
protein levels are a more accurate representation of in vivo enzyme activity and fluxes than transcript 
levels.  
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On the metabolic front, our present study focused mainly on the exometabolome, considering the 
oenological relevance of this information and the relative ease of experimental analysis. Only a few 
selected intracellular metabolites were measured experimentally (for validation of in silico models 
only). Clearly a truly comprehensive systems biology approach would have to include a significant 
representation of all layers of information, including transcript, protein and metabolite levels. The next 
step in our ‘omics’ workflow will be the integration of gene expression and protein levels with high 
quality metabolomic data, also generated in a multi-strain comparative framework. Integration and 
modeling of all the different ‘omics’ datasets should reveal new properties of the system, and improve 
our understanding wine yeast metabolism in the holistic sense. 
 
But for now, our systems biology study of fermenting wine yeast has proven reasonably comprehensive 
by current standards, and new knowledge and important insights have been established. To summarize, 
by analyzing large comparative transcriptomic datasets of five industrial wine yeast strains we were 
able to identify various genes/gene sets that could be linked with relevant aspects of yeast performance 
in key areas related to flocculation, stress tolerance and metabolism. Our study has shed light on some 
of the underlying molecular factors related to important phenotypic variations between strains, and also 
increased our understanding of metabolic changes that occur during fermentation under wine-making 
conditions. In addition, the research presented in this dissertation has provided new insights for 
improved, targeted engineering strategies aimed at optimizing the performance of wine yeast strains. 
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